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Organisation of thesis  
 
This thesis uses functional magnetic resonance imaging to examine brain activation 
patterns during episodic memory, in individuals at high genetic risk for psychosis with the 
disrupted in schizophrenia 1 (DISC1) t(1;11) translocation, and in patients with 
schizophrenia and patients with bipolar disorder. Overall this thesis spans two main areas 
of study 1) episodic memory in psychosis and 2) genetic imaging and DISC1. For this 
reason two introductory chapters (chapter one and two respectively) are included to cover 
these topics. A further chapter (chapter 3) links these two introductory chapters, provides 
justification for the current work and presents the hypotheses. As the same encoding and 
recognition task was used to study all participants, there is one methodology chapter 
(chapter 4) that covers recruitment, the groups studied, clinical and cognitive measures 
used, and the imaging protocol and analyses. There are two results chapters in this thesis 
investigating episodic memory function in individuals from a Scottish family with and 
without the DISC1 t(1;11) translocation (chapter 5), and healthy controls and patients with 
schizophrenia and bipolar disorder (chapter 6). Finally, chapter 7 provides an overall 
synthesis of the results presented in this thesis, with limitations and future research 
considerations. 
 
The main aim of this study was to investigate the effect of the t(1;11) translocation by 
comparing functional activation during an encoding and recognition memory task in 
translocation carriers and non-carriers from a Scottish family. The impact of this 
translocation on brain imaging measures is largely unknown, however this family offers a 
unique opportunity to examine the effects of this translocation. Healthy controls and 





patients with schizophrenia and bipolar disorder were recruited to compare the effects of 
the t(1;11) translocation to the effects of a having a psychiatric illness, while minimising 
key confounds. The analysis plan was therefore to examine the effects of the translocation 
in carriers and non-carriers, and then to relate any findings to controls versus patients with 
schizophrenia and bipolar disorder. A direct comparison between the translocation carriers 
and patients was not warranted given differences in degrees of relatedness and shared 
environmental effects between groups. 
 
Data for this thesis was collected as part of a wider multimodal imaging study, the Scottish 
Family Mental Health Study (SFMHS), which is a major third wave follow-up of the 
original Scottish pedigree. This study aims to investigate what effect the t(1;11) 
translocation has on brain structure, chemistry and function by comparing individuals with 
and without the translocation. Data was collected from five groups of participants; healthy 
controls, family members (with and without the translocation), patients with schizophrenia 
and patients with bipolar disorder. My primary role in this study was to analyse functional 
imaging data for the encoding and recognition task. I was also involved in recruitment, 
arranging study appointments, collecting and documenting cognitive and functional 


















A key feature of many psychiatric disorders, including schizophrenia and bipolar disorder, 
are pervasive deficits in several domains of cognition. Episodic memory is one of the most 
consistently observed cognitive deficits exhibited by patients with schizophrenia, and can 
be a predictor of overall functional outcome. Several neuroimaging studies have assessed 
episodic memory in psychosis, however the neural mechanisms underlying this deficit 
remain somewhat unclear. Studying the impact of rare genetic variants of large effect can 
offer a powerful method to further our understanding of the pathophysiology of psychiatric 
disorders. One such gene, DISC1 (Disrupted in Schizophrenia 1) is a putative susceptibility 
gene for a spectrum of major psychiatric disorders such as schizophrenia, bipolar disorder 
and major depression. DISC1 was originally identified in a large Scottish pedigree, in 
which it is disrupted by a balanced translocation between chromosomes 1 and 11, and this 
translocation confers a dramatically increased risk of major psychiatric disorder. However, 
the impact of this translocation on brain imaging measures is largely unknown. The rarity 
of this variation results in small group numbers for analysis, however rare variants are likely 
to have large neural effects. This thesis offers a unique investigation into the effects of the 
t(1;11) translocation, by examining fMRI of members of the original Scottish pedigree.  
 
Four groups of participants; 19 family members (8 with the translocation, 11 without), 30 
patients with schizophrenia, 11 patients with bipolar disorder and 40 healthy controls 
underwent a functional MRI episodic memory encoding and recognition paradigm. Data 
processing and statistical analyses were performed using the standard approach in SPM8. 
The primary aim of this work was to investigate functional activation during episodic 





memory in individuals with and without the translocation, to examine the impact of the 
t(1;11) translocation. Analyses were also performed to examine differences between 
controls and patients with schizophrenia and bipolar disorder, to compare the effects of the 
translocation to the effects of a having a psychotic illness. 
 
During encoding of neutral scenes, translocation carriers showed greater activation of the 
left posterior cingulate, right fusiform gyrus and right superior frontal gyrus compared to 
non-carriers. During recognition, carriers showed greater activation in the right fusiform 
gyrus, left posterior cerebellum, right superior temporal gyrus, left anterior cingulate, right 
ventrolateral prefrontal cortex (VLPFC) and right dorsolateral prefrontal cortex (DLPFC). 
For both contrasts, no regions were found to be more active in family members without the 
translocation when compared to carriers. There were no significant differences between the 
groups in terms of their performance or reaction time on encoding and recognition 
conditions. 
 
Compared to healthy controls, patients with schizophrenia demonstrated increased 
activation during encoding in the inferior parietal lobe bilaterally, and decreased activation 
during recognition in a region encompassing the caudate nucleus and anterior cingulate 
cortex. Patients with bipolar disorder showed no difference in activation compared to 
controls during encoding, and increased activation during recognition in a region 
encompassing the caudate and anterior cingulate, extending to the inferior frontal lobe and 
insula. There was also a significant difference between patients with schizophrenia and 
bipolar disorder during recognition, with patients with bipolar disorder again showing 
increased activation in the caudate extending to the anterior cingulate cortex. These 





findings support previous research suggesting overactivation of fronto-limbic and striatal 
structures including the anterior cingulate and caudate in bipolar disorder, with a relative 
underactivation in schizophrenia. 
 
This thesis presents the first evidence of functional alterations during episodic memory in 
association with the translocation, primarily in fronto-temporal regions. Brain regions that 
were over activated in translocation carriers have been shown to be involved in memory 
encoding and recognition, and are known to be affected in patients with major psychiatric 
disorders and unaffected relatives. Family members with the translocation demonstrated a 
more similar pattern of activation during recognition to patients with bipolar disorder 
compared to schizophrenia, perhaps due to the fact that most diagnoses in the carriers were 
of an affective disorder rather than a schizophrenia-related psychosis. Based on these 
findings it can be argued that the translocation has an influence on brain activations in areas 
associated with episodic memory processes. These findings begin to provide a better 
understanding of the neural effects of the t(1;11) translocation, and highlight the 












































Brain imaging is an important tool in trying to understand why some people develop mental 
health conditions whereas others do not. Functional magnetic resonance imaging can 
measure the way the brain functions during tasks that measure different aspects of 
cognition. Cognition is crucial for understanding and making sense of the world and 
includes thinking, learning and memory. Episodic memory, which is our ability to 
remember information about events in our lives, has been shown to be poorer in both 
patients with schizophrenia and with bipolar disorder. It has also been shown to negatively 
affect people’s living status, occupation and overall quality of life.  
 
This thesis is spilt into two parts. The first looked at members of a Scottish family, some 
who have a higher than usual risk of developing a mental health disorder, such as 
schizophrenia or bipolar disorder, because of a rare change in their genetic makeup. This 
work aimed to test whether this genetic change causes the brain to function differently 
during a task of episodic memory. It was found that this genetic variation was associated 
with greater activation in frontal and temporal parts of the brain. These brain regions have 
previously been shown to be linked to episodic memory and are known to be abnormal in 
patients with schizophrenia and bipolar disorder. However, it is important to note that all 
individuals with this rare genetic variant that took part had a diagnosis of an affective 
disorder, such as depression.  
 
The second part of this thesis looked at patients with schizophrenia, patients with bipolar 
disorder and individuals with no background of mental illness, and compared how these 
groups performed during the same memory task. People with a mental illness showed 





different patterns of brain activation compared to healthy individuals. There was also a 
difference between the patient groups; individuals with schizophrenia showed a pattern of 
underactivation in the caudate and anterior cingulate cortex, whereas patients with bipolar 
disorder showed overactivation in these regions. These findings highlight how functional 
imaging techniques can help us to understand the changes in how the brain works that 






















































Chapter 1: Episodic memory in psychosis  
This chapter introduces the different psychiatric disorders examined in this thesis, namely 
schizophrenia and bipolar disorder. It will also discuss the basic principles of the imaging 
technique used, that of functional magnetic resonance imaging (fMRI). It will then go on 
to discuss episodic memory in psychosis, providing a background on episodic memory 




Schizophrenia is a severe and debilitating psychiatric disorder with a lifetime prevalence 
of ~1% and is a major public health concern with a high cost for society. It is characterised 
by the presence of positive or psychotic symptoms, negative symptoms and cognitive 
dysfunction. Examples of psychotic symptoms include hallucinations and delusions, such 
as hearing or seeing things that are not there, or holding unusual beliefs that may seem 
irrational to others. Psychotic symptoms are characteristics of several psychiatric 
conditions including schizophrenia, schizoaffective disorder and bipolar disorder. Negative 
symptoms are a loss of normal functions such as lack of motivation, blunted affect and 
withdrawal from usual societal roles, and usually respond less well to medication (Murphy 
et al., 2006). Schizophrenia can be described as a polythetic disorder, in that no single 
characteristic is essential for a diagnosis and there are a wide range of heterogeneous 
symptoms that differ between individuals. 
 






Figure 1.1: DSM-5 diagnostic criteria for schizophrenia  
Source: Diagnostic and Statistical Manual (DSM-5), American Psychiatric Association  
 
1.1.2 Epidemiology and aetiology of schizophrenia 
The typical age of onset of schizophrenia is during adolescence or early adulthood, and 
occurs slightly earlier in males than females. There is also a higher rate of diagnosis in 
males with a male: female ratio of approximately 1.4:1 (Abel et al., 2010). Schizophrenia 
is a highly heritable disorder with heritability of around 80% (Sullivan et al., 2003) and 
therefore has a prominent genetic basis. The risk of developing schizophrenia increases 
exponentially with the degree of genetic relatedness to a relative suffering from it and is as 





high as 50% for monozygotic twins (Sullivan et al., 2003). However, schizophrenia is a 
complex disorder caused by both genetic and environmental factors such as urbanicity, 
advanced paternal age, obstetric complications and substance abuse (Sorensen et al., 2014). 
The genetics of schizophrenia will be discussed in greater depth in the following chapter. 
 
1.1.3 Neuroimaging findings in schizophrenia 
1.1.3.1 Structural imaging  
Abnormalities of brain structure and function are well established in schizophrenia. 
Research into structural abnormalities initially used Computerized tomography (CT) 
techniques, which demonstrated ventricular enlargement and an overall loss of brain tissue 
in patients compared to healthy controls (Johnstone et al., 1976, Lawrie et al., 2004, Raz 
and Raz, 1990). Structural magnetic resonance imaging has since replicated and furthered 
these findings showing additional volume reductions in the thalamus, hippocampus and 
anterior cingulate cortex (Konick and Friedman, 2001, Baiano et al., 2007, Nelson et al., 
1998).  
 
Investigations of brain structure, using diffusion tensor imaging (DTI) to map the diffusion 
of water molecules along white matter tracts, have also identified compromised white 
matter integrity in schizophrenia (Liu et al., 2013b). There is evidence of white matter 
volume or density reductions in a number of regions particularly in the frontal and temporal 
regions (Ellison-Wright and Bullmore, 2009, Samartzis et al., 2014). Deficits have also 
been identified in the anterior limb of the internal capsule (Shenton et al., 2001, Sussmann 
et al., 2009), left inferior longitudinal fasciculus and left inferior fronto-occipital fasciculus 
(Liu et al., 2013b). 





1.1.3.2 Functional imaging 
There has been a rapid increase over the past few decades in the use of fMRI to explore 
neural systems related to behavioural and cognitive deficits in patients with schizophrenia. 
Functional studies have reported abnormal activity in a wide range of tasks including 
memory, attention, word fluency and emotional processing (Gur and Gur, 2010), and 
during resting state  (Argyelan et al., 2013). 
 
1.1.3.3 Hypofrontality  
Early functional imaging studies suggested that a primary deficit of schizophrenia was a 
failure to activate the prefrontal cortex (PFC) (Ingvar and Franzén, 1974). This emphasis 
on hypofrontality has since been revised and findings to support this hypothesis are less 
consistently reported when controlling for task performance. A complex pattern of hyper 
and hypoactivation has now been demonstrated and it is understood that underactivation in 
patients who have difficulty performing a cognitive task may reflect a deficit in the 
underlying systems related to that task or a lack of engagement (Gur et al., 2007, Lawrie et 
al., 2008). 
 
1.1.3.4 Dysconnectivity  
One possible synthesis of the literature is the dysconnectivity hypothesis of schizophrenia 
(Friston and Frith, 1995). This suggests that schizophrenia occurs as a result of abnormal 
connectivity between different parts of the brain, particularly between the PFC and other 
structures including the temporal lobe, thalamus, and striatum. Dysconnectivity between 
regions is also thought to underlie cognitive abnormalities in schizophrenia. Functional and 
structural dysconnectivity are among the most replicable findings associated with 





schizophrenia (Schmitt et al., 2011), suggesting that brain dysconnectivity may be a 
plausible endophenotype for schizophrenia (White and Gottesman, 2012). 
 
1.1.4 Bipolar disorder 
Bipolar disorder is considered a primary disorder of mood, defined by episodes of mania 
and depression and characterized by recurring affective episodes. Symptoms of mania 
include racing thoughts, a decreased need for sleep, impulsivity and risky behaviour. These 
symptoms are accompanied by changes in activity levels and lead to marked disturbance 
of behaviour and function. There are different types of bipolar disorder depending on the 
duration and pattern of these affective symptoms. Elevated mood is more severe and 
sustained (mania) in bipolar I disorder and less severe with a lower level of disturbance 
(hypomania) in bipolar II disorder.  
 
Affective symptoms are also accompanied by deficits in cognitive processes, with the 
greatest impairment in verbal learning, memory, attention and executive processing 
(Robinson et al., 2006, Torres et al., 2007, Balanzá-Martínez et al., 2008). Symptoms of 
psychosis are also common in patients with bipolar disorder, with studies reporting up to 
68% of patients with the illness experiencing psychotic symptoms in their lifetime (Keck 
et al., 2003). There is substantial heterogeneity in the phenotype of bipolar disorder that 










Bipolar disorder diagnostic criteria DSM-5 (2014) 
Bipolar I disorder  
- Current or recent major depressive episode 
- One or more previous manic episode or mixed episode  
- The mood symptoms are not due to the direct physiological effects of a substance 
(a drug of abuse, medication or other treatment) or a general medical condition 
- The mood episodes are not better accounted for by Schizoaffective Disorder and 
are not superimposed on Schizophrenia, Schizophreniform Disorder, Delusional 
Disorder, or Psychotic Disorder Not Otherwise Specified 
 
Bipolar II disorder 
- Presence or history of one or more major depressive episodes  
- Current or history of at least one hypomanic episode  
- No history of manic episode or mixed episode 
- Mood symptoms not due to schizoaffective disorder or part of other disorders such 
as schizophrenia, schizophreniform disorder, delusional disorder, or psychotic 
disorder not otherwise specified 
- Symptoms cause significant distress as well as impairment in social occupational 
or other areas of functioning 
 
Figure 1.2: Summary of DSM-5 diagnostic criteria for Bipolar disorder 
 
1.1.5 Epidemiology and aetiology of bipolar disorder 
Bipolar disorder is usually shown to have an overall lifetime prevalence of around 1 % in 
the general population (Bauer and Pfennig, 2005). A recent worldwide study found a 
median age of onset of about 25 years, with a lifetime prevalence of 0.6% for bipolar I 
disorder (more common in males) and 0.4% for bipolar II disorder (with a female 
predominance) (Merikangas et al., 2011). 
 
Although the exact aetiology of bipolar disorder remains unknown, genetic 
epidemiological research (family and twin studies) supports a strong genetic component to 





the illness, with heritability estimates as high as 89–93% (McGuffin et al., 2003). Genome 
wide association studies (GWAS) have also identified several common polymorphisms 
linked to bipolar disorder, including variants within CACNA1C, ODZ4, and NCAN, and 
robust evidence suggests there is a polygenic contribution to risk for the illness (Craddock 
and Sklar, 2013). 
 
1.1.6 Neuroimaging findings in bipolar disorder 
There are fewer imaging studies of bipolar disorder compared to schizophrenia, which has 
resulted in less consistency and somewhat contradictory findings. As bipolar disorder is 
classified as a disorder of mood, it has been proposed that the brain systems most likely to 
underline this illness involve regions that modulate emotional control (Mayberg, 1997). 
These networks include ventral prefrontal networks and limbic brain regions including the 
amygdala. Neuroimaging findings support dysfunction of the structure, function and 
connectivity of these networks (Strakowski et al., 2012).  
 
1.1.6.1 White matter abnormalities in bipolar disorder 
White matter abnormalities have been demonstrated in bipolar disorder, however they tend 
to be less severe and involve fewer brain regions compared to schizophrenia (Skudlarski et 
al., 2013, Lu et al., 2011). White matter density and volume reductions have mainly been 
found in prefrontal and limbic regions supporting the model that bipolar disorder involves 
dysconnectivity in regions supporting emotion regulation (Mahon et al., 2010). White 
matter integrity reductions have also been identified in unaffected relatives with bipolar 
disorder, suggesting this could be a potential endophenotype for this illness (Sprooten et 
al., 2011a). Several studies have also found abnormal connectivity within a fronto-limbic 





pathway that may be an imaging marker in patients with bipolar disorder (Anand et al., 
2009, Chepenik et al., 2010, Öngür et al., 2010, Chai et al., 2011). 
 
1.1.6.2 Overactivation of medial temporal lobes and limbic regions  
As bipolar disorder is classified as a disorder of mood, research has usually focused on 
paradigms involving emotional stimuli known to activate these regions, in which patients 
typically show overactivation of limbic and medial temporal lobe (MTL) structures 
compared to healthy controls (Hall et al., 2009, Malhi et al., 2004, Whalley et al., 2011). It 
has been suggested that this overactivation reflects an oversensitive system for determining 
the emotional importance of stimuli. This is consistent with reports that patients tend to 
identify stimuli as emotional rather than neutral, which may consequently may produce 
dysfunctional affective states as seen in this illness (Phillips et al., 2003). In comparison 
there is a reported underactivation in patients with schizophrenia, for example during facial 
affect processing (Delvecchio et al., 2013).  
 
As previously mentioned, deficits in nonemotional, cognitive processes such as memory 
are also highly prevalent in this population. Comparatively few studies have examined the 
neural correlates of these deficits and whether limbic brain areas also show this pattern of 
abnormal overactivation during nonemotional, cognitive tasks. A recent study by Gruber 
et al. (2010) demonstrated hyperactivation of the amygdala in response to a non-emotional, 
working memory task (Gruber et al., 2010). However, due to the limited number of studies, 
overall findings are inconclusive demonstrating hyper and hypo-activations in prefrontal 
regions (including orbitofrontal cortex, medial prefrontal cortex including the anterior 





cingulate region, and dorsolateral prefrontal cortex) as well as in the basal ganglia 
(Blumberg et al., 2003c, Strakowski et al., 2005, Gruber et al., 2004). 
 
1.1.7 Overlap between schizophrenia and bipolar disorder 
Bipolar disorder and schizophrenia are considered separate disorders, however convergent 
genetic, neuroimaging and clinical evidence indicate both overlap and discontinuity 
between them. Although affective symptoms (depression and mania) are more 
characteristic of bipolar disorder and psychotic symptoms are primary to schizophrenia, 
both types of symptoms can occur in individuals with either diagnosis. The extent to which 
common and distinct neural mechanisms underlie these symptoms and syndromes remains 
unclear, however functional brain imaging could offer a greater understanding of the 
biological basis of symptoms in these disorders. 
 
Whalley et al. (2012) conducted a review of the fMRI literature to examine the evidence 
for diagnosis-specific patterns of brain activation in these two patient groups (Whalley et 
al., 2012b). Activation differences were found in the MTL and associated limbic regions, 
with additional limited evidence for the lateral PFC. These results suggest there are 
differences in the neurobiological substrates of schizophrenia and bipolar disorder, and 
functional neuroimaging may have utility as biomarkers to distinguish between disorders. 
 
Hall et al. (2010) compared patients with schizophrenia and bipolar disorder during an 
encoding and retrieval face-name pair memory task and were able to distinguish between 
disorders at a group level using fMRI by differences in hippocampal and PFC activation 
(Hall et al., 2010). During encoding patients with schizophrenia showed decreased anterior 





hippocampal activation and patients with bipolar disorder showed decreased dorsal PFC, 
relative to each other. These findings suggest a differential dysregulation of fronto-
temporal neural systems in these disorders. 
 
To generalise overall findings from the functional imaging literature in both disorders, it 
appears that there is an overactivation of MTL structures in bipolar disorder, and an 
underactivation of these structures in schizophrenia (Strakowski, 2012). However, there are 
a limited number of functional imaging studies reporting direct comparisons between the 





















1.2 Functional neuroimaging – functional magnetic resonance imaging (fMRI)  
Functional magnetic resonance imaging is a methodological technique that allows images 
to be taken of the brain in vivo in order to measure brain activity by detecting changes in 
cerebral blood flow associated with neural activity. Over the past few decades fMRI has 
made substantial advances in the field of neuroscience, furthering our understanding of 
brain systems underlying specific behavioural deficits in schizophrenia. fMRI has become 
a dominant method in this field as it provides a non-invasive method with good spatial 
resolution, without the need for ionising radiation in contrast to other imaging techniques 
such as CT or positron emission tomography (PET). 
 
1.2.1 Magnetic resonance imaging 
Magnetic resonance imaging (MRI) can be used to create detailed images of tissues and 
structures in the brain, using a strong magnetic field and radio waves. Protons, present in 
water molecules within our bodies, align with the direction of the magnetic field in the 
scanner. When radio waves (RF pulse) are applied at the appropriate frequency, this 
changes the orientation of the spins as the protons absorb energy. When the RF pulse is 
stopped, the protons return to their original orientation and emit energy in the form of radio 
waves. This process causes a change in voltage and is detected using a coil placed around 
the head of the individual in the scanner.  
 
Radio waves can be manipulated to change the contrast of the image acquired and can be 
T1 or T2 weighted. T1 is the longitudinal relaxation time and refers to the time it takes for 
the protons to realign with the magnetic field. T2 is the transverse relaxation time and is a 
measure of how long the protons remain in phase following a RF pulse. T2 decay is due to 





magnetic interactions that occur between spinning protons and unlike T1 interactions, do 
not involve a transfer of energy but only a change in phase. As a result of these different 
relaxation measures, tissues appear different for example water appears bright in T1 
weighted images but dark in T2 weighted images. fMRI uses acquisition techniques e.g. 
echo planar imaging (EPI) that are sensitive to changes in T2. EPI is capable of significantly 
shortening MRI acquisition time and reduces motion artefact, making it ideal for the 
application of fMRI. 
 
1.2.2 Basic principles of fMRI 
fMRI works by exploiting the fact that oxygenated and deoxygenated blood possess 
different magnetic properties (Pauling and Coryell, 1936). Haemoglobin is diamagnetic 
when oxygenated (oxyhaemoglobin) but paramagnetic when deoxygenated 
(deoxyhaemoglobin), and this leads to differences in the MR signal (areas with a greater 
concentration of oxyhaemoglobin will produce a higher signal and thus a brighter image). 
fMRI works on the principle that when a brain area is actively engaged the metabolic 
requirements of neurones increases, and this demand for energy causes vasodilation of local 
vessels resulting in increased cerebral blood flow to the region. There is also an increase in 
oxygen consumption, however the increase in oxygen supply exceeds the local demand for 
oxygen, resulting in an increased level of oxyhaemoglobin and a relative reduction of 
deoxyhaemoglobin (Fox and Raichle, 1986). 
 
1.2.3 The BOLD signal and haemodynamic response function 
There are different fMRI techniques that can detect a functional signal, however Blood 
oxygenation level-dependent (BOLD) fMRI, as discovered by Seiji Ogawa, is the most 





widely applied method in fMRI research. The BOLD signal relies on the level of 
deoxyhaemoglobin in the blood. Deoxyhaemoglobin distorts the magnetic field in the 
scanner and causes changes in the MR decay parameter T2*, leading to image intensity 
changes in T2* weighted images (the presence of deoxyhaemoglobin shortens the T2* 
relaxation time).  
 
BOLD signal changes are a dynamic process and are characterised by the haemodynamic 
response function (HRF) (see figure 1.4). There is typically an initial decrease in blood 
oxygenation immediately following exposure to stimuli known as the initial dip (Yacoub 
et al., 2001). This initial phase is hypothesised to originate from a rise in local 
deoxyhemoglobin due to an increase in metabolism as the neurons rapidly consume any 
available oxygen. This initial dip is not consistently reported and is more commonly 
observed at higher field strengths of >3T (Yacoub et al., 2001). This is followed by a 
dramatic increase in the supply of oxygenated blood, far more than is necessary, peaking 
at approximately 2s and lasting around 4s after stimulus onset. This is sustained for a short 
period of time before the blood oxygen concentration returns to pre-stimulus levels, which 
can take from 20s to up to 60s (Kwong et al., 1992). Some studies also report a post stimulus 
undershoot before levels return to baseline, which reflects an increase in local 
deoxyhaemoglobin that is hypothesized to be due to continued high metabolic demand of 











Figure 1.3: The haemodynamic response and BOLD signal  
 
Illustration of the steps involved in an fMRI experiment based on the episodic memory 
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Figure 1.4: Illustration of the BOLD haemodynamic response function  
 
 
1.2.4 Limitations of fMRI 
These changes in blood oxygenation mean that the temporal resolution of fMRI is relatively 
poor (takes seconds) compared to the speed of neuronal activation (in milliseconds). 
Therefore, the BOLD signal is only an indirect measure of brain activity and understanding 
the underlying neurophysiology of fMRI is essential when interpreting data. There are 
further limitations of fMRI including movement, low signal to noise ratio, and due to the 
strong magnetic field individuals with metallic implants cannot be scanned. fMRI is also 
prone to signal loss in regions with large differences in magnetic susceptibility for example 
at air-tissue boundaries such as the frontal lobes which are adjacent to air filled sinuses. 
This can produce susceptibility artefacts (Lipschutz et al., 2001).  
 
1.2.4.1 Movement  
One of the main problems of fMRI research is subject movement in the scanner, and this 
can be particularly challenging when studying patient populations. Head movement in the 
scanner can result in a specific voxel within an image not corresponding to the same 





location in the brain throughout the scan session. The standard realignment pre-processing 
stage in Statistical Parametric Mapping software (SPM) aims to realign all images in one 
session to a predefined scan, for example the first or mean volume in the series. Even after 
pre-processing excessive movement can still compromise the integrity of the data and can 
lead to exclusion of data from the analysis. Data loss due to this is especially problematic 
when working with rare patient groups such as the Scottish kindred in the research 














Figure 1.5: Within scanner movement for one subject 
 
This figure demonstrates the movement from a subject scanned as part of the current 









1.3 Episodic memory  
1.3.1 Cognitive function in psychosis 
As previously mentioned, schizophrenia is a severe and debilitating psychiatric disorder 
usually characterised by the presence of psychotic symptoms, primarily hallucinations and 
delusions, and negative symptoms such as blunted affect and social withdrawal. However, 
it is now widely accepted that schizophrenia is also characterised by pervasive deficits in 
several domains of cognitive function including memory, attention, generalized 
intelligence, and executive functions (Wang et al., 2010). In recent years, there has been an 
increase in research on cognition in schizophrenia, partly due to the notion that cognitive 
function is a primary determinant of overall functional outcome in schizophrenia, perhaps 
more so than the presence of positive symptoms (Nuechterlein et al., 2011). Cognitive 
disturbance is also thought to be an enduring characteristic of schizophrenia that can 
predate illness onset and often persists beyond acute symptom expression (Heinrichs, 
2005). 
 
Schizophrenia is currently classified as a psychotic disorder with the emphasis on psychosis 
as the primary target for diagnosis and treatment. However, there has been a recent debate 
regarding the importance of cognitive underperformance in schizophrenia. It has been 
suggested that the emphasis on psychosis in schizophrenia has resulted in a lack of progress 
in understanding this illness, and defining and treating schizophrenia on the basis of 
psychotic features is too narrow (Kahn and Keefe, 2013). The domain of cognition now 
deserves greater attention to help aid diagnosis and potentially develop new treatments to 
help with cognitive impairment, both pharmacological and non-pharmacological.  
 





The key symptoms seen in bipolar disorder are associated with states of depression such as 
low energy, low self-esteem and suicidal ideation, and states of mania including lessened 
need for sleep, impulsivity and risky behaviour. One of the more overlooked aspects of this 
illness is the degree of cognitive impairment that patients experience. Increasing evidence 
is emerging to disprove the Kraepelinian notion (Kraepelin, 1921) that bipolar disorder is 
not associated with cognitive decline.  A wide range of neurocognitive deficits have been 
observed during episodes of depression and mania (Quraishi and Frangou, 2002). Functions 
including   attention, processing speed, memory, and executive function have also been 
shown to be impaired in euthymic patients with bipolar disorder, reflecting trait features of 
the illness (Torres et al., 2007).  
 
Cognitive deficits in both bipolar disorder and schizophrenia show similarities, however 
tend to be more severe in patients with schizophrenia (Hill et al., 2014). This overlap in 
cognitive impairment across both disorders is in line with the notion that patients do not 
solely fit into a diagnosis of schizophrenia or bipolar, based on classification systems such 
as DSM-5, but instead exist upon a continuum. 
 
1.3.2 Episodic memory in schizophrenia 
Memory is now regarded as one of the key areas of cognitive impairment in schizophrenia, 
with particularly pronounced deficits observed in episodic memory for both encoding and 
retrieval of newly acquired information (Talamini et al., 2010, Danion and Berna, 2007, 
Leavitt and Goldberg, 2009, Lepage et al., 2010). Recent reviews and meta-analyses 
indicate episodic memory tests have among the largest effect sizes in schizophrenia patients 
versus healthy control subjects (Mesholam-Gately et al., 2009, Fioravanti et al., 2005). 





Research suggests that episodic memory deficits cannot be explained by demographic or 
clinical measures and cannot be entirely accounted for by impairments in other cognitive 
domains such as attention or executive functioning (Kopald et al., 2012). 
 
1.3.3 Episodic memory in bipolar disorder  
There is substantially less research on cognitive dysfunction in bipolar disorder compared 
to the literature on schizophrenia, and in the past cognition has been underestimated in this 
patient group. Episodic memory deficits are one of the most consistently reported findings 
in patients with bipolar disorder. There is increasing evidence that patients with bipolar 
disorder exhibit episodic memory impairments during both acute episodes (Quraishi and 
Frangou, 2002) and the euthymic state (Bourne et al., 2013, Bora et al., 2009, Torres et al., 
2007, Robinson et al., 2006). A key finding in the literature, evident in neuroimaging as 
well as cognitive testing, is that abnormalities found in bipolar disorder are generally less 
severe than those seen in schizophrenia (Whalley et al., 2012b, Seidman et al., 2002, 
Reichenberg et al., 2009). Effect sizes for episodic memory deficits have been found to be 
large for patients with schizophrenia (range 1–1.27) and moderate to large for patients with 
bipolar disorder (range 0.59–0.85) (Skelley et al., 2008, Bora et al., 2009, Lefèbvre et al., 
2010, Glahn et al., 2007a).  
 
1.3.4 What is episodic memory? 
The concept of episodic memory was introduced by Endel Tulving (Tulving, 1985) and can 
be defined as a form of declarative memory that consists of the ability to store and recall 
information about a seemingly endless series of episodes and events. Well-researched 
memory classification schemes have identified two types of long-term memory; declarative 





memory and non-declarative memory. Declarative memory encompasses both episodic 
memory for events and semantic memory for general factual knowledge, whereas non-
declarative memory is an implicit process that enables us to perform common tasks without 
conscious thought. Episodic memory can be distinguished from other forms of memory in 
terms of its ability to encode and store information about the spatial and temporal contexts 
of events i.e. what happened, in addition to where and when it happened. The ability to 
create accurate episodic memories of past events depends on the integration of different 
inputs of information about an event (Tulving, 1972).  
 
1.3.4.1 Encoding strategy  
The episodic memory system can be divided into three different stages; encoding, storage, 
and retrieval processes. There is substantial evidence to suggest that episodic memory 
dysfunction is primarily due to abnormalities at the encoding stage (Gold, 2004, Danion 
and Berna, 2007, Cirillo and Seidman, 2003, Talamini et al., 2005). For example, it has 
been proposed that individuals with schizophrenia fail to spontaneously engage in efficient 
elaborative processing during encoding and have an inability to spontaneously organize to-
be-remembered information (Koh and Peterson, 1978). Patients with bipolar disorder also 
appear to rely less on organizational strategies during encoding and this may offer an 
explanation for episodic memory impairments in this patient group, rather than deficits in 
the retention of information (Deckersbach et al., 2004a). 
 
Patients appear to process stimuli on a more superficial level and do not instinctively use 
semantic processing to assist encoding and retrieval (Ragland et al., 2001). However, 
research has demonstrated that patients are able to use elaborative strategies during 





encoding when they are explicitly instructed to do so and show recognition memory 
improvements when encouraged to use specific encoding strategies (Bonner-Jackson et al., 
2008). This suggests that episodic memory impairment can be somewhat alleviated and 
encoding strategies should perhaps be the focus of cognitive remediation therapies. 
Although most research supports a deficit at the encoding stage, evidence suggests that 
retrieval processing may not be entirely intact (Gold et al., 2000, Talamini et al., 2010). 
 
1.3.4.2 Context memory deficit  
Several theories have proposed there is a binding deficit in schizophrenia whereby 
contextual elements of an event are poorly linked during the encoding process (Waters et 
al., 2004). The context memory deficit theory suggests that patients encode and store 
certain information about what happened during an event relatively normally but have 
difficulty linking this with contextual components to form an intact memory representation 
(Rizzo et al., 1996, Ledoux et al., 2013). Therefore, patients are more likely to retrieve 
individual components of an event in isolation and have a more fragmented overall 
recollection of an experience.  
 
Patients with schizophrenia have also been found to exhibit deficits in reality-monitoring 
tasks that involve distinguishing whether information is self-generated or the result of an 
external source. Some theories regarding auditory hallucinations in psychosis suggest that 
these symptoms may occur because patients fail to recognise thoughts and memories as 
internal cognitive functions (Bentall et al., 1991).  
 





Contextual binding is associated with the function of medial temporal regions, including 
the hippocampus (Eichenbaum et al., 2007, Konkel and Cohen, 2009) and one of the most 
robust findings in schizophrenia is abnormal hippocampal structure and function (Weiss et 
al., 2005, Jessen et al., 2003). The hippocampus may reinforce newly encoded information 
by binding it with associations during encoding (Achim and Lepage, 2005). 
 
1.3.4.3 Core cognitive deficit or distinct episodic memory deficit 
A challenge researchers face in understanding the nature of episodic memory deficits in 
psychosis is whether such impairments are a distinct deficit with its own psychological and 
neural pathophysiology, or whether they share a common core mechanism with other 
cognitive domains such as working memory, language function, executive function, 
processing speed and attention (Barch and Ceaser, 2012). Many have argued that a common 
impairment in proactive control and the maintenance of goal representations contributes to 
a variety of cognitive deficits. At the neural level it has been suggested that abnormalities 
in the function and connectivity of the dorsolateral prefrontal cortex (DLPFC) and the 
influence of neurotransmitter systems, such as dopamine, GABA and glutamate (Lesh et 
al., 2011, Barch and Ceaser, 2012) contribute to a wide range of cognitive deficits. 
 
For example, Raganath et al. (2003) found a substantial degree of overlap in the prefrontal 
regions (dorsolateral prefrontal, ventrolateral and middle frontal gyrus) activated during 
both working memory and episodic long-term memory, suggesting that the same PFC 
regions support different cognitive functions (Ranganath et al., 2003). Other researchers 
highlight the independence of episodic memory and other cognitive functions, both in 





performance on various tasks and the brain regions supporting them (Cirillo and Seidman, 
2003). 
 
Schizophrenia is a complex psychiatric disorder and it would be an oversimplification to 
conclude that a single common mechanism could account for the wide range of cognitive 
impairments experienced by this patient population. Despite this, identifying a core 
mechanism that is central to at least a subset of deficits may act as a target for therapeutic 
interventions that could serve to broadly enhance cognitive function and overall outcome 
in these patients (Barch and Ceaser, 2012). 
 
1.3.4.4 Inter-individual variability in episodic memory deficits  
On the whole, the literature suggests that episodic memory is a cognitive domain that is 
robustly impaired in schizophrenia and bipolar disorder, however findings can be equivocal 
and a considerable degree of inter-individual variability exist (Leavitt and Goldberg, 2009). 
Methodological differences between studies may be partly responsible for this discrepancy, 
for example the use of verbal or nonverbal paradigms. Some studies report greater 
impairment in patients when using visual memory tasks (Heinrichs and Zakzanis, 1998), 
whereas others have found more reliable impairment using verbal memory stimuli (Cirillo 
and Seidman, 2003). 
 
One study found differential episodic memory deficits depending on the task material used 
(Tracy et al., 2001). They found that deficits were primarily limited to encoding during the 
non-verbal task, whereas retrieval and encoding processes were disrupted during the verbal 
task, suggesting a material-specific deficit for retrieval. The majority of reports of episodic 





memory impairments in schizophrenia have involved verbal measures such as words or 
narrative stories, whereas much less is known about the status of episodic memory for non-
verbal material. The majority of research on episodic memory in bipolar disorder has also 
focused on the verbal domain, however patients with bipolar disorder have been shown to 
exhibit deficits in both verbal and non-verbal episodic memory (Deckersbach et al., 2004a, 
Deckersbach et al., 2004b). Episodic memories are often stored non-verbally as visual 
representations, therefore an exclusive use of verbal paradigms is not sufficient to examine 
the full picture of episodic memory impairment in psychosis (Conway, 2009). 
 
1.3.4.5 Functional outcome 
Episodic memory deficits can be observed in approximately 75-80% of patients with 
schizophrenia (Weickert et al., 2000, Holthausen et al., 2002) and are a significant predictor 
of poor outcome. Cognitive impairments often emerge prior to psychotic symptoms, are 
relatively consistent over time and are less responsive to antipsychotic medication (Mishara 
and Goldberg, 2004). Recent reviews of cognitive function in schizophrenia have 
consistently shown that episodic memory deficits are associated with poor functional 
outcome including work performance, social adaptation, and overall quality of life (Green 
et al., 2000). Therefore, it is important to further our understanding of episodic memory 
impairment in schizophrenia in order to develop treatments such as cognitive remediation 
or pharmacological interventions that are likely to improve cognition and functional 
outcome in patients (Nestor et al., 2007). It is likely that cognitive remediation of episodic 
memory would be most effective by encouraging patients to use efficient encoding 
strategies (Danion and Berna, 2007). 
 





Cognitive deficits have also been shown to adversely affect functional outcomes in bipolar 
disorder. Cognitive factors contribute to psychosocial outcome in bipolar disorder and 
dysfunction is most evident in low-functioning patients, with verbal memory as the greatest 
predictor of functioning (Martinez‐Aran et al., 2007). This highlights the importance of 
acknowledging cognition in terms of treatment and long-term management of bipolar 
disorder.  
 
1.3.5 Confounding factors  
Episodic memory and underlying brain activation can be affected by many confounding 
factors including but not limited to age, attention, medication, duration of illness and 
symptomatology. It is therefore important to consider these when designing, running and 
analysing fMRI results. This section will discuss several of these confounds and how the 
current study will aim to control for them.  
 
1.3.5.1 Medication 
When studying psychiatric populations, effects of medication are an important confound to 
consider. Antipsychotic medications have been shown to affect the BOLD signal during 
performance of a variety of cognitive paradigms. Antipsychotic drugs may affect the BOLD 
signal in several ways such as modification of neurons or cerebral blood flood, which 
further complicates the biological interpretation of the BOLD signal (Abbott et al., 2013). 
Specifically, studies have shown that antipsychotic medication effects are in general likely 
to have a normalising effect on brain function in patients across a range of cognitive tasks. 
However, this may depend on the type of antipsychotic medication for example if they are 
first or second generation antipsychotics (Ettinger et al., 2011). 





A review by Ragland et al. (2009) examining functional imaging studies of episodic 
memory in schizophrenia reported that the majority of studies included patients who were 
receiving antipsychotic medication. However, when examining the few studies that only 
included unmedicated patients, similar patterns of activation in prefrontal, cingulate, 
thalamic and cerebellar regions were found to those studies of medicated patients. These 
results are reassuring, however it is still important to try and account for the effects of 
antipsychotic medication.  
 
One-way to avoid the confounds of antipsychotic medication is to investigate unaffected 
relatives, who share some of the genetic risk without illness-related confounds. Several 
studies have investigated episodic memory in first-degree relatives and found similar 
activation patterns to that of patients with schizophrenia (Reichenberg and Harvey, 2007, 
Whyte et al., 2005).  
 
Some of the patients in the current study were on a mood stabilizer (two individuals with 
schizophrenia and eight with bipolar disorder). Mood stabilizers, particularly lithium, have 
been shown to cause cognitive deficits primarily in tests of memory (Pachet and 
Wisniewski, 2003). A review examining medication effects in neuroimaging studies of 
bipolar disorder concluded that both antipsychotics and lithium either had no significant 
effect, or an ameliorative effect on abnormal functional neuroimaging measures, so that 
bipolar patients more closely resembled healthy controls (Phillips et al., 2008). A further 
study found that the effect of lithium was task, region and state-dependent. For example, 
there was no effect of lithium on working memory brain activation in both euthymic and 
depressed bipolar patients, however there was an effect during a word generation task but 





only in euthymic patients (Silverstone et al., 2005).  
 
1.3.5.2 Age 
Episodic and working memory appear to be the forms of memory that are most affected by 
ageing. Behavioural studies have shown that deficits in episodic memory are evident at 
both the encoding and recognition stage. There is also evidence that healthy ageing is 
associated with impaired memory functioning using functional brain imaging techniques. 
Age related changes have been reported in the PFC and MTL regions. In general studies 
report an age-related reduction in lateralization in the PFC (specifically reduced left PFC 
activity), and a reduction of activity in the MTL during episodic memory (Daselaar et al., 
2007). Therefore, it is important to try and match groups being studied as closely as possible 
in terms of age.  
 
1.3.5.3 Duration of illness and symptomatology 
There may be an effect of the duration of illness on episodic memory-related brain 
activation in patients. A longer period of illness has been linked with poorer performance 
on several cognitive tests including visual memory tasks in patients with schizophrenia 
(Cuesta et al., 1998). There is also evidence of an association of illness duration with 
structural brain changes, such as increased ventricles and decreased frontal lobe volume 
(Tomelleri et al., 2009). One study found sex-specific associations with illness duration and 
working memory activity for patients with schizophrenia, specifically illness duration 
correlated with reduced DLPFC activity in males and decreased activation of the 
cerebellum in females (Elsabagh et al., 2009). However, another study by Brandt et al. 
(2014) investigating functional activation patterns in schizophrenia and bipolar disorder 





compared to healthy controls found that there was no effect of illness duration on large-
scale brain networks associated with working memory (Brandt et al., 2014). 
 
As previously discussed schizophrenia is characterised by the presence of positive and 
negative symptoms, which differ considerably between patients. These symptoms may 
have an impact on memory performance and beyond that, an effect on underlying brain 
function. A study by Zierhut et al. (2010) used a declarative memory fMRI task to 
investigate the role of hippocampal dysfunction and positive symptoms in schizophrenia. 
They found that reduced performance was correlated with positive symptoms as measured 
by the PANSS, which was in turn linked to increased hippocampal activation during 
successful encoding (Zierhut et al., 2010). The authors conclude that these results suggest 
that patients with greater positive symptomatology may need to recruit additional neuronal 
activity to compensate for dysfunctional memory encoding. On the other hand, negative 
symptoms were not found to be associated with behavioural performance or functional 
activation in this study. Other research has reported a relationship between negative 
symptoms and prefrontal lobe dysfunction during memory and other cognitive functions 
(Mattson et al., 1997, Menon et al., 2001a). In addition to positive and negative symptoms, 
depressive symptoms have been linked to dysfunctional memory processing in patients 
with schizophrenia (Brebion et al., 1997, Möser et al., 2006), and so in the current study a 
measure of depressive symptoms, the HDRS, was included in the clinical assessment 









Bipolar disorder is considered a primary disorder of mood, defined by episodes of mania 
and depression. However, patients with bipolar disorder can be regarded as euthymic, 
which is defined as a relatively stable mood state, neither manic/hypomanic nor depressed. 
A wide range of neurocognitive deficits have been observed during episodes of both 
depression and mania (Quraishi and Frangou, 2002). However, there is increasing evidence 
that patients with bipolar disorder exhibit episodic memory impairments during the 
euthymic state, reflecting a trait feature of the illness (Bourne et al., 2013, Bora et al., 2009, 
Torres et al., 2007, Robinson et al., 2006). It has been proposed that bipolar disorder may 
arise from disruption in an anterior limbic network, and overactivation in this brain network 
leaves individuals at risk for mood and cognitive dysfunction, even during the euthymic 
state (Strakowski et al., 2004). Even though all bipolar patients in this study were euthymic 
at time of testing it is still important to consider symptoms of mania and depression by 
including relevant clinical measures.  
 
1.3.5.4 Controlling for confounding variables  
As discussed, these confounding factors can have a significant influence on overall memory 
performance and underlying brain activation, therefore it is important to try to control for 
these as much as possible. In the current study groups were matched as closely as possible 
on several demographic variables including age and gender. Premorbid and current IQ were 
measured to test whether there were significant differences between the groups being 
studied. Clinical assessments (the PANSS, HDRS, and YMRS) were performed on each 
participant to assess their level of symptomatology. An individual’s level of attention to the 
task could interfere with task performance and brain activation. Ideally all participants 
should be scanned at a time of day when they are able to perform at their optimum. During 





the quality assurance check, first level contrasts were visually examined for each subject to 
ensure there was significant activation, which provides an indication of whether 
participants were actively engaged with the task. During the task participants were also 
required to respond by pressing the corresponding trigger button, to encourage continuous 
attention to the task. 
 
Where it was not possible to control for differences between the groups in terms of any of 
these variables, and there was a significant difference between the groups, this was taken 
into account and the variable was added as a covariate into the second level fMRI analysis. 
Due to the potential impact of symptomatology on brain function, the current study also 
aimed to investigate the relationship between clinical symptoms and brain activation during 
episodic memory. Correlation analyses were performed to test whether any differences 
between the groups were associated with psychopathology, by looking at the relationships 
between functional activation and symptom severity ratings using various clinical measures 
(PANSS, YMRS, HDRS and GAF). 
 
With regards to medication effects, ideally drug free patients would have been recruited 
however these are rare, unrepresentative of the wider psychiatric population, and if 
unmedicated may not have been able to comply with experimental procedures, particularly 
the fMRI task. Therefore, antipsychotic medication status in the patient groups was 
recorded and was converted into chlorpromazine equivalents (CPZE). Medication effects 
could then be explored by performing correlations between antipsychotic medication and 
any significant results between patient groups and controls. Combining the antipsychotic 
doses as chlorpromazine equivalents is a useful way to examine different types of 





medication together, however it should be noted that this might be an oversimplification of 
the heterogeneity of different antipsychotics. For example, it does not take into account that 
the receptor profiles of typical and atypical antipsychotics are different.  
 
1.3.6 Neural correlates of episodic memory  
Several neuroimaging studies have been carried out to assess episodic memory in 
psychosis, however the neural mechanisms underlying this deficit remain unclear, with 
studies demonstrating heterogeneous results with respect to hyper or hypoactivation of 
certain brain regions (Weiss and Heckers, 2001).  Due to the complexity of the episodic 
memory system, it is assumed that the encoding, storage, and recognition of memories 
involve multiple brain regions (Leavitt and Goldberg, 2009). Patients with schizophrenia 
exhibit functional and structural abnormalities in brain structures that sub-serve episodic 
memory, most notably and consistently in the PFC and MTL including the hippocampus 
and parahippocampal gyrus (Stolz et al., 2012, Achim and Lepage, 2005, Ragland et al., 
2009). The functional underpinnings of episodic memory deficits in bipolar disorder are 
still debatable, however abnormal patterns of activation are most commonly observed in 
frontal, occipital and limbic regions (Oertel-Knochel et al., 2014, Oertel-Knochel et al., 
2015). 
 
Achim et al. (2005) conducted a meta-analysis to identify the brain regions in which activity 
is most consistently affected during the performance of episodic memory tasks, using a 
quantitative meta-analytic method for combining results from different imaging studies 
(Achim and Lepage, 2005). Regions of consistent differential activation between 
individuals with schizophrenia and healthy controls were primarily observed in the 





prefrontal cortex and in the temporal lobe, specifically in the left inferior prefrontal cortex, 
hippocampus, left cerebellum and medial temporal cortex bilaterally.  
 
1.3.6.1 Prefrontal regions  
The majority of research suggests that episodic memory deficits in schizophrenia are the 
result of MTL abnormalities, specifically in the hippocampus. However, the importance of 
prefrontal structures in the episodic memory network has become increasingly evident. One 
of the most convincing findings supporting a key role for prefrontal structures is that 
increased activation during encoding in frontal regions is highly predictive of subsequent 
memory performance (Wagner et al., 1998b). Further to this, lesion studies of PFC closely 
resemble episodic memory impairments similar to those experienced by individuals with 
schizophrenia.  
 
During both encoding and retrieval, Achim et al. (2005) found that control groups 
demonstrated increased activation in the left inferior prefrontal cortex, and this region 
proved to be the most consistent in distinguishing controls from patients. The inferior 
prefrontal cortex in the ventrolateral prefrontal cortex (VLPFC) has been shown to be 
involved in in encoding of verbal and nonverbal information (Poldrack et al., 1999, 
Blumenfeld and Ranganath, 2007) and in the maintenance of successfully retrieved 
information (Simons and Spiers, 2003, Badre and Wagner, 2002). There is also evidence 
for involvement in the implementation of strategies during memory encoding. However, in 
contrast to these findings Heckers et al. (2000) found increased left prefrontal activation in 
patients during impaired recognition of previously seen stimuli (Heckers et al., 2000). 
 





A more recent review by Ragland et al. (2009), using the same meta-analytic method but 
only examining whole-brain imaging studies, concluded that patients demonstrated less 
activation in the PFC during encoding in the frontopolar, dorsolateral and ventrolateral 
prefrontal cortex, and in the dorsolateral and ventrolateral prefrontal cortex during 
recognition (Ragland et al., 2009). However, when patients were encouraged to use explicit 
encoding strategies, only dorsolateral prefrontal cortex deficits remained, suggesting that 
ventral prefrontal regions are involved in the use of semantic elaboration strategies that 
promote subsequent memory.  
 
1.3.6.2 Dorsolateral prefrontal cortex prefrontal cortex (DLPFC) 
It has been suggested that abnormalities in the function and connectivity of the DLPFC 
may contribute to a wide range of cognitive deficits. There is recent evidence to suggest 
that the DLPFC may contribute specifically to relational memory, which refers to the ability 
to learn associations between items to encode, represent and bind individual memory traces 
(Murray and Ranganath, 2007, Blumenfeld et al., 2011). Increased DLPFC activation has 
been found in patients with schizophrenia and has been associated with lower levels of 
confidence during recognition, perhaps reflecting greater recruitment of resources to 
achieve a similar degree of accuracy during recognition (Buckner et al., 1998). Research 
suggests that DLPFC is more reliably activated during episodic recognition than encoding, 
and a similar pattern of activation can be seen during working memory. 
 
A study investigating patients with bipolar disorder found that verbal episodic memory 
deficits were associated with abnormalities in brain regions involved in episodic memory 
including reduced activation in the DLPFC and increased MTL activity in the 





hippocampus/parrahippocampus and fusiform gyrus (Deckersbach et al., 2006). Increasing 
evidence also supports DLPFC pathology in bipolar disorder (Cotter et al., 2002, 
Rajkowska et al., 2001).  
 
Other prefrontal areas have shown involvement in episodic memory. The middle frontal 
gyrus has been shown to support post-retrieval monitoring, with activation usually in the 
right middle frontal gyrus for simplistic tasks and additional recruitment of the left 
hemisphere for more complex monitoring (Achim and Lepage, 2005). Increased activation 
in the left middle frontal gyrus during recognition in controls compared to patients has been 
reported, suggesting a specific impairment of more complex memory processing in 
schizophrenia. This is consistent with the finding that more complex memory tasks expose 
greater memory impairment (Danion et al., 1999). The anterior medial prefrontal cortex 
has also demonstrated increased activation during encoding and recognition, as this region 
is thought to be involved in the recognition of self-important information (Fossati et al., 
2004, Simons and Spiers, 2003).  
 
1.3.6.3 Anterior cingulate cortex (ACC) 
The anterior cingulate cortex has also been implicated during memory retrieval. Retrieval 
associated activation of the ACC is a common finding in a variety of word recognition 
paradigms. It has been suggested that the ACC plays a role in cognitive control, and 
increased activity in this region may reflect the greater effort needed by patients to perform 
episodic memory tasks (Paus et al., 1998, MacDonald et al., 2000). Using a memory 
recognition task requiring the control of interfering information, Herrmann et al. (2001) 
found an anterior cingulate-prefrontal activation pattern, indicating that the control of 





semantic interference in episodic memory recognition selectively engages specific PFC 
areas (Herrmann et al., 2001). Activity in the ACC has also been found to be positively 
correlated with the degree of task difficulty (Barch et al., 1997). 
 
A recent study by Oertel-Knochel et al. (2014) examined episodic memory impairments in 
bipolar disorder during fMRI using a non-verbal memory task (Oertel-Knochel et al., 
2014). Patients showed reduced activation during encoding in the ACC, precuneus and the 
left lingual gyrus, and during recognition showed higher activation in the left temporo-
parietal junction. They also found structural abnormalities in the patient group including 
reduced gray matter volumes in the ACC, the precuneus/cuneus and the left temporo-
parietal region. This is in contrast to other findings that show hyperactivity of limbic 
regions in this patient group (Chen et al., 2011). 
 
1.3.6.4 Medial Temporal Lobes (MTL) 
Functional neuroimaging studies in healthy controls have robustly implicated the MTL, 
which includes the hippocampus, in both memory encoding and recognition. Activation 
within and between the PFC and hippocampus is critical for different aspects of memory 
function including working memory and episodic memory. Anatomic and 
electrophysiological studies have shown that the PFC and hippocampus are mutually 
connected via both monosynaptic and polysynaptic pathways (Bertolino et al., 2006), and 
the PFC is believed to support control processes that facilitate the encoding and recognition 
of memory via the hippocampal formation.  
 
The dysconnection hypothesis of schizophrenia suggests that the disorder occurs as the 





result of abnormal connectivity between different parts of the brain, particularly between 
the PFC and other structures including the temporal lobes. For example, reduced 
connectivity has been found between the DLPFC and parrahippocampus (Wolf et al., 
2007). Therefore, it has been proposed that a disruption in frontotemporal connectivity 
plays a key role in the memory deficits exhibited by individuals with schizophrenia. 
 
In schizophrenia alterations in hippocampal volume, perfusion and activation have been 
consistently reported (Heckers, 2001), and the integrity of the hippocampus is necessary 
for declarative memory. The hippocampus is the key area implicated in the formation of 
associations and is responsible for the integration of different features of an event, to 
support the encoding of information in a meaningful way (Davachi and Wagner, 2002), and 
may be responsible for conscious recollection during retrieval (Yonelinas and Levy, 2002).  
 
Research has found evidence of abnormal hippocampal neuronal activation in 
schizophrenia during episodic memory performance that may be affected by specific 
genetic variations (Goldberg et al., 2006, Hariri et al., 2003, Bertolino et al., 2006, Di 
Giorgio et al., 2008). Reduced hippocampal activation in patients relative to controls during 
encoding has been robustly reported (Heckers et al., 1998, Jessen et al., 2003, Achim and 
Lepage, 2005, Ledoux et al., 2013) and may reflect the less efficient use of encoding 
strategies in individuals with schizophrenia. 
 
In contrast, a review by Ragland et al. (2009) did not find evidence to support a reduction 
in hippocampal activation in patients during both encoding and retrieval (Ragland et al., 
2009). The only MTL activation difference identified was increased activity in the 





parahippocampal gyrus in patients during both encoding and recognition. The 
parahippocampal gyrus has been shown to be involved in familiarity assessment (Yonelinas 
and Levy, 2002). 
 
Research into hippocampal structure and function in bipolar disorder is less clear. There is 
some evidence of volume reduction in bipolar disorder (Blumberg et al., 2003a) and studies 
have shown evidence of increased hippocampal activation during affect processing tasks 
(Lawrence et al., 2004) and during verbal episodic memory (Deckersbach et al., 2006). 
 
1.3.6.5 Other regions (cerebellum, thalamus) 
Other regions have also been implicated in episodic memory, such as the thalamus and 
cerebellum. Achim et al. (2005) and Ragland et al. (2009) both identified abnormalities in 
these regions, providing support for disruptions to a frontocortical–thalamic cerebellar 
circuit in schizophrenia (Andreasen et al., 1996). The cerebellum has previously been 
implicated in episodic memory processes, for example cerebellar activity has frequently 
been found during recognition (Cabeza et al., 2002, Fliessbach et al., 2006, van der Veen 
et al., 2006). Evidence also supports a role of the cerebellum during memory encoding with 
visual stimuli (Weis, 2004, Fliessbach et al., 2007). Additionally, there is evidence for 
subtle episodic memory deficits in patients with cerebellar lesions (Gottwald et al., 2004). 
 
Evidence suggests that a network between the PFC and cerebellum, linked through 
synapses in the thalamus, plays a crucial role in coordinating motor and cognitive functions. 
The thalamus is involved in attentional processing during the encoding of novel objects, 
and structural abnormalities of the thalamus have also been reported in schizophrenia 





(Heckers et al., 2000). Heckers et al. (2000) used PET to investigate episodic object 
recognition in schizophrenia and found decreased right hemispheric thalamic activation 
during the recognition of novel visual stimuli. Other research has reported increased 
activation during retrieval in prefrontal regions, thalamus and insula in patients with 
schizophrenia compared to controls, and similar but milder abnormalities in first-degree 
relatives (Stolz et al., 2012).  
 
1.3.6.6 Summary of neuroimaging findings  
On review of the literature, it is evident that findings are not straightforward and are 
somewhat contradictory with respect to hyper or hypoactivation of certain brain regions. In 
patients with schizophrenia the key regions involved appear to be prefrontal and medial 
temporal regions. The main findings in bipolar disorder seem to be hypoactivity in frontal 
and hyperactivity in limbic brain regions involved in episodic memory processing (Brooks 
et al., 2009a, Deckersbach et al., 2006, Oertel-Knochel et al., 2014). 
 
Findings depend on the experimental setting and design, for example whether verbal or 
visual stimuli, or strategic memory tasks are used. For example, incidental encoding has 
been associated with substantially fewer differences between controls and patients 
compared to intentional encoding. Bonner-Jackson et al. (2008) found that use of an 
incidental encoding strategy e.g. making living/non-living judgments improved retrieval in 
patients and resulted in a more similar pattern of activation to that of controls (Bonner-
Jackson et al., 2008). Despite this, they did find increased activity in patients in bilateral 
inferior frontal gyrus, left inferior parietal lobe and the cerebellum, regions known to 
support episodic memory function.  





Different memory tasks may also engage different regions of the PFC to enable successful 
memory performance. Memory can also be affected by many factors, therefore it is 
important to carefully address the confounding factors that are associated with memory 
performance such as age, overall intellectual ability, attention, medications and symptoms. 
Overall however the literature does point to episodic memory deficits in schizophrenia and 
bipolar disorder that are linked to several regions known to be involved in episodic memory 
in healthy controls. 
 
1.3.7 Genetic component of episodic memory 
Both the liability to developing a major psychiatric disorder, episodic memory itself, and 
several neuroimaging measures are highly heritable (Glahn et al., 2007b, Blokland et al., 
2011). Schizophrenia and bipolar disorder are both highly heritable disorders with a 
heritability rate of around 80% for schizophrenia (Sullivan et al., 2003) and as high as 89% 
for bipolar disorder (McGuffin et al., 2003). Episodic memory can be defined as a 
genetically complex behavioural trait that shows substantial heritability, with values 
ranging from 30% to 60% (Papassotiropoulos and de Quervain, 2011). Episodic memory 
deficits are a putative endophenotype for schizophrenia, as milder deficits are evident in 
patients prior to the onset of psychotic symptoms, and in the unaffected relatives of 
individuals with schizophrenia (Reichenberg and Harvey, 2007, Whyte et al., 2005).  
 
Unaffected relatives of patients with schizophrenia or bipolar disorder show episodic 
memory deficits of moderate effect size (range 0.44–0.65 for schizophrenia and 0.33–0.53 
for bipolar disorder) (Christodoulou et al., 2012, Whyte et al., 2005, Snitz et al., 2006, 
Lefèbvre et al., 2010, Arts et al., 2008). Neuroanatomical findings of temporal lobe and 





hippocampal volume reductions in unaffected relatives also suggest a genetic basis for 
deficits in episodic memory (Leavitt and Goldberg, 2009). This suggests that these 
impairments are at least in part heritable and are independent of psychotic symptoms 
(Cirillo and Seidman, 2003, Di Giorgio et al., 2013).  
 
A twin study by Owens et al. (2011) investigated the heritability of visual and verbal 
episodic memory and its genetic relationship with schizophrenia (Owens et al., 2011). They 
found episodic memory was moderately heritable and shared substantial genetic overlap 
with schizophrenia, suggesting that episodic memory is a valid endophenotype. Therefore, 
episodic memory impairments appear to fit the criteria for the identification of 
endophenotypes set out by Gottesman and Gould (Gottesman and Gould, 2003). However, 
relatively little is known about the heritability of task-related BOLD signal phenotypes, as 
measured with fMRI during episodic memory related activation.  
 
Employing a genetic approach may help to further our understanding of deficits in episodic 
memory in psychosis (Leavitt and Goldberg, 2009). Candidate genes for episodic memory 
dysfunction in schizophrenia have been selected on the basis of reported associations, 
including an allelic variation of the DISC1 gene. There is mounting evidence that the 
DISC1 gene contributes to sensitivity to schizophrenia and memory dysfunction (Hennah 
et al., 2006). Investigating endophenotypes, such as episodic memory, may help to bridge 
the gaps between genetic expression and clinical presentation (Hill et al., 2008). Genetic 
imaging approaches, with a focus on DISC1, will be discussed in the following chapter.  
 
 































































Chapter 2: Genetic imaging  
This chapter will review the recent literature on genetic imaging in schizophrenia using 
DISC1 as an example of a risk genetic variant for psychosis. There is a focus on functional 
genetic imaging, specifically fMRI, because of its non-invasive ability to examine the 
effects of functional polymorphisms on information processing in multiple brain systems. 
The use of paradigms to examine complex cognitive processes and the relative ease with 
which large numbers of participants can be accumulated also makes fMRI the current 
functional method of choice for genetic imaging (Kempf and Meyer-Lindenberg, 2006). 
The potential challenges inherent in the field and implications for future research are also 
discussed in this chapter, including approaches to account for the complexity of epistatic 
effects, the study of rare structural variants, the importance of task selection, and the ethical, 
legal and social implications of the clinical application of genetic imaging are considered.  
 
2.1 Genetic imaging approach 
In recent years there has been a surge of interest in the application of imaging genetics to 
investigate the impact of genetic variation on the structure, function and connectivity of the 
human brain (Glahn et al., 2007b). Advances in neuroimaging techniques have resulted in 
a more comprehensive understanding of the structure and function of the brain in 
psychiatric disorders. For example, several imaging studies in patients with schizophrenia 
have found widespread structural and functional abnormalities in key brain regions, 
particularly in the frontal and temporal lobes (Lawrie and Abukmeil, 1998, Shenton et al., 
2001, Frith et al., 1995). Further to this, major advances in molecular genetics research, 
primarily the Human Genome Project, have led to the ability to map the human genome 
sequence including particular risk genes (Lander et al., 2001). More recently, the advance 





of genome-wide association studies (GWAS) has allowed researchers to examine the whole 
genome for either common or rare disease risk variants of small or large size, respectively. 
The role of rare genetic variants, including copy number variants (CNVs), have become a 
significant focus of genetic research in the aetiology of schizophrenia (Rodriguez-Murillo 
et al., 2012). 
 
There has also been a complimentary increase in research integrating the fields of imaging 
and genetics to gain a more comprehensive understanding of the pathophysiology of 
complex psychiatric diseases such as schizophrenia. The emerging field of genetic imaging 
applies structural and functional neuroimaging to study individuals carrying susceptibility 
genes that relate to the disease of interest. Genetic imaging usually involves identifying a 
functional variant within a candidate gene that is thought to impact at the molecular and 
cellular level, searching for differences in the frequency of a particular allele in a specific 
population, and examining differences in neuroimaging results between genotype groups 
(Hariri and Weinberger, 2003). 
 
Combining genetic and neuroimaging domains can help to further our understanding of the 
biological systems and neural mechanisms involved in mediating the effect of genetic 
variants on psychosis risk. In the future, this approach could have the potential to improve 
predictive testing of disorders in the at-risk population and may offer early intervention and 
novel targets for therapeutic interventions. For example, genetic imaging techniques could 
help to understand how individual genetic variation influences medication response, with 
the potential to offer more precisely tailored treatment plans for individual patients (Blasi 
and Bertolino, 2006). 





2.1.1 Imaging genetics of psychosis 
Schizophrenia is highly heritable, with multiple genetic components at work including both 
multiple common alleles and rare highly penetrant variants conferring susceptibility (Sawa 
and Snyder, 2002). A recent GWAS study by the Schizophrenia Working Group of the 
Psychiatric Genomics Consortium, using vast sample sizes, identified 108 schizophrenia 
associated genetic loci  (Ripke et al., 2014).  These findings were not randomly distributed 
across the genome but appeared to converge upon genes that are expressed in the brain, 
providing potential insight into the biology of schizophrenia. This study also found an 
overlap between genes affected by rare variants and more common loci identified by 
GWAS, supporting a complimentary mechanism involving both genetic components. 
Although the aetiology of schizophrenia remains uncertain, research consistently 
demonstrates that genetic factors play a fundamental role in the development and risk, and 
a number of candidate risk genes have been identified (Stefansson et al., 2008, Harrison 
and Owen, 2003), including DISC1. 
 
Despite this clear genetic component and high heritability estimates of around 80% 
(Buchman and Illes, 2010), identifying psychosis susceptibility genes has been challenging 
and researchers are far from fully understanding the mechanisms by which genes increase 
the risk of schizophrenia (Blasi and Bertolino, 2006). Specific genetic variants are often 
inconsistently identified and difficult to replicate, and it is likely to be the combination of 
multiple genes in addition to a range of other factors including environmental, epigenetic 
and gene-environment interactions that results in the expression of the full clinical 
syndrome (Bearden et al., 2007). It is also probable however that a small number of cases 





may be related to structural variants of large effect such as CNVs and the DISC1 
translocation. 
 
As with schizophrenia, there is a substantial genetic contribution to the aetiology of bipolar 
disorder with heritability estimates ranging from 89% (McGuffin et al., 2003) to as high as 
93% (Kieseppä et al., 2014). Genome wide association studies and whole genome linkage 
scans have identified several chromosomal regions and susceptibility genes that are 
associated with increased risk of bipolar disorder (Alsabban et al., 2011). Individually these 
risk variants only account for a small proportion of the heritability, suggesting that risk for 
bipolar disorder is due to the cumulative effect of multiple loci each with modest effect 
(Craddock and Sklar, 2009). 
 
There is evidence of an overlap in the genetic architecture of bipolar disorder and 
schizophrenia for example from genome wide linkage studies (Berrettini, 2003, Tsuang et 
al., 2004). A recent population-based study found evidence of a genetic association between 
these disorders, with 63% of comorbidity due to additive genetic effects common to both 
disorder (Lichtenstein et al., 2009). Genes implicated in schizophrenia have also been 
studied for their potential involvement in bipolar disorder, including DISC1, which has 
been associated with bipolar disorder in several studies (Hennah et al., 2009, Perlis et al., 
2008, Hodgkinson et al., 2004). Variation at the DISC1 locus increases risk to a variety of 
psychiatric disorders, which merits further study of this gene in bipolar disorder. These 
findings support the idea that schizophrenia and bipolar disorder have partially overlapping 
genetic aetiology.  
 






Direct associations between genes and clinical target variables have been difficult to 
determine, largely due to the subtle effects of genes on behaviour. Research suggests that 
the alleles that underlie the genetic risk to schizophrenia may largely exert their effects on 
endophenotypes such as brain function and structure (Meyer-Lindenberg and Weinberger, 
2006, McIntosh et al., 2007). An endophenotype refers to a measurable component along 
the pathway between the disease syndrome itself and the underlying genotype and can be 
cognitive, neuroanatomical, neuropsychological, endocrinological or biochemical in nature 
(Gottesman and Gould, 2003). Gottesman and Gould (2003) set out criteria for the 
identification of endophenotypes including that they should be heritable, state-independent, 
co-segregate within families and occur in unaffected family members at a higher rate than 
in the general population. This approach is increasingly employed in psychiatric research, 
based on the hypothesis that endophenotypes are coded by a smaller number of genes 
compared to more complex clinical classification systems such as DSM-5, and may have a 
more straightforward inheritance pattern (Allen et al., 2009). 
 
The penetrance of genetic effects is likely to be greater at the intermediate neural systems 
level than at the level of a more complex clinical disorder.  Endophenotypes should 
therefore offer a powerful way to bridge the neurobiology of genes and behaviour (Kempf 
and Meyer-Lindenberg, 2006). Functional and structural brain imaging measures have been 
identified as attractive putative endophenotypes. For example, researchers have found more 
robust effects when comparing patients and controls using brain activation than with 
performance on a range of cognitive tasks (Weiss et al., 2003, Honey et al., 2002). This 
approach also allows for the study of smaller sample sizes than in conventional genetics. 





Further to this, endophenotypes are usually more objectively measurable compared to the 
subjective behavioural and neuropsychological experience of these same processes (Hariri 
and Weinberger, 2003). Therefore, identifying an endophenotype through the use of 
imaging genetic techniques may one day provide a more accurate means for diagnosis 
compared to clinical assessments that are often affected by subjectivity and heterogeneity 
in symptoms (Hyde et al., 2011). However, it is important to note that neuroimaging 
measures are variable and prone to artefact due to experimental, statistical, or population 
stratification errors. Further to this, heritability has not been conclusively demonstrated for 
many functional imaging measures, including episodic memory, and research suggests that 
few candidate endophenotypes fulfill all the criteria outlined earlier.  
 
Although the sensitivity of imaging genetics is markedly higher compared to studies 
focused solely on behavioural or clinical measures, comparatively large groups divided by 
genotype are required to find reliable differences, and the application of this technique at 
the individual level is not currently feasible. Further, due to the overlap between 
schizophrenia and other psychiatric disorders, imaging genetics is likely to predict a 
broader diagnostic range of diseases rather than specifically predicting schizophrenia. 
 
2.1.3 Genome-wide Association Studies (GWAS) 
There are a number of different techniques for identifying and mapping genetic variants 
that underlie complex traits and common diseases. GWAS examine the whole genome for 
genetic variants without prior assumptions regarding the genomic location of the causal 
variants. This approach has a number of advantages compared to traditional candidate gene 
studies that rely on prior information regarding gene function and location, and potentially 





allows for the simultaneous detection of multiple susceptibility genes when sufficiently 
large sample sizes are assayed (Lee et al., 2012a). 
 
Recently, the first common genetic variant associated with schizophrenia on a genome-
wide level was discovered in the ZNF804A gene (rs1344706), encoding zinc-finger protein 
of undefined function (O'Donovan et al., 2008). Esslinger et al. (2009) demonstrated, using 
an imaging genetics approach, that healthy carriers of rs1344706 risk genotypes have 
marked alterations in functional coupling of the DLPFC across hemispheres and with the 
hippocampus during working memory (Esslinger et al., 2009). There is also further 
evidence that ZNF804A is of functional relevance to schizophrenia because this gene has 
been shown to influence the antipsychotic response of positive symptoms and may be a 
novel target for pharmacological treatment (Mössner et al., 2012). 
 
2.1.3.1 Limitations of GWAS 
Currently, there are several limitations of GWAS including the problem of multiple testing, 
the presence of variable extents of linkage disequilibrium, and the absence of biologically 
established causal variants (Porteous et al., 2006). Further to this, GWAS is neither 
powered nor designed for the detection of rare risk alleles and this is the case even for 
variants with high penetrance and impact. As a result, the full scientific potential of GWAS 
cannot be realised until sample sizes are sufficiently large enough and technological 
limitations are overcome. However, recent advances in next-generation sequencing 
technologies could facilitate progress in the identification of rare variants in individual 
samples.  
 





Genes with strong biological validity have also been identified through other approaches, 
such as using linkage and the candidate gene approach, for example DISC1. However, there 
are currently no results demonstrating genome-wide levels of significance for these 
prominent candidate genes. Despite this, it must be acknowledged that the failure of a gene 
to achieve the genome-wide significance threshold (the standard is generally considered to 
be p < 1 × 10-8) should not necessarily be interpreted as rejection of a genetic hypothesis, 
as it may still be genuinely contributing to the aetiology of the disease (Lee et al., 2012a). 
DISC1 has strong independent evidence from other sources including convergent 
biological support for their involvement in schizophrenia (Chubb et al., 2008, Porteous et 
al., 2006), and is amongst the most strongly associated genes in schizophrenia as ranked on 
the Schizophrenia Research Forum (http://www.schizophreniaforum.org). 
 
Ayalew et al. (2012) used a translational convergent functional genomics approach to 
integrate available evidence across multiple sources in the field, including GWAS data, 
gene expression studies, CNVs and animal model data, in order to identify genes potentially 
involved in schizophrenia (Ayalew et al., 2012). This approach prioritized genes, of which 
DISC1 was identified as the top candidate, with weaker GWAS data but with stronger 
evidence in terms of gene expression work and human or animal genetic studies. In 
comparison, some of the top genes identified in the GWAS data including ZNF804A, were 
assigned a lower prioritization score due to do fewer independent sources of evidence. 
Ultimately this highlights the fact that different genetic techniques can potentially identify 
different candidate genes for schizophrenia.  
 
 





2.1.4 Polygenic risk 
Research has demonstrated a significant polygenic contribution to major psychiatric 
disorders including schizophrenia, bipolar disorder and major depressive disorder (MDD), 
where risk is attributed to the cumulative effect of many common alleles of small effect 
(Purcell et al., 2009, Lubke et al., 2012). This is in line with the polygenic model of 
inheritance (Gottesman and Shields, 1967). Polygenic risk score (PRS) is a quantitative 
measure of the sum of trait-associated alleles across several genetic loci and can clinically 
be considered a genetic liability to disease risk. To obtain polygenic risk scores, a GWAS 
is conducted on an initial training sample to identify markers, which are then ranked by 
their evidence for an association with a particular disorder (usually by their p-value). PRS 
is then calculated in an independent replication sample by summing the trait-associated 
alleles within each subject, for a subset of top ranking markers (Dudbridge, 2013). This 
score can then be related to disease state or traits in the independent sample.  
 
Research has found that PRS can discriminate between individuals with a diagnosis of 
schizophrenia from control subjects (Purcell et al., 2009). Data has also found overlapping 
genetic susceptibly between schizophrenia and bipolar disorder using PRS. Top markers 
identified from schizophrenia GWAS have been found to be associated with bipolar 
disorder and vice versa, and have been used to differentiate between different forms of 
bipolar disorder (Hamshere et al., 2011). These findings support the notion that psychiatric 
disorders have a substantial shared polygenic component. 
 
Several studies have examined associations between PRS for different disorders and 
various neuroimaging measures. For example, Whalley et al. (2012) generated PRS for 





bipolar disorder based on psychiatric GWAS consortium summary data. They found that 
increased PRS for bipolar disorder was associated with greater activation in limbic regions 
during a language based executive function task, as seen in patients with bipolar disorder 
(Whalley et al., 2012a). Another study investigated PRS for schizophrenia and working 
memory-related brain activation (Kauppi et al., 2014). They found that increased 
cumulative genetic risk for schizophrenia was associated with dysregulation of the frontal 
lobe, in both patients and controls. This approach to investigating imaging data using PRS 
may help to establish a link between additive genetic predisposition to psychiatric illness 
and neuroimaging markers of disease, to potentially inform models of risk.  
 
A recent study investigated the neural effects of a cross-disorder PRS for a range of 
disorders during a language/executive task. They found an association between increased 
polygenic loading and increased frontal activation in healthy controls, again supporting 
shared genetic aetiology across the major psychiatric disorders (Whalley et al., 2015b). 
 
2.2 Disrupted in Schizophrenia 1 (DISC1) 
DISC1 is a putative susceptibility gene for a spectrum of major psychiatric disorders such 
as schizophrenia, bipolar disorder and major depression. It was originally identified in a 
large Scottish pedigree, in which it is disrupted by a balanced translocation between 
chromosomes 1 and 11 (Blackwood et al., 2001, St Clair et al., 1990).  This translocation 
simultaneously disrupts two novel genes; DISC1, a conventional protein coding gene, and 
DISC2, a noncoding RNA gene antisense to DISC1 (Millar et al., 2000). Subsequently, 
several DISC1 single nucleotide polymorphisms (SNPs) and haplotypes have been related 





to schizophrenia and other psychiatric conditions, albeit without consistently implicating 
any one SNP in particular. 
 
2.2.1 The DISC1 translocation  
DISC1 was first described as a risk factor for major psychotic disorders in a multiply 
affected Scottish pedigree (St Clair et al., 1990, Blackwood et al., 2001, Jacobs et al., 1970). 
This family was first discovered by Jacobs et al. (1970) who reported the translocation in 
an adolescent with conduct disorder (Jacobs et al., 1970). Years later it was found that the 
same chromosomal abnormality spanned four generations. The family has been regularly 
followed up as a consequence of this original finding by direct interview and review of 
medical case-notes. This revealed an increased incidence of major psychiatric disorders 
among relatives with the translocation but found no cases of these disorders in relatives 
with a normal karyotype (St Clair et al., 1990). However, it is important to note that 
penetrance of the translocation is incomplete and there are individuals with a normal 
karyotype with a psychiatric diagnosis, although none with major mental illness. Genetic 
and environmental interactions may partly explain this incomplete penetrance (Blackwood 
et al., 2001). 
 






Y: t(1;11) carrier 
Carriers scanned 
 Non-carriers scanned 
 
Diagnoses: 
Unknown – unknown psychiatric status 
Psychosis – schizophrenia, schizoaffective or 
psychotic bipolar disorder 
MDD(R) – recurrent major depression 
Other – single episode depression, 
cyclothymia or conduct disorder 
 
Figure 2.1: DISC1 Scottish kindred 
DISC1 family tree diagram. Individuals scanned and  
included in current analysis are highlighted in red/blue.  
Image created in Haplopainter. 





An interesting feature of this family is the diversity of clinical diagnoses associated with 
the translocation including schizophrenia, recurrent major depression and bipolar disorder. 
Carriers of the translocation have a fifty-fold increased risk of developing a major 
psychiatric disorder, whereas relatives without the translocation face the same risk as in the 
general population (Blackwood and Muir, 2004). Linkage analysis yielded a log of the odds 
(LOD) score of 3.4 when the diagnosis was restricted to schizophrenia alone, and a LOD 
score of 7.1 when the phenotype was expanded to include recurrent major depression and 
bipolar disorder (Blackwood et al., 2001). Research has also provided independent 
evidence for the involvement of the DISC1 locus in psychiatric illness from linkage and 
association studies in other populations (Ekelund et al., 2000, Hovatta et al., 1999, Hwu et 
al., 2003). 
 
The study of multiply affected families is important for the identification and investigation 
of variants that that are too rare to be detected by GWAS and have relatively large effects 
on illness risk. Insights from unique families have repeatedly served medical research well 
across the spectrum of conditions generally considered ‘common and complex’ 
(Blackwood et al., 2001). However, findings from family-based studies may be unique to 
one specific family, and as a result, not relevant to the disease itself. Additionally, because 
the translocation is rare, it is important to investigate possible phenotype differences 
between members of this family and unrelated individuals with psychosis.  
 
2.2.2 Function of DISC1 
Despite a wealth of research into the function of DISC1, the precise mechanisms by which 
variation in the DISC1 gene impacts upon risk for psychosis remain unknown. DISC1 





encodes a multifunctional scaffold protein that impacts on many aspects of central nervous 
system function likely to be involved in the pathophysiology of schizophrenia (Bearden et 
al., 2007), and the translocation directly disrupts this protein sequence. For example, DISC1 
is thought to be involved in mechanisms of neurodevelopment and synaptic plasticity 
including neuronal proliferation, differentiation and migration, through interaction with a 
number of proteins (Porteous et al., 2006, Mao et al., 2009, Brandon and Sawa, 2011, 
Porteous et al., 2011). This reflects the diversity of potential roles of DISC1 and its 
importance to overall brain function. Subsequent genetic association and linkage studies 
have replicated the original linkage findings and evidence now implicates DISC1 as one of 
the most potent risk genes for psychopathology (Chubb et al., 2008, Porteous et al., 2006). 
Certainly, the translocation in the original DISC1 family confers a dramatically increased 
risk of major psychiatric disorder.  
 
Efforts to model DISC1 disease biology in transgenic mice, and more recently in drosophila 
and zebrafish, have been relatively successful (Sawamura et al., 2008, Wang et al., 2008, 
Drerup et al., 2009, Kellendonk et al., 2009). DISC1 mutant mice display behavioural 
abnormalities, information processing deficits and structural anomalies similar to those 
seen in patients with schizophrenia, bipolar disorder or major depression (Hikida et al., 
2007, Shen et al., 2008). 
 
2.2.3 Cognition in DISC1 
Studies investigating cognitive function and genetic variation associated with DISC1 have 
reported significant findings across a range of cognitive domains (Burdick et al., 2005, 
Gasperoni et al., 2003, Paunio et al., 2004, Hennah et al., 2005, Cannon et al., 2005, 





Thomson et al., 2005, Liu et al., 2006, Palo et al., 2007). Several human neuroimaging 
studies have used of a variety of genetic imaging techniques to investigate DISC1 and brain 
structure and function (Duff et al., 2013).  
 
Blackwood et al. (2000) conducted a study on cognitive function in 12 relatives with the 
t(1;11) translocation and 8 relatives with a normal karyotype, and provided the first 
evidence that DISC1 variation might have subclinical effects (Blackwood, 2000). They 
found reduced event-related potential (ERP) P300 amplitude and increased latency, 
indicating deficits in the speed and efficiency of information processing. This amplitude 
abnormality was also independent of clinical symptoms because translocation carriers 
without symptoms also showed similar P300 abnormalities. These findings are similar to 
those found in other families with multiple members with schizophrenia, (Blackwood et 
al., 1991, Sham et al., 1994), are consistent with findings in patients with schizophrenia 
and their relatives (Schreiber et al., 1992, Blackwood, 2000) and also in families of patients 
with bipolar disorder (Pierson et al., 2000).  
 
The impact of the t(1;11) translocation on brain imaging measures was largely unknown 
until the SFMHS, from which data in this thesis is part of. Research is emerging from this 
study providing greater insight into the impact of this translocation on several imaging 
measures including structural and functional MRI, spectroscopy and DTI. Whalley et al. 
(2015) found decreased white matter integrity using DTI in multiple neural pathways 
including callosal fibers and tracts connecting frontal regions, in carriers compared to non-
carriers (Whalley et al., 2015a). White matter integrity in the corpus callosum was also 
significantly negatively correlated with positive symptoms on the positive and negative 





symptom scale (PANSS), and was found in patients versus controls, indicating a potential 
role for DISC1 in the development of positive psychopathology.  
 
2.2.4 DISC1 Single Nucleotide Polymorphisms (SNPs) 
Studies examining the effects of common variants in DISC1 alleles in humans have 
suggested that variation at the DISC1 locus contributes to structural and functional changes 
across the brain (Duff et al., 2013). Research suggests that DISC1 is expressed at high 
levels within the hippocampus (Ma et al., 2002), and there is evidence to suggest that it is 
pivotal during hippocampal development (Callicott et al., 2005). However, DISC1 is also 
highly expressed in the developing brain and brain stem after birth (Schurov et al., 2004). 
The DISC1 locus contributes to structural and functional alterations in the PFC and 
hippocampus, and there is a relationship between DISC1 variation and several quantitative 
cognitive traits including altered working and episodic memory performance in 
schizophrenia patients and their relatives (Bearden et al., 2007). Prefrontal and 
hippocampal abnormalities are robust features of psychotic disorders and a risk gene would 
be expected to influence the structure and function of these brain regions. 
 
2.2.4.1 Ser704Cys SNP 
Callicott et al. (2005) explored the functional impact of the DISC1 polymorphism on 
phenotypes related to hippocampal formation (Callicott et al., 2005). They identified a 
common SNP within the DISC1 gene, resulting in a serine to cysteine substitution 
(Ser704Cys) that was associated with schizophrenia and also had a measurable impact on 
hippocampal structure and function as assayed with BOLD fMRI. They found that the 
common Ser allele was over-transmitted in schizophrenic patients, and in healthy subjects 





this allele was associated with a significant reduction in hippocampal gray matter volume 
and altered engagement of the hippocampus during a range of cognitive tasks. Compared 
to Cys homozygotes, Ser subjects showed increased hippocampal activation during the n-
back working memory task and abnormally decreased activation during an episodic 
memory task. These results lend support for findings in the wider clinical literature and are 
analogous to findings described in patients with schizophrenia (Hariri and Weinberger, 
2003, Callicott et al., 2003, Hariri et al., 2003). 
 
This study also implemented an extensive assessment battery to measure aspects of 
cognitive performance. DISC1 was found to have a greater impact on brain activation than 
on measures of cognition, which demonstrates the superior ability of neuroimaging to 
differentiate Ser and Cys subjects (Callicott et al., 2005). These findings support evidence 
that the penetrance of genetic variants is more robust at the level of brain information 
processing than at the level of behaviour (Egan et al., 2001). Despite the weaker association 
of Ser704Cys to measures of cognition, the Ser allele was associated with impaired logical 
memory performance in patients with schizophrenia. This suggests that additional genetic 
or environmental factors and epistatic interactions with other risk genes may be 
fundamental to produce measurable effects on these phenotypes. This study supports an 
association between variation in DISC1 and schizophrenia and suggests that the mechanism 
of this effect may involve neurodevelopmental abnormalities of the structure and function 
of the hippocampal formation. 
 
DeRosse et al. (2007) investigated the association between Ser704Cys genotype and 
lifetime severity of positive symptoms in schizophrenia, detecting significantly higher 





ratings of paranoid delusions in at-risk Ser carriers (DeRosse et al., 2007). However, in this 
sample the DISC1 haplotype was not significantly associated with a diagnosis of 
schizophrenia, therefore the authors suggest it is more likely that Ser704Cys acts as a 
modifier gene (Fanous and Kendler, 2005) that affects clinical features of schizophrenia 
rather than increasing overall risk for the illness itself.  
 
A later study examined the association between the Ser704Cys polymorphism and the 
structure and function of the hippocampus (Di Giorgio et al., 2008). They found that healthy 
individuals homozygous for the Ser allele displayed greater engagement of the HF and 
greater hippocampal DLPFC functional coupling during encoding of recognition memory. 
These results suggest that the Ser704Cys polymorphism plays an important role in the 
modulation of functional connectivity between the hippocampus and DLPFC, and DISC1 
genotype may affect functional coupling of these regions during information processing 
within the memory encoding neural network.  
 
However, contrary to Callicott et al. (2005), this study found that the Ser allele was linked 
with increased gray matter volume in the hippocampus (Di Giorgio et al., 2008). Research 
has identified that the same DISC1 allele may display alternate risk or protection for 
schizophrenia, suggesting that the effect of a specific susceptibility gene is dependent not 
only on the existence of one risk variant on the gene, but also on the presence or absence 
of other risk variants within the same gene (Hennah et al., 2009). This demonstrates the 
complex nature of gene interactions and the need to take other genetic and environmental 
factors into consideration that might mediate the phenotypic consequence of DISC1 and 
risk for schizophrenia. 





In addition to the hippocampal abnormalities addressed above, altered PFC activation has 
been consistently associated with psychosis and may contribute to many of the cognitive 
symptoms present in schizophrenia (Gur et al., 2007). For example, Prata et al. (2008) used 
fMRI during a verbal fluency task, a standard measure of prefrontal activation, to test the 
influence of DISC1 on prefrontal function in healthy volunteers (Prata et al., 2008). They 
found that Ser704 homozygotes demonstrated less efficient prefrontal activation, with 
greater function required to achieve the same behavioural outcome. This is consistent with 
the findings of Callicott et al. (2005) that there is an association between the Ser704 
polymorphism and schizophrenia.  
 
Prata et al. (2011) recently extended their research to examine the influence of the DISC1 
polymorphism Ser704Cys on prefrontal activation in patients with schizophrenia and 
bipolar disorder (Prata et al., 2011). In contrast to their previous findings in healthy 
subjects, no significant effect of DISC1 variation was detected in the PFC or any other 
region in patients with schizophrenia. The authors interpret the absence of an observable 
effect in a patient sample as an indication of underlying interactions between DISC1 
genotype and a multitude of other risk genes that have been implicated in schizophrenia 
together with potential interactions with unknown genetic factors. 
 
Sprooten et al. (2011) reported an association between white matter integrity and variation 
in the DISC1 SNP (Ser704Cys) in healthy controls, as measured by DTI (Sprooten et al., 
2011a). Individuals carrying the major Ser allele exhibited reduced white matter integrity 
in several regions. There is strong evidence of white matter abnormality in schizophrenia, 
and these findings support a role for DISC1 in white matter development. This suggests 





that white matter integrity and density are potential endophenotypes for schizophrenia and 
other psychiatric disorders. 
 
2.2.4.2 Leu607Phe SNP 
Whalley et al. (2012) sought to examine the effects of another common SNP (Leu607Phe) 
on brain activation during a language task, in a group of subjects at high familial risk of 
schizophrenia (Whalley et al., 2012c). In comparison to the control group, there was no 
significant effect of the Phe risk variant on brain activation in the high risk subjects. This 
suggests that the effect of the Leu607Phe variant on brain activation differs in unaffected 
relatives at high familial risk versus healthy controls, presumably because relatives have a 
higher genetic loading and are more likely to reach a threshold of liability for schizophrenia. 
 
Szesko et al. (2008) investigated the effect of the Leu607Phe polymorphism on cortical 
grey matter and positive symptoms in schizophrenia (Szeszko et al., 2008). They found that 
individuals (patients and healthy controls) with the risk allele had significantly reduced 
grey matter in the superior frontal gyrus and anterior cingulate gyrus. Further to this, 
patients with schizophrenia who had the risk variant (Phe carriers) had greater severity of 
positive symptoms compared to those who were leu/leu homozygotes.  
 
2.2.4.3 DISC1 interactors 
The influence of DISC1 is complicated, with allelic or haplotypic association reported over 
a large proportion of the DISC1 region (Hennah et al., 2006), and it appears to be the 
specific combination of DISC1 variants that results in increased susceptibility. This 
suggests that the DISC1 risk alleles identified thus far are not entirely causative, but might 





be in disequilibrium with yet to be discovered gene variants (Mata et al., 2010). To gain a 
greater understanding of how variation within the putative DISC1 pathway affects brain 
function and increases risk for schizophrenia, further research must examine interactions 
with other candidate DISC1 polymorphisms, as well as with other potential DISC1-
interacting partners. 
 
DISC1 is a hub protein in a multidimensional risk pathway, and several interactors have 
been identified as independent genetic susceptibility factors for psychiatric illness (Chubb 
et al., 2008). Mutations within DISC1 affect multiple systems involved in central nervous 
system development and function, and are usually sufficient to substantially increase risk 
of developing major mental illness. Therefore, it is likely that DISC1 interactors and other 
genetic mechanisms that modulate the level of DISC1 expression can account for the 
growing evidence for this gene as a key risk factor for schizophrenia (Porteous et al., 2006). 
 
Nicodemus et al. (2010) explored the potential interactions between 50 SNPs in DISC1 and 
five other potential interacting partners (Nicodemus et al., 2010a). They found evidence 
that SNPs in three genes in the DISC1 pathway, DISC1, CIT and NDEL1 act in epistasis 
to increase susceptibility to schizophrenia. Three significant interactions were then 
biologically validated using fMRI during a working memory task in a sample of controls. 
Carriers of the risk associated variants for both loci demonstrated a pattern of inefficient 
prefrontal cortical activity that has been linked to schizophrenia and is also seen in 
unaffected siblings (Callicott et al., 2003). This provides support to the notion that different 
genes interact to increase the risk for schizophrenia, however future research should 





examine the many other networks and susceptibility gene variants linked to the DISC1 
pathway. 
 
2.2.5 Current challenges of genetic imaging 
Recent advances in imaging genetics have made a substantial contribution to our 
understanding of major psychiatric disorders. This novel technique provides the tools 
necessary to explore the mechanisms through which the dynamic interplay of genes, brain 
and environment shapes individual differences in behaviour and risk for schizophrenia. 
Developments in genetic imaging represent a new era in predictive medicine, however there 
are difficulties interpreting the findings accurately and meaningfully. Therefore, it is 
important for researchers to understand and address the challenges to progress inherent in 
the field.  
 
To date the potential of genetic imaging has been plagued by inconsistent attempts at 
replication of associations between specific genetic variants and psychosis (Viding et al., 
2006). This inability to validate findings through independent replication may be due to 
methodological limitations such as insufficient power, or sample heterogeneity between 
different sites, for example the inclusion of different ethnic groups or gender. Alternatively, 
and arguably more importantly, inconsistency in the literature may reflect the stratification 
of genetic risk and the complexity of phenotypic association. This suggests that a new level 
of analysis is required to account for such complex functional interactions between larger 
sets of genes as they impact on imaging data (Hennah et al., 2009, Viding et al., 2006). For 
example, a novel approach is the use of genetic imaging to investigate the effects of 
multiple interacting risk variants using an overall genetic risk score for schizophrenia. 





There are currently only a limited number of endophenotypes that are truly indicative of 
increased susceptibility for schizophrenia, and replication of these findings can be a 
formidable challenge. Functional neuroimaging offers a promising technique to further our 
understanding of the aetiology of schizophrenia, although notable problems remain, 
including both technical and statistical issues. Future research will benefit from 
collaboration and multi-centre imaging to obtain the substantially larger sample sizes that 
are required in imaging genetics research.  
 
As larger numbers of genotype and phenotypes are becoming available for genetic imaging 
studies, there is an increasing concern over the possibility of spurious positive findings due 
to multiple comparisons. Meyer-Lindenberg et al. (2008) estimated the rate of false 
positives in imaging genetics by analysing a set of genetic variants without likely impact 
upon brain structure or function linked to schizophrenia (Meyer-Lindenberg et al., 2008). 
They observed low rates of positive findings, reflecting an empirical estimate of the 
expected rate of false positives. These findings provide encouraging evidence that the false 
positive association rate is well controlled by current commonly used multiple correction 
measures, however only in the context of adequately selected neuroimaging paradigms and 
specific analysis procedures. For example, permutation testing is currently considered the 
gold standard for accurate multiple testing correction, and may be a necessary step in 
bringing psychiatric genetic findings convincingly to the larger genetics community. 
 
Further to this, Meyer-Lindenberg and Weinberger (2006) propose that a statistically 
significant result in neuroimaging is not sufficient to conclude that a given genetic variant 
is functional (Meyer-Lindenberg and Weinberger, 2006). Given the modest and equivocal 





contribution of any single variant, it is essential to control for potential confounding 
variables. For example, when examining the influence of a specific genetic variant it is 
important to assess whether the studied groups, defined by genotype, differ in the 
distribution of other risk variants. A major issue to consider in genetic imaging research is 
that allele frequencies can be extremely rare and vary considerably within and across 
populations, for example between different ethnic groups or genders. Alleles that exist at 
relatively low frequencies can be a barrier to recruitment and can also be difficult to 
interpret during analysis (Casey et al., 2010). Therefore, it is important to consider possible 
stratification effects that might mask or enhance the influence of a specified variant, in 
addition to demographic variables such as gender, age, ethnicity and IQ. 
 
2.2.5.1 Pleiotropy 
Convergent genetic, neuroimaging and clinical evidence indicate both overlap and 
discontinuity between schizophrenia and other psychiatric disorders. Pleiotropy, the 
influence of a single gene on multiple phenotypic traits, has been demonstrated in a variety 
of susceptibility genes. For example, research suggests that DISC1 is a genetic risk factor 
for a wide spectrum of psychiatric disorders including schizophrenia, bipolar disorder, 
major depression and autism spectrum disorders (Whalley et al., 2012c, Hennah et al., 
2009, Millar et al., 2000). Research has also identified that genes such as DISC1, which act 
as a ‘hub’ or scaffold protein, are generally more complex in their regulation (Camargo et 
al., 2006), and are therefore associated with greater phenotypic diversity. Therefore, the 
presence or absence of a specific risk variant does not necessarily entail a vulnerability to 
schizophrenia, but potentially alters the risk for a range of psychiatric disorders. 
 





2.2.5.2 Research on healthy controls 
An important caveat in considering the literature is that the vast majority of imaging 
genomic research has been conducted on healthy controls with the assumption that patients 
will demonstrate similar effects. Therefore, it is difficult to infer a direct relationship 
between specific genetic variants and clinical phenotypes in schizophrenia. However, the 
existence of potential confounders related to illness and treatment in patients such as 
medication effects, may mask the effects of individual variants, potentially rendering them 
less detectable than in controls that carry the at-risk variant. Despite this, it is important for 
researchers to study patient samples as this allows for a more direct examination of 
genotype-disease interactions (Roffman et al., 2006). 
 
A common practice in functional imaging research is to average data over groups of 
participants, and there is doubt as to whether such findings can accurately predict pathology 
at the individual level due to the heterogeneity of human structural, functional and chemical 
brain signatures (Buchman and Illes, 2010). Although the sensitivity and specificity of 
genetic imaging assessments is markedly higher than cognitive and behavioural measures, 
there will still be an inevitable number of diagnostic errors. Until it can be demonstrated 
that such errors are outweighed by true positives and negatives, it would be premature to 
rely on statistical parametric maps of brain activation linked to genetic risk variants as 
objective diagnostic measures (Hariri and Weinberger, 2003). However, it is questionable 
as to whether genetic imaging will ever be informative at the individual level. Rather, its 
purpose may be to biologically validate genetic variants using neuroimaging and identify 
imaging biomarkers that could be applied in a clinical setting to aid diagnosis or predict the 
onset of illness in individuals with a family history of schizophrenia.  





A major challenge is to account for the complexity of gene-gene and gene-environmental 
interactions when understanding the effects of genetic variation on behaviour. The 
relatively small effect of any single polymorphism highlights the need for the examination 
of a broader network of genetic variation and its environmental influences, as progress is 
unlikely to come by focusing on a single variant, no matter how penetrant (Blakely and 
Veenstra-VanderWeele, 2011). Hyde et al. (2011) advocate an integrative strategy of 
imaging gene-environment interactions to help understand the mechanisms through which 
genetic variation, environmental factors and the brain interact to predict risk for 
schizophrenia (Hyde et al., 2011). Further to this, the true potential of genetic imaging is 
arguably only likely to be realised through its application within longitudinal 
developmental studies (Viding et al., 2006). 
 
2.2.5.3 Rare structural or copy number variants 
The majority of research supports the hypothesis that the genetic influence on 
schizophrenia is the result of a combination of common alleles, each contributing a small, 
additive effect. However, recent research has also identified certain genetic variants 
predisposing to schizophrenia that are highly penetrant but are individually rare (Walsh et 
al., 2008). This ‘common disease; rare variant’ hypothesis proposes that schizophrenia is a 
genetically heterogeneous disorder and many predisposing mutations are highly penetrant 
and individually rare, even specific to single cases or families (McClellan et al., 2007), of 
which the DISC1 translocation is a prime example.  
 
Several case-control and family based studies have shown that the mutational burden of 
novel genomic deletions and duplications of genes is significantly greater in patients than 





in healthy controls (Stone et al., 2008). These rare mutations appear to disrupt genes in 
neurodevelopmental pathways and confer substantial risk for psychiatric illness. The risk 
associated with some CNVs is substantially higher compared to frequent genetic variants 
such as SNPs, and in some cases can correspond to a tenfold increase in disease 
susceptibility (Meyer-Lindenberg and Weinberger, 2006). Evidence also indicates that rare 
structural variants are dispersed throughout the genome, involve many different genes and 
are likely to confer risk to a spectrum of other psychiatric disorders (Sebat et al., 2009). 
Further to this, mutations that are unique to single patients appear to demonstrate the 
strongest association with schizophrenia. 
 
A major barrier to the investigation of rare variants is that large sample sizes are required 
due to the relatively low prevalence of these variants, even in clinical populations. For 
example, the presence of rare causal variants at any single locus is likely to be less than one 
in 500 patients (Sebat et al., 2009). However, a paramount aim of such research is to 
understand the penetrance of individually rare variants for a variety of clinical phenotypes. 
Grouping patients by specific CNV genotype could enhance the power of genetic imaging 
to investigate how rare variants influence the function of genes and neurobiological 
pathways, to increase susceptibility to schizophrenia. However, analysis of imaging data 
would need to be performed retrospectively on a small genetically pre-defined patient 
group.  
 
2.2.5.4 Task selection 
The interpretation of genetic effects depends largely on the validity of the neuroimaging 
paradigm used. Task selection must be carefully considered in order to identify the most 





appropriate paradigms that maximize the sensitivity to be able to detect the relatively small 
effect of risk variants (Hariri and Weinberger, 2003).Whilst a wide range of fMRI tasks 
have been used in genetic imaging research, the majority of studies have focused on 
paradigms that activate PFC or pre-frontal interactions with other cortical regions, such as 
the n-back working memory paradigm (Egan et al., 2001, Weinberger et al., 2001, Callicott 
et al., 2005, Nicodemus et al., 2010b) and verbal fluency tasks such as the Hayling Sentence 
Completion Test (Whalley et al., 2012c, Hall et al., 2006, Krabbendam et al., 2005).  
 
2.2.5.5 Limitations of current imaging paradigms 
Further research is required to determine which imaging paradigms are the most conducive 
to genetic imaging studies. Future research should focus on the design and implementation 
of more effective stimulus paradigms specific to schizophrenia so that imaging genetics 
can be applied more efficiently in clinical settings (Demirci and Calhoun, 2009). For 
example, in comparison to the extensive work on working memory, the genetic impact on 
neural activation during social cognition has received limited attention. Walter et al. (2011) 
examined the effects of a genome-wide supported psychosis risk variant in the ZNF804A 
gene on brain activation during a theory of mind task (Walter et al., 2011). They found a 
significant risk allele dose effect in parts of the neural network supporting theory of mind 
functions therefore identifying dysfunction of this network as a potential endophenotype.  
 
 As previously mentioned, endophenotypes should be found in non-affected family 
members at a higher rate than in the general population, but heritability has not been 
conclusively demonstrated for the majority of functional parameters used. Imaging genetics 
paradigms must reach a higher threshold of heritability in order to be used as a putative 





endophenotype, however there is currently limited data available to support 
endophenotypes outside of working memory. 
 
2.2.6 Conclusion 
Neuroimaging techniques offer a unique opportunity to explore the functional impact of 
brain-relevant genetic polymorphisms. It is expected that future research will increasingly 
focus on epistatic effects of multiple common variants of modest effect, account for the 
complexity of gene-environment interactions and characterize rare high risk structural 
variants. Further to this, the integration of research across disciplines, for example 
connecting human studies with animal models, will provide a more unified understanding 
of the biological and neural mechanisms that influence the aetiology and pathophysiology 
of schizophrenia (Casey et al., 2010).  
 
It is estimated that 23% of variation in liability to schizophrenia is explained by common 
variants, providing support for an imaging genetic approach based on SNPs (Lee et al., 
2012b). Given the polygenic nature of schizophrenia, summing the collective impact of 
multiple risk alleles to generate an overall genetic risk score is a novel and promising 
approach to identify individuals at risk of psychosis. Walton et al. (2012) derived a measure 
of cumulative genetic risk score, which combined the additive effects of 41 SNPs from 34 
genes associated with schizophrenia, including DISC1 (Walton et al., 2012). Using genetic 
imaging, they investigated the effect of overall polygenic risk on functional activation 
during working memory. They found a relationship between genetic risk score and DLPFC 
inefficiency, which was not attributable to symptom severity. These findings suggest that 
genetic imaging of polygenic risk, using a widely accepted endophenotype, could be 





advantageous compared to the study of single risk genes. With advances in computational 
modelling, future studies should aim to incorporate existing biological evidence and gene-
gene interactions into this genetic risk score. 
 
A promising development in the field of genetic imaging is the identification of novel 
genetic variants associated with pre-specified brain phenotypes of interest. This forward 
genetics strategy requires a combination of neuroimaging with genome-wide analysis, and 
requires relatively smaller sample sizes compared to using clinical phenotypes alone 
(Meyer-Lindenberg, 2010). For example, Potkin et al. (2009) discovered and verified the 
association of two novel genes, RSRC1 and ARHGAP18, not previously associated with 
schizophrenia (Potkin et al., 2009), using DLPFC activation as a phenotype. This approach 
should be further explored in post-mortem or animal studies in order to further evaluate the 
biological function of these novel variants, but has the potential to identify new molecular 


























































Chapter 3: Aims and hypotheses 
The previous chapters introduced the two main areas of study in this thesis; episodic 
memory in psychosis, and genetic imaging and DISC1. This chapter aims to link the 
literature from these introductory chapters and provide justification for the current work. It 
will discuss the existing literature and knowledge about episodic memory and DISC1, and 
outline the overall aims and hypotheses of the current study.  
 
3.1 The effects of genetic variation in DISC1  
There are two main ways to examine the role of DISC1 in humans. First, genetic variation 
in DISC1 that occurs in the general population can be exploited to test whether common 
variants increase liability to develop psychiatric illness or have an impact on brain function. 
Second, the effect of rare variants such as the DISC1 t(1;11) translocation can be studied 
in depth, however this results in substantially smaller numbers of participants. The latter 
approach is the focus of the current work, however as the SFMHS is the first investigation 
into the effect of the translocation on several imaging modalities, we need to discuss the 
current knowledge gained from the first approach, looking into DISC1 SNPs. 
 
3.2 Episodic memory and DISC1 
There is currently limited research into the effect of DISC1 SNPs on episodic memory-
related activation. A recent review by Duff et al. (2013) reviewed all human brain imaging 
studies of DISC1 in schizophrenia, bipolar disorder and depression, of which there were 
twenty-two at the time of publication. Of these, eight studies examined DISC1 variant 
effects on brain function using fMRI, and only two looked specifically at episodic memory, 
the remainder using tests of verbal fluency or working memory.  





The two studies that investigated the effect of DISC1 variation of episodic memory, both 
looked at the Ser704Cys polymorphism, as previously outlined in chapter 2. Callicott et al. 
(2005) explored the impact of the Ser704Cys DISC1 polymorphism on declarative 
memory, using the same episodic memory task as the current work (Callicott et al., 2005). 
They found that healthy controls with the Ser allele (which was found to be over-
transmitted in schizophrenic patients) showed decreased hippocampal activation during 
encoding and recognition, in comparison to Cyz homozygotes. Contrary to these findings, 
a further study by Di Giorgio et al. (2008) using the same task and investigating the same 
common variant, found that healthy controls with the Ser allele demonstrated increased 
activation of the hippocampus during encoding. Exploratory whole brain analyses also 
demonstrated increased activation in Ser subjects in temporal and frontal regions, including 
increased DLPFC activation and coupling with the hippocampus. So, whilst these studies 
begin to offer a clue about the effect of DISC1 on episodic memory function, further study 
is needed.  
 
These studies only examined the effect of a single SNP. Studying a single common genetic 
variant may be problematic as little is known about the effect these small variations have 
on the complex biology of DISC1. The effect of one SNP may be relatively small, and may 
be interacting with many other unknown genetic variants. This may explain the 
contradictory results of the studies described above. Existing research into DISC1 and 
episodic memory has only investigated the Ser704Cys SNP, however there is no direct 
molecular evidence that this variant is functional and it may be a proxy for the actual 
causative loci in the gene (Callicott et al., 2005). Therefore, more robust effects may be 
found by examining other forms of variation within the DISC1 gene, such as the t(1;11) 





translocation. Further to this, a recent meta-analysis found no evidence that common 
variants in DISC1, such as the Ser704Cys SNP, are markers for schizophrenia. However, 
evidence suggests that rare variants, such as the translocation, do show an association 
(Mathieson et al., 2012).   
 
Previous research looking at DISC1 SNPs has done so in groups of healthy controls, 
patients with a range of psychiatric disorders, and those at high risk for illness. This is 
important to test whether effects of a single genetic variant vary depending on the presence 
or absence of other genetic and environmental effects. In a similar vein, it is also of interest 
to examine the effect of the translocation in carriers with a range of clinical diagnoses 
including schizophrenia, bipolar disorder, depression or no diagnosis, to determine if it is 
in fact the translocation that is causing an effect on brain activation, rather than the presence 
of a particular psychiatric condition. Therefore, this study aimed to recruit as many 
members of the family as possible to reflect the range of diagnoses present in this Scottish 
family. However, it is important to note that due to the rarity of this genetic alteration and 
the limited number of family members, this was somewhat out of the researcher’s control.  
 
Rare variants are likely to have larger neural effects and can offer a powerful method to 
further our understanding of the underlying neurobiology of psychiatric disorders. 
Specifically rare family-specific variants such as the translocation may play an important 
role due to the reduced genetic complexity present within families and the greater 
penetrance on endophenotypes. The endophenotype approach is further justification for 
why functional imaging was used in the current work. Research suggests that the 
penetrance of genetic effects is likely to be greater at the intermediate neural systems level 





such as brain function, than at the level of behavioural performance on a cognitive task 
(Meyer-Lindenberg and Weinberger, 2006).  
 
In conclusion, rare variants in DISC1 remain largely unexplored yet could provide valuable 
insight into DISC1 as a candidate gene for involvement in psychiatric conditions. The 
translocation has been shown to be associated with an increased risk of developing a major 
psychiatric disorder including schizophrenia, bipolar disorder and depression. Therefore, 
studying the translocation can help us to further understand the underlying biology of these 
conditions. The SFMHS aimed to expand on existing research into common DISC1 
variants, to establish whether the translocation was associated with abnormalities in brain 
development and adult neuronal plasticity using structural and functional fMRI. As part of 
this same study, a group of healthy controls, patients with schizophrenia and patients with 
bipolar disorder were recruited, to compare the effects of the translocation to the effects of 
having a psychiatric illness, while minimising key confounds. Specifically the work in this 
thesis aimed to investigate the translocation in relation to episodic memory related brain 
activation using fMRI. 
 
3.3 Why episodic memory? 
Episodic memory was chosen as the cognitive function to investigate in the current work 
for several reasons, which will be discussed here. It should be noted that there are several 
other cognitive domains that would be of interest to investigate in relation to the DISC1 
translocation. The wider SFMHS also investigated fMRI during a working memory task, 
however this data is not presented in the current thesis. 
 





Previous research investigating the effect of DISC1 variation supports the idea that DISC1 
increases risk for psychosis and that the mechanism of this effect may involve development 
and plasticity of the hippocampus (Callicott et al., 2005, Di Gorgio et al., 2008). Further to 
this, research suggests that DISC1 is expressed at high levels within the hippocampus (Ma 
et al., 2002), and there is evidence to suggest that it is pivotal during hippocampal 
development (Austin et al., 2004, Lee et al., 2015). Much remains to be investigated for 
DISC1, however the expression and function of DISC1 in the hippocampus, and evidence 
of hippocampal dysfunction in schizophrenia, gives the association between DISC1 and 
schizophrenia a biological appeal (Callicott et al., 2005). Therefore, it is of interest to 
investigate the effect of the DISC1 translocation, by measuring the impact on hippocampus-
related intermediate phenotypes, and it was logical to select a task that is known to be 
dependent on the hippocampal formation, such as the episodic memory task used in this 
work.  
 
The impact of DISC1 is not restricted to the hippocampus, as studies examining the effects 
of common variants in DISC1 suggest that variation at the DISC1 locus contributes to 
structural and functional changes across the brain, primarily in prefrontal and temporal 
regions (Duff et al., 2013). Patients with psychotic disorders exhibit functional and 
structural abnormalities in brain structures that sub-serve episodic memory, most notably 
and consistently in the prefrontal cortex and in the temporal lobe, which includes the 
hippocampus. Therefore, a risk gene for psychosis would be expected to influence the 
structure and function of these brain regions.  
 





The current study aimed to investigate whether the DISC1 translocation influences brain 
activation primarily in prefrontal and temporal regions, which are key areas of episodic 
memory processing. The current task was chosen because it has been shown to activate 
regions including prefrontal (including DLPFC and VLPFC) and medial temporal regions, 
including the hippocampus.  
 
Further to this, it is of interest to investigate episodic memory because it has been proposed 
to be a potential endophenotype. Episodic memory deficits are one of the most consistently 
reported findings in patients with schizophrenia and patients with bipolar disorder, and 
deficits are also evident in their unaffected relatives (Christodoulou et al., 2012). Episodic 
memory also appears to be a trait marker of illness and has shown to be linked to overall 
functional outcome (Nuechterlein et al., 2011, Green et al., 2000). Patients with 
schizophrenia and bipolar disorder show episodic memory related neural abnormalities in 
prefrontal and temporal regions (Ragland et al., 2009, Oertel-Knochel et al., 2014), which 
have also been demonstrated in unaffected relatives (Cannon et al., 2005) supporting a 
genetic basis for deficits in episodic memory function (Leavitt and Goldberg, 2009). 
Studying endophenotypes may help to bridge the gap between underlying genetic 
expression and clinical phenotypes, because the penetrance of genetic effects is likely to be 
greater at the intermediate systems level, such as brain function. 
   
3.4 Why this episodic memory task? 
The current task was chosen as it has been used in previous genetic imaging research (on 
DISC1 and other variants), and provides a point of reference between the current novel 
results and the wider literature. For example, it has been used to examine the effects of 





DISC1 (Callicott et al., 2005), COMT (Bertolino et al., 2004, Di Giorgio et al., 2011), 
BDNF (Hariri et al., 2003, Baig et al., 2010) and NRG1 (Krug et al., 2010). Therefore, this 
task has previously been shown to be sensitive to effects of genetic variation.  
 
This task has been used in previous studies examining episodic memory in a range of 
participant groups including healthy controls, patient groups, high risk groups, and has been 
shown to activate an extensive network of brain regions such as prefrontal (including 
DLPFC and VLPFC), cingulate, medial temporal and parietal regions (Hariri et al., 2003, 
Bertolino et al., 2006, Callicott et al., 2005, Stolz et al., 2012, Di Giorgio et al., 2008). This 
task has also consistently been shown to produce activation of the hippocampal formation 
(hippocampus and parahippocampal gyrus) during both encoding and recognition (Hariri 
et al., 2003). Further to this, this task requires a low cognitive demand, allowing it to be 
performed by participants with a wide range of abilities. 
 
3.5 Overall aims and hypotheses 
3.5.1 DISC1 t(1;11) translocation carriers and non-carriers  
The aim of this study was to investigate the effect of the t(1;11) translocation by comparing 
functional activation during an encoding and recognition memory task in individuals with 
and without the translocation. The impact of this translocation on brain imaging measures 
is largely unknown, however this family offers a unique opportunity to examine the effects 
of this translocation. 
 
It has previously been shown that there is a link between the t(1;11) translocation and 
several psychiatric disorders including schizophrenia and bipolar disorder, and this thesis 





aimed to investigate the effect of the translocation on a putative endophenotype, episodic 
memory related activation. The analysis approach described in this chapter was chosen to 
simplify the reporting of results. No previous research has been carried out on this family 
to investigate functional brain activation, therefore the experiments reported in this thesis 
were exploratory and used a conservative whole brain approach. 
 
It was hypothesised that episodic memory fMRI BOLD activation profiles would be 
abnormal in t(1;11) translocation carriers in contrast to related non-carriers. Given the 
known functions of DISC1 in vitro and in animal models, as well the heritability of certain 
brain regions and their involvement in psychosis, it was hypothesised that the translocation 
would have a measurable impact on brain activations in key areas associated with episodic 
memory. Research suggests that variation at the DISC1 locus contributes to structural and 
functional changes across the brain, primarily in prefrontal and temporal regions, 
specifically the hippocampus and PFC (Duff et al., 2013). Therefore, it was hypothesised 
that the translocation would impact upon hippocampal activation, based on expression of 
DISC1 in the hippocampus and evidence that allelic variation in this gene influences 
hippocampal function in humans (Callicott et al., 2005), and in the PFC. Prefrontal and 
hippocampal abnormalities are robust features of psychotic disorders and it is expected that 
a risk gene will influence the function of these brain regions. 
 
3.5.2 Controls and Patients 
As discussed in the literature review contained within chapter 1, the neuroimaging findings 
of episodic memory in patients are not straightforward and are somewhat contradictory 
with respect to hyper or hypoactivation of certain brain regions. Findings also depend on 





the experimental setting and design, for example the task or stimuli used or patient 
population studied. However, for patients with schizophrenia the key regions involved in 
episodic memory appear to be prefrontal, including DLPFC, and medial temporal regions, 
specifically the hippocampus. The main findings in bipolar disorder seem to be 
hypoactivity in frontal regions, and more consistently hyperactivity in limbic brain regions 
involved in episodic memory processing. It was therefore hypothesised that in comparison 
to healthy controls, patients with schizophrenia would show abnormal activation in key 
regions associated with episodic memory including the hippocampus and prefrontal 
regions, specifically the DLPFC, whereas patients with bipolar disorder would show 
hyperactivity in limbic brain regions involved in episodic memory processing. 
 
There are limited studies directly comparing episodic memory function between patients 
with schizophrenia and patients with bipolar disorder. However, based on the wider 
literature comparing these disorders, findings suggest an overactivation of MTL structures 
or limbic regions in bipolar disorder, and a relative underactivation of these structures in 
schizophrenia. It was therefore hypothesised that there would be a difference between these 
disorders at the functional level during episodic memory processing, specifically in MTL 




































Chapter 4: Methodology 
This chapter will detail the methodology for the two subsequent results chapters comparing 
(i) t(1;11) translocation carriers and non-carriers and (ii) patients and controls. The same 
assessments, fMRI task and data analysis were used in both experiments to compare 
different groups of participants, therefore methods for each of the results chapters have 
been combined. It will also outline recruitment, inclusion and exclusion criteria, and 
justification for inclusion of the different groups of participants.  
 
4.1 Participants  
Participants were recruited as part of a wider multimodal imaging study (SFMHS). The 
current study included three groups of participants;  
1. Family members (with and without the t(1;11) translocation) 
2. Patients (with schizophrenia or bipolar disorder) 
3. Controls (with no history of serious mental disorder) 
 
Participants who were aged 16 or over were eligible to take part, with no upper age 
restriction. This was the same across all groups of participants, in order to maximise the 
number of family members recruited. All participants were interviewed by an experienced 
psychiatrist and diagnoses were confirmed using the Structured Clinical Interview for 
DSM-IV (SCID) (First and Gibbon, 2004) and the Operational Criteria (OPCRIT) 
symptom check-list (McGuffin et al., 1991).  All diagnoses were reviewed by a second 
psychiatrist. All participants received a detailed description of the study and provided 
written informed consent to participate in the trial. The study was approved by the 
Multicentre Research Ethics Committee for Scotland.  





Exclusion criteria for each group were as follows: 
Exclusion Criteria 
For patients:  
- Impaired ability to provide informed consent to the study    
- MRI safety: potential participants could not take part if:    
o They had a cardiac pacemaker 
o Had metal fragments in or near their eyes 
o Had other magnetic metal implants  
- Current substance dependency  
- A history of major neurological disorders or serious brain injury 
For controls: 
- As above for patients, with an additional criterion: 
o No history of psychosis, or diagnosed mental health problem based on 
the SCID or OPCRIT  
For family members: 
- In order to maximise the number of family members recruited, the only exclusion 
criteria for this group were:  
o Impaired ability to provide informed consent to the study    
o MRI safety considerations (as described above) 
 
Figure 4.1: Exclusion criteria  
 
Participants excluded 
A total of 132 subjects were recruited to the SFMHS. 17 subjects did not participate in the 
functional imaging protocol (for various reasons such as concerns about the scanner 
environment, unwillingness or unavailability), leaving 115 who completed the episodic 
memory paradigm. Of this number, 15 subjects were excluded, leaving 100 participants in 
the final analysis (see figure 4.2). Seven participants were excluded at the quality assurance 
stage due to poor scan quality. The reason for poor scan quality could have been due to 
several factors, for example poor positioning of the subject relative to the head coil, 
excessive motion causing significant image artefact, or incomplete scan data. Five scans 





were excluded due to movement when examined in ArtRepair software, as they showed > 
20% of volumes with excessive movement (further information provided in quality 
assurance section on page 122). Unfortunately these participants could not be rescanned 
due to time and financial restrictions. 
 
Excluded participants (n = 15) 
- Carriers: none excluded 
- Non-carriers: 2 excluded due to; movement (n = 1) and incomplete scan data (n 
= 1) 
- Controls: 2 excluded due to; movement (n = 1) and withdrawal of consent (n = 
1) 
- Patients with schizophrenia: 6 excluded due to; movement (n = 2),  
scan quality (n = 3), and invalid date due to participant being intoxicated during 
scanning session (n = 1) 
- Patients with bipolar disorder: 5 excluded due to; movement (n = 1),  
scan quality (n = 4) 
 
Figure 4.2: Excluded participants  
 
It is of interest to test whether those who were excluded from the analysis differ from those 
who were included. From the 15 who were excluded, data is available for 14 participants 
(one individual withdrew consent and requested for their data to be destroyed). However, 
it should be noted that some of these participants did not complete certain clinical or 
cognitive assessments. There were no significant differences between the groups in terms 
of age, gender, premorbid IQ (NART), or manic symptoms (YMRS). The groups did differ 
on current IQ (WASI), with excluded individuals showing a lower IQ. They also differed 
on PANSS total score (p = 0.027), with excluded participants demonstrating higher scores, 
however they did not differ on the positive or negative subscale of the PANSS. There was 





also a significant difference between groups on the HDRS with excluded participants 
demonstrating higher levels of depressive symptoms (p = 0.021). This group also had 
significantly lower GAF scores, reflecting lower overall functioning (p = 0.015). Therefore, 
it would appear that those participants who were excluded had worse symptomatology and 
this may explain why they were unable to provide usable fMRI data. 
 








Demographic and Clinical Measures 
Mean age (years) (SD) 38.38 
(14.54) 
42.29 (14.88) U = 595, 0.364* 
Gender (M:F) 
31:19 4:3 
X2 = 0.122, 
0.727** 
Mean NART score (SD) 109.77 
(8.71) 
106.2 (8.02) T = 1.24, 0.219 
Mean WASI score (SD) 107.68 
(16.6) 
95.8 (13.24) T = 2.25, 0.027 
Mean PANSS total score (SD) 40.72 
(14.92) 
55.92 (23.36) T = -2.56, 0.027 
Mean PANSS positive score 
(SD) 
9.5 (4.06) 11.85 (6.2) T = -1.65, 0.120 
Mean PANSS negative score  
(SD) 
9.35 (4.65) 12.42 (6.35) T = -2.1, 0.054 
Mean YMRS score (SD) 1.22 (2.94) 2.42 (4.12) T = -1.27, 0.206 
Mean HDRS score (SD) 4.17 (6.78) 8.86 (8.55) T = -2.34, 0.021 
Mean GAF score (SD) 72.12 
(22.20) 
55.61 (24.3) T = 2.47, 0.015 
*non parametric – Mann Whitney U ** Chi-square. Positive and negative symptom scale 
(PANSS), National adult reading test (NART), Young mania rating scale (YMRS), Hamilton 
depression rating scale (HDRS), Global assessment of functioning (GAF) 
Significant results highlighted in bold 





It should be noted that no power calculation was performed to determine the appropriate 
sample size for the control and patient sample. For the family member comparison a power 
calculation was not appropriate due to the nature of the sample being studied, and therefore 
as many family members as possible were recruited. The limitations of not performing a 
power calculation are discussed later in chapter 7. However, it is reassuring that the current 
sample of controls (n = 40) and patients (n = 41) is larger than many previous studies using 
the same task. For example other studies have recruited group sizes of 12 vs. 16 (Callicot 
et al., 2005), 9 vs. 18 (Bertolino et al., 2006), 14 vs. 14 (Hariri et al., 2003), 22 vs. 16 vs. 
28 (Stolz et al., 2012). Therefore, with a similar or greater sample size it was hoped that 
there would be a similar effect, without running an actual power analysis.  
 
4.1.1 DISC1 t(1;11) translocation carriers and non-carriers 
A large, previously reported Scottish kindred known to carry a unique genetic t(1;11) 
translocation (St Clair et al., 1990) were approached to participate. Researchers from the 
University of Edinburgh have been in contact with members of this family for several 
decades and through these original contacts, other family members were invited to 
participate in the current study. Due to the sensitive nature of the study for members of this 
family, a skilled research nurse was present at all study visits, with support from a 
psychologist if required. Inclusion criteria for this group was simply being a member of 
this unique family and ability to provide informed consent. The t(1;11) translocation status 
of each individual was then confirmed, dividing the group into those with and without the 
translocation. From the translocation carriers, all received a diagnosis of either recurrent 
major depression (n=2), single episode depression (n=2), cyclothymia (n=3) or conduct 
disorder (n=1). All non-carriers had no psychiatric diagnosis at time of testing. 





Translocation status was tested on blood samples obtained from participants using 
polymerase chain reaction (PCR) based methods. This analysis was carried out by other 
members of the research team (please see appendix for further details). 
 
A total of 30 members of this family took part in the study, 12 with the translocation, and 
18 without. Of these, fMRI data was acquired during the episodic memory task for 8 
translocation carriers, and 13 non-carriers. Two of the non-carriers were excluded (one due 
to movement artefacts and the other was unable to complete the scan thus leaving 
incomplete data) leaving 11 in total.  
 
4.1.2 Patients (with schizophrenia or bipolar disorder) 
A second group of participants consisted of patients with either schizophrenia or bipolar 
affective disorder. Inclusion criteria were having a diagnosis of either schizophrenia or 
bipolar disorder as determined by the SCID assessment, and being able to provide consent. 
This group was recruited from people who were in contact with secondary care mental 
health services Edinburgh. Consultant psychiatrists were approached to enquire whether 
people on their case load would be interested in taking part in the study. Once verbal 
consent was sought from the patient and their care team, the individual was approached by 
a researcher from the study team, who would provide further information about the study. 
It should be noted that all patients with bipolar disorder were euthymic at time of scanning, 
as determined by the SCID. This can also be reflected by the relatively low scores on the 
YMRS and HDRS in the bipolar group (see results section in chapter 6). Positive symptoms 
on the PANSS were also measured in all patients, including those with bipolar disorder, as 
a measure of psychotic symptoms. 





In the patient group there was a mix of patients with schizophrenia and bipolar disorder, 
which reflects the range of conditions that the t(1;11) translocation was strongly associated 
with when the genetic association was first described, together with the evidence of 
overlapping genetic architecture between mood disorders and schizophrenia (Craddock and 
Owen, 2010). It is also in line with current approaches that look to investigate mental 
disorders not constrained by DSM diagnostic categories (Insel et al., 2010). Further to this, 
the recent revaluation of the extended family (Lawrie et al., In Press) found that linkage 
analysis yielded a log of the odds (LOD) score of 3.3 when the diagnosis was restricted to 
schizophrenia alone, a LOD score of 3.5 for only affective disorders (bipolar disorder and 
recurrent major depression), but a LOD score of 6.1 when including both cases of 
schizophrenia and bipolar disorder.  
 
A total of 59 patients took part in the study, of which 52 were scanned during the episodic 
memory task. Of these, 11 scans were excluded; due to movement (n = 3), scan quality (n 
= 7), and one subject was excluded due to being intoxicated during the scan session. The 
final group therefore included 41 patients in the analysis, and consisted of 30 patients with 
schizophrenia and 11 patients with bipolar disorder. The recruitment of this group allows 
for the comparison of the effects of the t(1;11) translocation within the family to the effects 
of a having a psychotic illness, while minimising key confounds. 
 
Medication status 
From the subjects included in the analysis, twenty-seven patients with schizophrenia and 
four with bipolar disorder were treated with antipsychotic medication. Additional 
information regarding specific medication in the patient groups is provided in chapter 6. 





All other patients, translocation carriers, non-carriers and healthy controls were un-
medicated at the time of testing. The effect of antipsychotic medication was examined by 
converting different antipsychotic drug doses into chlorpromazine equivalents (CPZE) 
(Gardner et al., 2014). 
 
4.1.3 Healthy controls 
Healthy control subjects were recruited from the same geographical areas and social 
communities as both the patients and the t(1;11) kindred where possible. A primary source 
of recruitment was the Scottish Mental Health Research Register, which is a database of 
people who have previously agreed to be contacted about taking part in mental health 
research in Scotland. Other controls were recruited from the support network of patients 
who were involved in the study. 
 
Research into how similar family members’ brains are anatomically has suggested that 
certain areas are highly heritable (Glahn et al., 2007b). This means that direct comparisons 
between members of one family with a group of unrelated individuals would be 
significantly confounded by the shared heredity within the family. Therefore, direct 
comparisons between the t(1;11) kindred and patients or controls were not performed. The 
recruitment of the patient and control groups allows for the comparison of the effects of 
having a psychiatric disorder in general to the effects of the t(1;11) translocation within the 
family, without the need for direct comparisons between family members and patients. A 
total of 43 healthy controls took part in the study, 42 of which completed the episodic 
memory task. Two individuals were excluded (one withdrew consent, and one due to 
excessive movement in the scanner), leaving a total of 40 controls in the analysis. 






4.2.1 Clinical Measures 
All participants were assessed using the Structured Clinical Interview for DSM-IV (SCID) 
and Positive and Negative Symptoms Scale (PANSS). The SCID is a structured clinical 
interview used to determine axis-1 psychiatric disorders, for example schizophrenia, 
bipolar disorder and MDD (First and Gibbon, 2004). The PANSS was developed by Kay, 
Fiszbein and Opler, (1987) to assess symptom severity in schizophrenia and other psychotic 
disorders (Kay et al., 1987). The PANSS is a 30 item, 7-point rating instrument that 
evaluates positive, negative and other general symptomatology on the basis of a formal 
semi-structured clinical interview and other informational sources. The positive and 
negative symptom subscales each consist of seven items (see figure 4.3). There is also a 
general subscale consisting of 16 items. This clinical interview was conducted by an 
experienced psychiatrist and took approximately 45 minutes to complete with each 
participant. Each item is rated on a 7-point rating scale, therefore the lowest possible total 
PANSS scores is 30. PANSS scores were obtained from all participants except 5 controls 
and 1 patient with bipolar disorder, who were unable to complete the assessment. When 














PANSS Positive items PANSS Negative items 
Delusions Blunted affect 
Conceptual disorganisation Emotional withdrawal 
Hallucinatory behaviour Poor rapport 
Excitement  Passive/apathetic social withdrawal 
Grandiosity Difficulty in abstract thinking 
Suspiciousness/persecution Lack of spontaneity and flow of 
conversation 
Hostility  Stereotyped thinking 
 
Figure 4.3: Positive and Negative Symptoms Scale subscale items 
 
The Young mania rating scale (YMRS), Hamilton depression rating scale (HDRS) and 
global assessment of functioning (GAF) were also completed by a clinician for all 
participants. The YMRS (Young et al., 1978) consists of 11 items to measure the severity 
of manic symptoms and is based on the individuals’ subjective report of their condition 
over the previous 48 hours and clinical observations during the interview. The HDRS, 
developed by Hamilton (1960), is a 17-item rating measure and is the most widely used 
depression assessment scale, assessing depressive symptoms over the past week (Hamilton, 
1960). The GAF is a subjective clinician rating scale measuring an individual’s overall 
level of functioning including social, occupational and psychological functioning. For 
example, it will consider how well or adaptively one is meeting various problems in life 
including work issues, interpersonal relationships, involvement in adequate activities, 









4.2.2 Cognitive Measures 
Participants were administered two standardised neuropsychological measures to assess 
intelligence. The National Adult Reading Test (NART) (Blair and Spreen, 1989) measures 
pre-morbid intelligence and  consists of 50 words that are irregular with respect to the 
common rules of pronunciation. It is administered by asking the participant to read each 
word out loud to the best of their ability. The total error score is obtained and then converted 
into a predicted full-scale IQ measure.  
 
The Wechsler Abbreviated Scale of Intelligence (WASI) (Wechsler, 1955) was 
administered to produce an estimate of general intelligence. The WASI consists of four 
subtests; 1) vocabulary (42 word items that the participant has to verbally define), 2) 
similarities (abstract verbal reasoning in which participants are required to assess how 26 
sets of word pairs are alike), 3) block design (spatial perception in which a set of 13 
geometric patterns have to be replicated using coloured cubes within a specific time limit), 
and 4) matrix reasoning (a measure of nonverbal abstract problem solving consisting of 35 
incomplete grid patterns that the participant has to complete by selecting the correct 
response). Scores on these subtests are combined to create an overall measure of IQ, and 
take approximately 30 minutes in total to complete. WASI and NART data could not be 
collected for 4 individuals without the translocation, 2 healthy controls, 6 patients with 
schizophrenia, and 1 with bipolar disorder. 
 
Clinical and cognitive measures were analysed using SPSS for windows (version 19.0, 
SPSS Inc., USA), using parametric tests when data met assumptions of normality (Shapiro-





Wilk test) and homogeneity of variance (Levene’s test), or nonparametric tests when data 
did not meet these assumptions. 
 
4.2.3 Polygenic risk score  
Polygenic profile scores were generated from the whole genome sequencing data using the 
most recent Psychiatric Genomics Consortium summary GWAS reference data for 
schizophrenia (Ripke et al., 2011), bipolar disorder (Sklar et al., 2011) and MDD (Ripke et 
al., 2013). Polygenic scores were calculated according to the methods by Purcell et al. 
(2009) with the following adjustments. Polygenic profiling was performed using PLINK 
(an open-source whole genome association analysis toolset) (Chang et al., 2014) and as 
scoring was performed on a single family, no pruning for linkage disequilibrium was 
performed. As recommended by Dudbridge (2013), no p-value threshold was applied to the 
summary data, maximising the information retained. The author of this thesis did not carry 
out this analysis. Higher positive scores represent a higher polygenic risk of psychiatric 
illness. The number of variants scored in each individual was retained and used as a 
covariate in all analyses.  
 
4.3 Functional magnetic resonance imaging protocol 
Data for this thesis was collected as part of a wider multimodal imaging study (SFMHS) 
and included structural and functional MRI, spectroscopy, and diffusion tensor imaging 









4.3.1 Episodic memory paradigm  
To test declarative memory, subjects performed an episodic memory task in the scanner 
that involved the encoding and subsequent recognition of novel, complex scenes. Prior to 
entering the scanner participants were given instructions by a research assistant to ensure 
they understood the task. They were told they would see a series of visual scenes and would 
be asked to judge whether each image represented an ‘indoor’ or ‘outdoor’ scene, by 
pressing the corresponding button to the instructions on screen. They were then told they 
would see a further set of scenes and would be asked whether they recalled the images by 
responding ‘old’ or ‘new’, again by pressing the corresponding trigger button. Participants 
were not explicitly instructed to memorize scenes during encoding for later recognition. 
They were also told that there would be a rest period between each set of scenes and to look 
at the cross displayed on screen during this time. They were informed that before each 
series of scenes there would be a brief instruction screen explaining what they had to do, to 
ensure continuous attention to the task. 
 
This task has been used in previous studies examining episodic memory in a range of 
participant groups e.g. healthy controls, patient groups, high risk groups, and has been 
shown to activate an extensive network of brain regions such as prefrontal (including 
DLPFC and VLPFC), cingulate, medial temporal and parietal regions (Hariri et al., 2003, 
Bertolino et al., 2006, Callicott et al., 2005, Stolz et al., 2012, Di Giorgio et al., 2008). This 
task appears to activate a wide range of brain regions commonly associated with 
visuospatial information processing. Main effects of the task have also shown activation in 
the middle and medial frontal gyrus (BA 10), superior parietal lobule (BA 7), precuneus 
and the precentral gyrus (Stolz et al., 2012). This task has also consistently been shown to 





produce activation of the hippocampal formation (hippocampus and parahippocampal 
gyrus) during both encoding and recognition (Hariri et al., 2003).  
 
Variations of this task have been implemented using different stimuli for example verbal 
versions (Baig et al., 2010) and emotional stimuli or faces (Krug et al., 2010). Depending 
on the type of material to be encoded, other brain structures have been shown to be engaged 
including limbic regions, the amygdala, fusiform gyrus and parietal regions (Cabeza et al., 
2002, Fernández and Tendolkar, 2001). This task has also been used to examine the effects 
of several genetic variants e.g. DISC1 (Callicott et al., 2005), COMT (Bertolino et al., 2004, 










Figure 4.4: Encoding and recognition task design  
 
Illustration of the encoding and recognition task described in this thesis. Images were 
interleaved with a baseline fixation cross. The task consisted of four blocks of encoding, 
followed by four blocks of recognition (see text for further details).  
 
 
Stimuli were presented in a block design to maximize statistical power and sensitivity for 
BOLD signal change in this region. During encoding blocks participants were shown a 
series of visual scenes of neutral emotional valence, derived from the International 
Affective Picture System (Lang et al., 1997) and asked to judge whether each image 
represented an ‘indoor’ or ‘outdoor’ scene. During recognition blocks, subjects were 
presented with a further set of visual scenes and asked whether they recalled the images by 





responding ‘old’ or ‘new’; half of the images were ‘old’ (i.e. also presented during the 
encoding blocks) and the other half were ‘new’ (i.e. novel images) (figure 4.4). Prior to the 
start of each block, participants were shown a brief instruction asking them to respond by 
pressing the corresponding trigger button, which ensured continuous attention to the task 
and allowed for the determination of response accuracy and reaction time. The 
experimental paradigm was created and presented using Presentation software 
(https://www.neurobs.com) run on a Windows PC. The task was projected onto a screen, 
which subjects viewed using the goggles provided. The task was explained to participants 
prior to entering the scanner and an opportunity for questions was provided to ensure 
participants had a full understanding of the task. 
 
The task consisted of four encoding blocks followed by four recognition blocks, interleaved 
with nine passive rest periods, during which participants were instructed to fixate on a 
centrally presented cross-hair. Each block lasted 20 sec and consisted of six images 
presented serially for three seconds each, resulting in a total of 48 images and 17 blocks, 
and a total scanning time of 5 minutes and 50 seconds. The images were presented in a 
random order throughout both the encoding and recognition conditions, and an equal 
number of ‘indoor/outdoor’ and ‘old/new’ scenes were shown in each block. 
 
4.3.2 Behavioural data acquisition and processing  
Behavioural performance and reaction time were recorded electronically with the 
Presentation programme. The dependent variable measuring performance on the episodic 
memory task was the percentage of correct responses. Percentage correct was calculated as 
the number of correct responses divided by the total possible correct responses, and was 





determined for encoding and recognition conditions separately. Data was analysed using 
SPSS for windows (version 19.0, SPSS Inc., USA). Task performance was analysed using 
non-parametric tests (Kruskal–Wallis or Mann-Whitney U), as the data was not normally 
distributed. Mean reaction time in seconds across the whole experiment (encoding and 
recognition phases combined) was recorded for each participant and differences between 
groups were analysed using one-way ANOVA (in patients and controls) or independent 
samples t-test (t(1;11) carriers and non-carriers). 
 
4.3.3 Scanning procedure 
Functional imaging was carried out at the Clinical Research Imaging Centre for Scotland 
on a 3T Siemens Magnetom Verio Syngo MR scanner (Siemens, Erlangen, Germany). 
Structural images were acquired using T1-weighted, magnetisation prepared rapid 
acquisition gradient echo (MP-RAGE) images prescribed parallel to the AC-PC line, 
providing 160 sagittal slices of 1.0mm thickness, field of view (FOV) 256mm x 256mm, 
matrix size 256 x 256. Further scan parameters were repetition time (TR) 2300ms, echo 
time (TE) 2.98ms, inversion time (TI) 900ms and a flip angle 9°. Functional data was 
acquired using an EPI sequence.  
 
Functional data was acquired using a T2* echo planar sequence sensitive to BOLD contrast, 
using the following parameters: axial orientation TR = 1560ms, TE = 26ms, matrix size 64 
x 64, FOV 220mm x 220mm, 26 slices (slice thickness 4mm with a 1mm interslice gap) 
and voxel size 3.4 x 3.4 x 4.0mm. A total of 228 volumes were acquired, of which the first 
six volumes were discarded to avoid T1 saturation effects (to allow magnetisation to reach 
a steady state). 





4.3.4 Image processing and Analysis 
4.3.4.1 Pre-processing  
Data processing and statistical analyses were performed using the standard SPM approach 
in SPM8 (Statistical Parametric Mapping: The Wellcome Department of Cognitive 
Neurology and collaborators, Institute of Neurology, London), running in Matlab version 
7.13 (The MathWorks, Natick, MA). All functional volumes were spatially realigned to the 
mean volume in the series, normalised to MNI space (Montreal Neurological Institute 
template) and spatially smoothed with a 3-dimensional isotropic 8mm x 8mm x 8mhm full 
width half maximum (FWHM) Gaussian kernel. Functional data has a lower resolution and 
is not as detailed as the anatomical T1 image. Therefore, coregistration and segmentation 
steps were also performed using each individual’s structural scan, to allow for better 
normalisation to the MNI template (see below for order of pre-processing stages). 
 
Pre-processing stages: 
- Realignment: for each participant the EPI volumes were realigned to the mean 
volume in the series, in order to correct for motion within each scan.  
- Coregistration: each participant’s anatomical scan was registered to their mean 
functional image.  
- Segmentation: this stage separates the T1 image into CSF, white matter and grey 
matter, based on the MNI template. This information is required for normalisation. 
- Normalisation: each participant’s data was warped into MNI standard space in 
order to register images from different participants into roughly the same co-
ordinate system. Normalisation of images from an individual scan is required before 
performing group comparisons.   





- Spatial smoothing: this step averages the intensities of adjacent voxels to minimize 
residual inter-subject differences, and improves signal to noise ratio by removing 
high frequency information.  
Figure 4.5: Pre-processing and first level analysis steps  
 
4.3.4.2 Data quality and movement  
To assess data quality, a quality assurance script was run in Matlab, after the pre-processing 
stage. This script produced a composite summary figure for each subject, to be visually 
inspected, to check image quality and to ensure that the image processing had been 





successfully completed (see figure 4.6 for example). It displays motion parameter graphs, 
the raw functional and structural data before pre-processing, normalised data, and first level 
contrast (activation during baseline, to check subjects were engaged with the task). These 
were visually inspected for movement or any issues with the realignment or normalisation 
process, to identify if any subjects needed to be corrected for motion in ArtRepair or 
excluded. Seven subjects (three individuals with a diagnosis of schizophrenia and four with 
bipolar disorder) were excluded at this stage due to poor scan quality. The reason for poor 
scan quality was due to several factors, for example poor positioning of the subject relative 
to the head coil, excessive motion causing significant image artefact, or incomplete scan 
data. Unfortunately these participants could not be rescanned due to time and financial 
restrictions.  
 
Subjects demonstrating excessive movement (>1.5mm motion per TR) at this stage were 
then examined further using ArtRepair software (Centre for Interdisciplinary Brain 
Sciences Research, Stanford University, Stanford, CA, USA). Volumes demonstrating 
>1.5mm of motion relative to the previous one were corrected by interpolating the 
immediately adjacent volumes (figure 4.7). These volumes were encoded as nuisances 
within the first-level general linear model (GLM). No more than 20% of the volumes were 
interpolated i.e. any subject with > 20% repaired volumes was excluded from the analysis. 
This is a standard threshold in the fMRI literature. Five scans were excluded due to this 
reason (one control subject, one non-carrier, two individuals with schizophrenia and one 
with bipolar disorder). 
 





Figure 4.6: Subject output from quality assurance check 
This output was created from the quality assurance script. It displays the raw functional 
and structural data before pre-processing (left), normalised data (centre), first level 
contrast (activation during baseline) (right), motion parameters (top left) and motion per 
TR (top centre) for one subject. With thanks to Liana Romaniuk for writing this script. 







Figure 4.7: Subject output from ArtRepair  
 
This output was generated using ArtRepair software. It identifies outlier volumes to be 
repaired for one subject (‘outlier indices’). Volumes demonstrating >1.5mm of motion 




4.3.4.3 First level analysis  
Statistical analysis was performed using the general linear model approach as implemented 
in SPM8. Estimates of head movement from the realignment stage of pre-processing were 
included as additional regressors in the first level analysis. At the individual subject level 
the data were modelled with three conditions ‘encoding’, ‘recognition’ and ‘baseline’, each 
modelled by a boxcar convolved with a synthetic haemodynamic response function. Before 
fitting the model, the subject’s data were filtered in the time domain using both a low-pass 





(Gaussian kernel, 4 s FWHM) and a high‐pass (400 s cut‐off) filter. Due to the large number 
of participants that took part in this experiment, the pre-processing and 1st level analyses 
were performed using batch scripts. These scripts were pre-existing but tailored to the 
specific requirements of the current experiment. 
 
 
Figure 4.8: First level design matrix 
 
The first 3 columns represent the 3 task conditions (encoding, recognition and baseline) 
and the remaining 6 represent the movement parameters (estimates of each subject’s 
movement from the realignment stage of pre-processing – translations and rotations in x, 
y and z, were entered as covariates of no interest in the model). Numbers on y-axis 
represent images 1-220. 
 
 
4.3.4.4 Second level analysis  
All second level statistical analyses were conducted in SPM8. For each contrast of interest 
(encoding > baseline, recognition > baseline) one contrast image per subject was entered 
into a second-level random effects analysis to compare translocation carriers and non-





carriers, and to compare patients with healthy controls (two sample t-test). The encoding > 
baseline contrast examined activation during all scenes presented during the encoding 
phase versus baseline. The recognition > baseline contrast examined all scenes presented 
during the recognition phase (both old and new images) versus baseline.  
 
Age was entered as a covariate in the second-level analysis when comparing individuals 
with and without the t(1;11) translocation, as this differed significantly between groups. 
Statistical maps were thresholded at a level of p = 0.001 uncorrected unless indicated 
(additional results are reported at a threshold of p = 0.005 uncorrected in the family analysis 
due to the small number of scans, and in the bipolar disorder analysis again due to small 
sample size). Regions were considered significant at p < 0.05 cluster level corrected for 
multiple comparisons across the whole brain volume. Cluster-extent based thresholding is 
considered to be the most common method for multiple comparison correction for whole 
brain analysis of statistical maps in fMRI studies. Cluster-level statistics take into account 
the spatial extent or width of the cluster (ke) when assessing significance, and accounts for 
the fact that voxel activations are not entirely independent of each other. In comparison, 
peak-level inference refers only to the height or intensity at one voxel. Therefore, the p-
value is presented for the cluster rather than the peak voxel, and this was decided prior to 
analysis of the data. Based on prior reports regarding hippocampal involvement, small 
volume corrections (SVCs) were applied for region of interest (ROI) analyses in the 
hippocampus using the Wake Forest University (WFU) PickAtlas software. Co-ordinates 
are given using the MNI convention (http://www.mni.mcgill.ca). Brain regions were 
visualised using the MANGO software package (Multi-image Analysis GUI) 
(http://ric.uthscsa.edu/mango) and images from SPM are presented. 





4.3.4.5 Correlation analyses 
Whether any significant differences between the groups were associated with 
psychopathology (in all groups) or medication status (only in the patient and control 
analyses) was evaluated by looking at the relationship between functional activation and 
symptom severity ratings (PANSS total, positive and negative score, YMRS, HDRS and 
GAF) and antipsychotic medication dose (CPZE). Correlations between PRS score (for 
schizophrenia, bipolar disorder and major depressive disorder) and significant between 
group activations were also performed in the family (PRS data was only available in 
carriers and non-carriers). For these analyses, only areas that showed significant differences 
during the group comparison were investigated within each group. Activation data was 
extracted (for peak voxel of activation) from SPM for use in SPSS correlation analyses. 
Pearson correlations were carrier out in the control and patient samples as data met 
assumptions for parametric statistics, however Spearman’s rank correlations were 
performed on the family member data as it did not meet the required assumptions. 
Correlation results are presented with and without correction for multiple comparisons, 
using false discovery rate (FDR) controlling procedures. FDR procedures have greater 
power than other methods of correcting for multiple comparisons such as Bonferroni. 
Bonferroni correction focuses on trying to reduce the familywise error rate, whereas FDR 
aims to reduce the rate of false discoveries. FDR correction ranks p-values in order of 
significance and applies a cut off p-value threshold, which is adjusted and reapplied for 
each significant result. For all correlations, p values were corrected using the Benjamini 
and Hochberg FDR procedure (1995), and considered significant when pFDR ≤ .05. This 
was conducted using SPSS syntax. 
 

















Chapter 5:  Functional magnetic resonance imaging comparison of 


















Chapter 5: Functional magnetic resonance imaging in the DISC1 t(1;11) 
translocation carriers and non-carriers 
This chapter aims to describe the investigation of functional activation during an episodic 
memory paradigm in individuals with and without the DISC1 t(1;11) translocation, to 
examine the impact of this translocation.  
 
5.1 Demographic details 
Demographic and clinical data are summarized in table 2. The final fMRI sample 
comprised 19 members from the t(1;11) kindred, 8 with the translocation and 11 without 
the translocation. All translocation carriers received a diagnosis of either recurrent major 
depression (n = 2), single episode depression (n = 2), cyclothymia (n = 3) or conduct 
disorder (n = 1). Therefore individuals with the translocation appear to have diagnoses of 
an affective nature rather than schizophrenia-related psychosis. In the non-carrier group, 
none received a current or past mental health diagnosis. All carriers and non-carriers were 
un-medicated at the time of testing. 
 
The mean age of the translocation carrier group was significantly higher than non-carriers 
(p = 0.039) and is therefore used as a covariate in the following analyses. There were no 
significant differences between the groups in terms of gender, current (WASI) and 
premorbid (NART) IQ, or on ratings of depression (HDRS). The groups did differ on 
PANSS total score (p = 0.005), which is expected due to the psychiatric diagnoses in the 
carrier group, however they did not differ on the positive or negative subscale of the 
PANSS. There was also a significant difference between groups on the YMRS with carriers 
demonstrating higher levels of manic symptoms (p = 0.011). The carriers also had 





significantly lower GAF scores, reflecting lower overall functioning (p = 0.048). Symptom 
rating scales were obtained from all participants to determine whether any differences 
between the family members were related to an illness effect and/or a direct effect of the 
translocation. 










Demographic and Clinical Measures 
Mean age (years) (SD) 52.25 
(16.82) 
32.09 (18.68) U = 19, 0.039* 
Gender (M:F) 
1:1 6:5 
X2 = 0.038, 
0.845** 
Mean NART score (SD) 103.88 
(4.29) 
100.8 (4.09) T = -1.28, 0.227 
Mean WASI score (SD) 94.13 
(13.13) 
92.43 (11.46) T = -0.265, 0.795 
Mean PANSS total score (SD) 40.38 (9.81) 31.45 (3.24) U = 12.5, 0.005 * 
Mean PANSS positive score 
(SD) 
8.5 (3.85) 7 (0) U = 33, 0.088 * 
Mean PANSS negative score  
(SD) 
7.38 (1.06) 7 (0) U = 38.5, 0.241* 
Mean YMRS score (SD) 3.5 (6.89) 0 (0) U = 22, 0.011* 
Mean HDRS score (SD) 3.75 (5.28) 1.27 (2.76) U = 25, 0.087 * 
Mean GAF score (SD) 80.63 
(11.48) 
89.5 (10.92) U = 18.5, 0.048* 
Task Performance 
Mean encoding % correct (SD) 91.15 
(13.82) 
88.63 (6.88) U = 26, 0.129 * 
Mean recognition % correct (SD) 85.41 
(21.60) 
89 (15.62) U = 34.5, 0.421 * 
Mean reaction time (SD) 1.21 (0.28) 1.15 (0.26) F = 0.2, 0.65 
*non parametric – Mann Whitney U ** Chi-square. Positive and negative symptom scale 
(PANSS), National adult reading test (NART), Young mania rating scale (YMRS), Hamilton 
depression rating scale (HDRS), Global assessment of functioning (GAF) 
Significant results highlighted in bold 





5.2 Episodic memory task performance  
Episodic memory task performance data are shown in table 2 and figure 5.1. There were 
no significant differences between the groups in terms of their performance (% correct) on 
encoding (p = 0.129) and recognition conditions (p = 0.421). There was also no difference 
between groups on mean reaction time across the episodic memory paradigm (p = 0.65). 
 
 
Figure 5.1: Episodic memory performance in t(1;11) carriers and non-carriers 
Mean % of correct responses during encoding and recognition in individuals with and 
without the t(1;11) translocation (error bars: 95% CI). 
 
 






For the imaging results, within group activations for encoding and recognition will be 
presented for each group in turn (carriers and non-carriers). Between group results will then 
be reported for encoding and recognition between groups. Statistical maps were 
thresholded at a level of p = 0.001 uncorrected (unless indicated at a level of p = 0.005 
uncorrected due to small sample size) and regions were considered significant at p < 0.05 
cluster level corrected for multiple comparisons across the whole brain volume. Brain 
regions were visualised using the MANGO software package and images from SPM are 
displayed. Mann-Whitney U nonparametric test revealed that there were no significant 
differences between the groups in terms of average motion per TR (mm) in the scanner (p 
= 0.186) (table 3). 
 








Mean motion per TR (mm) 
(SD) 
0.35 (0.17) 0.27 (0.21) U = 28 0.186* 
*non-parametric test used (Mann-Whitney U) 
 
5.3 Task-related activation - within group results 
Tables 3 and 4 list the regions that were significantly activated during the encoding and 
recognition stages of the task within each group. Consistent with prior reports, significant 
activation of the hippocampal formation was found during both encoding and recognition 
in all subjects (using SVC for the hippocampus). For results of large clusters the threshold 
was set to p < 0.0001 to define more specific areas of activation. 






For the encoding > baseline contrast non-carriers showed clusters of activation in the 
inferior frontal lobe, cingulate gyrus and precentral gyrus. A large cluster with the peak 
voxel at the right parrahippocampus (30, -49, -11, p < 0.001) showed significant activation, 
encompassing the cerebellum, inferior parietal lobe and the cingulate gyrus. Significant 
activation was also found in a smaller cluster in the parrahippocampus when using a SVC. 
Translocation carriers showed bilateral inferior parietal gyrus, insula, inferior/middle 
frontal gyrus and precentral gyrus activation. Significant activation was found in a large 
cluster with the peak at the left middle occipital lobe (-15, -94, 16, p < 0.001), which 
covered multiple regions including the thalamus, fusiform gyrus and cingulate gyrus.  
Significant activation was also found in the bilateral hippocampus in carriers, when using 
a SVC (see table 4 and figure 5.2). 
 




ke Z Peak Height 
(x, y, z) 
Peak voxel location, 
Brodmann area 
Encoding > Baseline     
Translocation carriers (n=8) 
<0.001 5486 5.19 -15, -94, 16 L middle occipital, 18 
0.034 44 4.11 -42, -7, -2 L insula, 13 
0.016 52 3.97 -48, -4, 49 L precentral gyrus, 4 
<0.001 248 4.56 63, -19, 25 R inferior parietal gyrus, 40 
<0.001 141 3.96 -60, -25, 31 L inferior parietal gyrus, 40 
0.002 80 3.93 63, 11, 22 R inferior frontal gyrus, 9 
0.014 54 3.75 42, 26, 16 R middle frontal gyrus, 46  
0.004* 25 4.41 33, -37, -8 R hippocampus 
0.049* 7 3.73 -27, -37, -5 L hippocampus 





Table 4 continued 
P value (cluster-level)      ke                     Z           Peak height (x, y, z)     Peak voxel location,          
                                                                                                                        Brodmann area 
Non-carriers (n=11) 
<0.001 6755 6.03 30, -49, -11 R parrahippocampus, 37 
0.019* 17 4.37 -18, -28, -8 
L parrahippocampus, 28  
0.001 119 4.78 51, 26, 34 R precentral gyrus, 9 
0.001 135 4.51 -9, 14, 43 L cingulate gyrus, 32 
0.003 104 4.07 -45, 32, -20 L inferior frontal gyrus, 47  
*thresholded at p=0.005 uncorrected 
Regions were considered significant at p < 0.05 cluster level corrected for multiple comparisons 




(a) Translocation carriers            (b) non-carriers 
 
Figure 5.2: Within group analysis in t(1;11) translocation carriers and non-carriers for 
encoding > baseline  
Encoding versus baseline analysis within groups in (a) translocation carriers (n=8), (b) 
non-carriers (n = 11). Sagittal, axial and coronal sections displayed. Maps thresholded at 









5.3.2 Recognition  
For the recognition > baseline contrast non-carriers showed clusters of activation in the 
superior frontal gyrus and bilateral insula (right insula activation thresholded at p = 0.005 
uncorrected). There was significant activation in a large cluster with peak voxel location at 
the right posterior cerebellum (21, -76, -14, p <0.001). This cluster covered several regions 
including the superior/inferior frontal gyrus, insula and precentral gyrus. Significant 
activation was also found in the bilateral parrahippocampus in non-carriers when using a 
SVC. Carriers showed bilateral activation in the lentiform nucleus, bilateral superior 
parietal gyrus, insula, superior frontal gyrus, bilateral precentral gyrus and middle frontal 
gyrus. Significant activation was also found in a smaller cluster in the right hippocampus 
when using a SVC (see table 5 and figure 5.3). 
Table 5: Within group activations in t(1;11) carriers and non-carriers during recognition  
p value (cluster-
level) 
ke Z Peak Height 
(x, y, z) 




    
Translocation carriers (n=8) 
<0.001 297 5.85 21, 20, -7 R lentiform nucleus, sub-lobar 
<0.001 210 4.11 -15, -7, -5 L lentiform nucleus, sub-lobar 
<0.001 473 5.79 30, -61, 43 R superior parietal lobe, 7 
<0.001 122 4.35 -36, -55, 55 L superior parietal lobe, 7 
<0.001 111 4.54 36, 26, 4 R insula, 13 
0.001 87 4.14 42, 44, 28 R superior frontal gyrus, 9 
0.002 76 4.12 -48, -7, 46 L precentral gyrus, 4 
0.013 53 4.03 30, -4, 55 R precentral gyrus, 6  
0.001 80 4.01 42, 8, 31 R precentral gyrus, 0 
0.028 45 3.91 36, 41, 10 R middle frontal gyrus, 10 
0.043** 39 3.35 36, -25, -17 R hippocampus 





Table 5 continued 
P value (cluster-level)      ke                     Z           Peak height (x, y, z)     Peak voxel location,          
                                                                                                                        Brodmann area 
Non-carriers (n=11) 
<0.001 
5711 5.67 21, -76, -14 
R posterior cerebellum 
 
0.020 
72 4.02 -30, 23, -2 L insula, 13 
 
0.015 
76 3.91 0, 14, 49 L superior frontal gyrus, 6 
 
<0.001* 
522 3.91 30, 26, 13 R insula, 13 
 
0.002** 
48 4.14 24, -28, -8 R parrahippocampus, 28 
 
0.036** 
11 3.67 -18, -28, -8 L parrahippocampus, 28 
*thresholded at p = 0.005 uncorrected 
** with SVC for hippocampus  
Regions were considered significant at p < 0.05 cluster level corrected for multiple comparisons 




(a) Translocation carriers            (b) non-carriers 
 
Figure 5.2: Within group analysis in t(1;11) translocation carriers and non-carriers for 
encoding > baseline  
Encoding versus baseline analysis within groups in (a) translocation carriers (n=8), (b) 
non-carriers (n=11). Sagittal, axial and coronal sections displayed. Maps thresholded at p 
<0.001 uncorrected voxel level.  





5.4 Between-group results 
Between group comparisons for encoding and recognition contrasts are displayed in table 
6. For both encoding and recognition contrasts, no regions were found to be more active in 
family members without the translocation compared to translocation carriers.  
 
Table 6: Between group activations in t(1;11) translocation carriers and non-carriers 
during encoding and recognition 
p value (cluster-
level) 
ke Z Peak Height (x, y, z) Peak voxel location, 
Brodmann region 
Encoding > Baseline     
Carriers > non-carriers 
0.001* 561 4.51 -15, -61, 16 L posterior cingulate, 30  
0.02* 263 3.99 51, -37, -14 R fusiform gyrus, 37 
0.022* 260 3.79 21, 59, 28 R superior frontal gyrus, 9 
Recognition > 
Baseline 
    
Carriers > non-carriers   
0.012 108 4.92 57, -61, -17 
R Fusiform gyrus, 37  
0.001 164 4.46 -3, -85, -32 
L posterior cerebellum,  
0.007* 298 4.53 66, -10, 4 
R superior temporal gyrus, 
22 
0.022* 237 4.29 -3, 50, -2 
L anterior cingulate, 32 
0.038* 209 4.22 30, 29, -11 
R inferior frontal gyrus, 47 
(VLPFC) 
0.041* 206 3.83 39, 50, 28 
R middle frontal gyrus, 9 
(DLPFC) 
*thresholded at p = 0.005 uncorrected 
Reverse contrasts of non-carriers > carriers were not significant 
Regions were considered significant at p < 0.05 cluster level corrected for multiple comparisons 










During encoding, translocation carriers showed greater activation in the left posterior 
cingulate, right fusiform gyrus, and right superior frontal gyrus (figure 5.4, 5.5 and 5.6). 
 
 
(a) left posterior cingulate            (b) right fusiform gyrus 
 
(c) right superior frontal gyrus 
 
Figure 5.4: Between group results for encoding > baseline in t(1;11) translocation carriers 
> non-carriers 
Effect of the t(1;11) translocation on fMRI activation during encoding. Encoding > baseline 
in carriers > non-carriers (p = 0.005) (a) left posterior cingulate (b) right fusiform gyrus (c) 
right superior frontal gyrus 
 







Figure: 5.5: Between group analysis for encoding > baseline in t(1;11) translocation 
carriers > non-carriers  
Significant activations between groups (carriers > non-carriers) during encoding. 
















Figure 5.6: Extracted values from peak voxels of activation for between group differences 
during encoding 
Extracted values from peak voxel in L posterior cingulate (-15, -61, 16), R fusiform gyrus 
(51, -37, -14) and R superior frontal gyrus (21, 59, 28) in non-carriers and carriers. Graph 
shows greater activation in carriers versus non-carriers  
 
 
5.4.2 Recognition  
During recognition translocation carriers showed greater activation in six regions; the right 
fusiform, left posterior cerebellum, right superior temporal gyrus, left anterior cingulate, 
right inferior frontal gyrus and right middle frontal gyrus (figure 5.7, 5.8 and 5.9). 
 






(a) right fusiform gyrus            (b) left posterior cerebellum 
 
(c) right superior temporal gyrus          (d) left anterior cingulate cortex 
 
(e) right inferior frontal gyrus                     (f) right middle frontal gyrus 
Figure 5.7: Between group results for recognition > baseline in t(1;11) translocation 
carriers > non-carriers 
Effect of the t(1;11) translocation on fMRI activation during recognition. Recognition > 
baseline in carriers > non-carriers (p = 0.005)  

















Figure 5.8: Between group analysis for recognition > baseline in t(1;11) translocation 
carriers > non-carriers 
Significant activations between groups (carriers > non-carriers) during recognition. 














Figure 5.9: Extracted values from peak voxels of activation for between group differences 
during recognition 
Extracted values from peak voxel in R fusiform gyrus (57, -61, -17), L posterior cerebellum 
(-3, -85, -32), R superior temporal gyrus (66, -10, 4), L anterior cingulate cortex (-3, 50, -
2), R inferior frontal gyrus (30, 29, -11) and R middle frontal gyrus (39, 50, 28) in non-
carriers and carriers. Graph shows greater activation in carriers versus non-carriers. 
 
 
5.4.3 Post-hoc ROI analysis: hippocampus 
Based on prior reports regarding hippocampal involvement in episodic memory, SVCs 
were applied for the hippocampus using the WFU PickAtlas software, however no 
significant hippocampal results were found.  
 
 





5.4.4 Correlation analyses  
Whether any differences between the groups were associated with psychopathology was 
evaluated by looking at the relationships between functional activation and symptom 
severity ratings using PANSS total score, PANSS positive, PANSS negative, YMRS, 
HDRS and GAF. For these analyses, activation data was extracted (for peak voxel of 
activation) from SPM for use in SPSS correlation analyses, in the areas that showed 
significant differences between groups (as shown in table 6). Spearman correlations were 
performed, as the data did not meet assumptions of normality. Exploratory correlations 
were examined for each group independently to avoid confounding the effects of group 
differences on correlation strengths. Correlation results are presented with and without 
correction for multiple comparisons (P-values were corrected using the FDR procedure and 
considered significant when pFDR ≤ 0.05). 
 
5.4.4.1 Encoding 
No correlations were significant during encoding in the carrier and non-carrier groups, 
between all imaging results (activation in the posterior cingulate, fusiform gyrus and 
superior frontal gyrus) and clinical measures (PANSS total score, PANSS positive, PANSS 












In the carrier group, there was a significant negative correlation between activation in the 
left ACC and scores on the YMRS (rs(8) = -0.736, p = 0.038), however this correlation did 
not survive FDR correction. In non-carriers, no correlation between activation in ACC and 
YMRS scores could be calculated because this clinical variable was constant across this 
group. In the non-carrier group there was a significant negative correlation between 
activation in the right middle frontal gyrus and scores on the HDRS (rs(11) = -0.740, p = 
0.009). This correlation survived FDR correction (pFDR = 0.009), (see table 7 and figure 
5.11). There was no significant correlation between carriers and activation in the right 
middle frontal gyrus (p = 0.740). No further correlations were significant between imaging 
data and other clinical measures during recognition (PANSS total, PANSS positive, 
PANSS negative and GAF, all p > 0.05). 
 
Table 7: Correlations between clinical variables and significant between group activations 
during recognition  
 L anterior cingulate 
cortex 
Carrier group  
(n = 8) 
L anterior cingulate 
cortex 
Non-carrier group  
(n = 11) 
R middle frontal 
gyrus 
Carrier group  
(n = 8) 
R middle frontal gyrus 
Non-carrier group  
(n = 11) 
PANSS 
total 
p = .382, rs = -.359 p = .509, rs = -.224 p = .599, rs = .117 p =.373, rs = -.298 
PANSS 
positive 
p = .162, rs  = .546 n/a p = .476, rs = .296 n/a 
PANSS 
negative 
p = .861, rs = .043 n/a p = .310, rs = .412 n/a 
HDRS p = .134, rs = -.577 p = .196, rs = -.422 p = .740, rs = -.140 pFDR = .009, rs = -.740 
GAF p = .379, rs = -.361 p = .475, rs = .325 p = .475, rs = .385 p = 0.375, rs = 0.315 
YMRS p = .038, rs = -.736 
(pFDR not sig) 
n/a 
 
p = .565, rs = .241 n/a 
 
rs = Spearman rank-order correlation coefficient, significant results highlighted in bold                               
n/a -  correlations could not conducted because the clinical variable was constant 











(a) carriers      (b) non-carriers  
Figure 5.11: Scatterplots showing correlations between extracted values and clinical 
measures during recognition in (a) carriers and (b) non-carriers 
Graphs showing (a) significant negative correlation between YMRS total score and 
activation in the left anterior cingulate cortex (p = 0.038, rs = -0.736) in carriers (n = 8) (b) 
significant positive correlation between HDRS score and activation in the right middle 
frontal gyrus (pFDR = 0.009, rs = -0.740) in non-carriers (n = 11) during recognition. Result 
in carriers not FDR corrected. 
 
5.4.5 Polygenic risk score 
There was no difference between carriers and non-carriers in terms of their polygenic risk 
scores (PRS) for schizophrenia, bipolar disorder or major depressive disorder (all p > 0.05) 
(table 8). Partial correlations, controlling for the number of risk variants scored for each 
individual, were conducted to investigate the relationship between polygenic risk and 
imaging findings. There were no significant correlations between polygenic risk and 
imaging during encoding.  
 
During recognition, when looking at the carrier group alone there were two significant 
correlations. There was a positive correlation between activation in the left ACC and PRS 
for bipolar disorder (rs(5) = 0.814, p = 0.026), and between activation in the right superior 





temporal gyrus and PRS for depression (rs (5) = 0.775, p = 0.041) (table 9 and figure 5.12). 
However these correlations did not survive FDR correction procedures (pFDR >0.05). There 
were no significant correlations in the non-carrier group (all p > 0.05).  
 
Table 8: Polygenic risk scores for carriers and non-carriers 





Polygenic Risk Score 




t = 0.719, 0.482 




t = -0.943, 0.359 




U = 40.5, 0.772* 
*non-parametric test used (Mann-Whitney U) 
 
Table 9: Correlations between polygenic risk scores and significant between group 
activations during recognition  
 L anterior cingulate 
Carrier group  
(n = 8) 
L anterior cingulate 
Non carrier group  
(n = 11) 
R superior temporal 
gyrus 
Carrier group  
(n = 8) 






p = 0.760, rs = 0.143 p = 0.463, rs = -0.263 p = 0.835, rs = -0.097 p = 0.483, rs = 0.252 
PRS bipolar 
disorder 
p = 0.026, rs = 0.814 
(pFDR not sig) 
p = 0.916, rs = -0.039 p = 0.989, rs = 0.006 p = 0.546, rs = 0.217 
PRS depression p = 0.388, rs = 0.390 p = 0.696, rs = 0.142 p = 0.041, rs = 0.775 
(pFDR not sig) 
p = 0.319, rs = 0.352 
rs = Spearman rank-order correlation coefficient, significant results highlighted in bold 
 





(a)           (b)     
                            
Figure 5.12: Scatterplots showing correlations between extracted values and PRS during 
recognition  
Graphs showing significant positive correlation between (a) PRS for bipolar disorder and 
activation in the left anterior cingulate in carriers (n = 8) (b) PRS for depression and 





















5.5.1 Summary of findings 
This experiment used fMRI to investigate the BOLD response during an episodic encoding 
and recognition memory task in family members with and without the DISC1 t(1;11) 
translocation. During encoding of neutral scenes, carriers of the translocation showed 
greater activation of the left posterior cingulate, right fusiform gyrus and right superior 
frontal gyrus compared to non-carriers. During recognition, carriers showed greater 
activation in the right fusiform gyrus, left posterior cerebellum, right superior temporal 
gyrus, left anterior cingulate, right inferior frontal gyrus (VLPFC) and right middle frontal 
gyrus (DLPFC). For both contrasts, no regions were found to be more active in non-carriers 
than in translocation carriers. There were no significant differences between the groups in 
terms of their performance on encoding and recognition conditions. The mean age of the 
carriers was significantly higher than non-carriers and was therefore included as a covariate 
in the analysis. 
 
Regions that were found to be over-active in carriers have been shown to be involved in 
memory encoding and recognition processing, and activation differences have been found 
in patients with schizophrenia and bipolar disorder, as will be discussed in this chapter. 
These findings begin to provide a better understanding of the neural effects of the t(1;11) 
translocation and support a role for the DISC1 translocation in episodic memory related 
brain activation. 
 
This section will first discuss the sample of translocation carriers included in the analyses 
and justify why it is still relevant to discuss the current findings in relation to psychosis. It 





will then discuss each significant between group result in carriers vs. non-carriers during 
encoding and recognition, focusing on the general function of each brain region, any 
evidence of an effect of DISC1 on the structure or function of each region, and finally its 
association with schizophrenia or bipolar disorder. It will then discuss limitations and 
strengths of the current experiment and future research considerations. 
 
5.5.2 Translocation carriers 
The current sample of family members with the translocation that took part all had a 
diagnosis of an affective nature ranging from MDD to cyclothymia, rather than a psychotic 
illness such as schizophrenia or bipolar disorder. This was not anticipated and is not 
representative of the wider family. From the recent re-evaluation of the family as part of 
the SFMHS, it can be noted that there has been a substantial increase in the proportion of 
translocation carriers with a diagnosis of schizophrenia since the original discovery of the 
family. Additional carriers that were recruited to the SFMHS had a diagnosis of either 
schizophrenia or bipolar disorder, however unfortunately they did not manage to complete 
the imaging section of the study. The sample of carriers who took part in the current study 
is discussed further as a limitation in chapter 7. 
 
It was planned to compare the effect of the t(1;11) translocation to that of having a psychotic 
disorder, therefore the current results will still be discussed in relation to schizophrenia and 
bipolar disorder, despite the affective diagnoses in the carrier group. This is because the 
translocation is associated with a range of clinical outcomes in the family, but has been 
proposed to have a more homogeneous effect on imaging measures. Previous research has 
found an effect of the translocation on brain function similar to that of patients with 





schizophrenia. Blackwood et al., (2001) found that translocation carriers (with a range of 
diagnoses including schizophrenia, depression or no diagnosis/symptoms) were similar to 
patients with schizophrenia on measures of P300 amplitude and latency, but differed 
significantly from non-carriers and controls. Further to this, they still found an effect of the 
translocation similar to that of schizophrenia, even when they only included carriers 
without a clinical diagnosis. Therefore, significant changes in the amplitude and the latency 
of P300 in translocation carriers appears not to be restricted to individuals with a psychiatric 
diagnosis, suggesting a trait marker of risk rather than state markers reflecting the presence 
of symptoms.  
 
These findings, together with the results from the wider SFMHS, suggest that the presence 
of the translocation may result in disturbances of brain function in all individuals, even 
though it only leads to major psychotic illness in a subgroup, presumably due to other 
interacting genetic (including structural genetic variants and polygenic risk loads) and 
environmental factors. As will be discussed in chapter 7, results from the SFMHS suggest 
a greater genetic impact upon neurobiological measures than clinical phenotypes, which is 
consistent with the previous P300 event-related potential results by Blackwood et al. 
(2001). These findings support the interpretation that the brain imaging abnormalities 
evident in the t(1;11) carriers are primarily genetic in origin and confer risk across a range 
of phenotypes. Based on this approach, although the current affective diagnoses in the 
carrier group are acknowledged as a potential limitation, this may not be as problematic as 
first thought.  
 





Further to this, there is substantial evidence in the literature to suggest that DISC1 is 
implicated in both schizophrenia and bipolar disorder (Ekelund et al., 2000, Hennah et al., 
2003, Thomson et al., 2005), so it is still of interest to compare the effect of the translocation 
to that of having a psychotic disorder, regardless of carriers clinical diagnosis. A challenge 
now will be to determine why the outcomes of DISC1 dysfunction are so variable, and why 
some individuals with the translocation are protected (Thomson et al., 2013). Therefore, 
although it is important to acknowledge that none of the carriers included in this study had 
a diagnosis of schizophrenia or bipolar disorder, it is still relevant to compare the effect of 
the translocation to that of having a psychotic disorder.  
 
However, it is still important to note that two explanations for the current findings are 
possible; the effect of the mental health disorders experienced by the carriers could be 
impacting brain function, or the translocation itself could be having the effect. The 
significant imaging findings were not correlated with psychotic or affective 
psychopathology in the carrier group, suggesting that the increased activation during 
episodic memory processing is due to the effects of the t(1;11) translocation, rather than 
the effects of having a disorder. This study is however unable to conclusively determine 
which explanation is correct and a more detailed evaluation of the family would be needed. 
However, the current results provide insight into the potential effect of the translocation.  
 
5.5.3 Encoding 
During encoding translocation carriers showed greater activation of the left posterior 
cingulate, right fusiform gyrus and right superior frontal gyrus compared to non-carriers. 
 





5.5.3.1 Posterior cingulate cortex  
The posterior cingulate cortex (PCC) has been shown to play an important role in cognition 
although there is no clear consensus regarding its function (Leech and Sharp, 2014). The 
PCC is a key part of the default mode network (DMN), which generally shows greater 
activation during periods of rest or internal thought, as well as deactivation during cognitive 
tasks requiring external attention (Buckner et al., 2008). This pattern of activation has been 
reported for a range of cognitive paradigms including a visual detection task (Singh and 
Fawcett, 2008). Episodic memory can be considered as internally directed cognition e.g. 
autobiographical memories, therefore increased activation in this network has been found 
during episodic memory recognition, specifically in posterior nodes (Sestieri et al., 2011, 
Spreng and Grady, 2010). 
 
The DISC1 Ser704Cys polymorphism has been associated with reduced PCC volume. For 
example, one study found that healthy individuals carrying the Cys allele demonstrated 
gray matter reduction in this region, compared to Ser carriers (Hashimoto et al., 2006). 
Reductions in this region were found in addition to reduced bilateral ACC and cingulate 
gyrus grey matter volume. There are no current functional imaging results showing an 
effect of DISC1 on this region.  
 
A failure to deactivate this network has been associated with cognitive impairment and is 
evident in many psychiatric disorders including schizophrenia (Kim et al., 2009, Pomarol-
Clotet et al., 2008, Salgado-Pineda et al., 2011). A mixed pattern of findings in 
schizophrenia has been reported with studies either reporting greater deactivation of certain 
regions of the DMN compared to controls (Harrison et al., 2007), or a failure to deactivate 





other regions, including the PCC (Garrity et al., 2007). Neuroimaging studies have found 
abnormalities of the structure of the PCC, primarily reduced gray matter volume (Pol et al., 
2001, Koo et al., 2008), and its white matter connections in schizophrenia (Fujiwara et al., 
2007).  
 
5.5.3.2 Fusiform gyrus 
Increased activation in translocation carriers was found during both the encoding and 
recognition of neutral scenes, in the right fusiform gyrus. The fusiform gyrus is part of the 
occipitotemporal lobe and is typically associated with facial recognition (Kanwisher et al., 
1997, Cabeza and Nyberg, 2000). However, there have been reports of activation during 
the processing of visual stimuli including scenes (Stern et al., 1996, Gabrieli et al., 1997), 
and object recognition (Ishai et al., 1999, Chao et al., 1999). Co-activation of the fusiform 
gyrus and hippocampus has also been found during encoding of novel visual stimuli (Rand-
Giovannetti et al., 2006, Golby et al., 2005), and a recent study by Smith et al. (2009) 
identified a pathway connecting the mid-fusiform and the amygdala/hippocampus that is 
important in object recognition (Smith et al., 2009). The fusiform gyrus may also be 
involved in novelty detection, (Tulving et al., 1996, Kirchhoff et al., 2000), which may 
support the current findings as novel visual scenes were presented during both encoding 
(all scenes) and recognition (of which half of the stimuli presented were ‘new’ scenes). 
 
Previous research has found an effect of the DISC1 Ser704Cys polymorphism on grey 
matter volume in the fusiform gyrus (Di Giorgio et al., 2008). This study found a positive 
correlation between the number of Ser alleles and gray matter volume in bilateral fusiform 
gyrus in healthy individuals. An association between activation in this region has also been 





found with other susceptibility genes for schizophrenia. For example, increased activation 
in the fusiform gyrus during episodic memory encoding has been associated with NRG1 
genotype (Krug et al., 2010), which has been shown to interact with DISC1 (Mata et al., 
2010). 
 
Previous research has found activation in the fusiform gyrus during a novel picture 
encoding task in healthy controls (Stern et al., 1996), highlighting the importance of this 
region for visual object recognition. A further study using the same picture encoding task 
compared activation of patients with schizophrenia and controls using fMRI, and found 
decreased activation in the fusiform gyrus in their patient group (Zorrilla et al., 2003). 
Structural imaging studies have also revealed a reduction in grey matter volume in the 
fusiform gyrus in patients with schizophrenia compared to controls (Lee et al., 2002, 
Onitsuka et al., 2003). 
 
5.5.3.3 Superior frontal gyrus 
The superior frontal gyrus has been shown to play a role in higher cognitive functions 
including working memory (du Boisgueheneuc et al., 2006), however the nature of its exact 
involvement remains unclear. Several studies have shown an association between DISC1 
polymorphisms and the structure and function of the superior frontal gyrus. Trost et al. 
(2013) found reduced grey matter volume in superior frontal regions was associated with 
the minor allele status for two DISC1 SNPs (Leu607Phe and Ser704Cys) (Trost et al., 
2013). This is in line with other research that has demonstrated reduced superior frontal 
volumes in healthy subjects with the minor allele of the Ser704Cys polymorphism 
(Takahashi et al., 2009), and reduced grey matter in patients and controls with the 





Leu607Phe risk allele (Szeszko et al., 2008). A further study Di Giorgio et al. (2008) has 
also provided evidence of an effect of DISC1 genotype in the Ser704Cys SNP on brain 
function in the superior frontal gyrus during the same memory encoding task used in the 
current experiment (Di Giorgio et al., 2008). This study found greater activation in this 
region in ‘risk’ Ser allele carriers using an exploratory whole-brain analysis. 
 
Patients with schizophrenia have been found to have reduced cortical thickness compared 
to healthy controls in this region, which was unrelated to antipsychotic medication and 
duration of illness (Tully et al., 2014). This study also found that thinner cortex in this 
region was related to reduced cognitive control on a category fluency task and overall 
functional outcome. These results suggest that abnormalities in the superior frontal gyrus 
affect cognitive processing and have an influence upon real world functioning. Episodic 
memory deficits have also been associated with poor functional outcome (Green et al., 
2000). 
 
A recent meta-analysis of studies investigating individuals at high-risk for bipolar disorder 
concluded that increased activation in the superior and medial frontal gyrus was evident in 
those at high risk, regardless of the imaging task used (Fusar-Poli et al., 2012). These 
results, together with evidence of prefrontal hyperactivation in euthymic patients with 
bipolar disorder (Adler et al., 2004, Wessa et al., 2007), suggest that enhanced activation 










During recognition, carriers showed greater activation in the right fusiform gyrus, left 
posterior cerebellum, right superior temporal gyrus, left anterior cingulate, right inferior 
frontal gyrus (VLPFC) and right middle frontal gyrus (DLPFC) compared to non-carriers.  
 
5.5.4.1 Prefrontal cortex 
The current results found that individuals with the t(1;11) translocation demonstrated 
increased activity compared to non-carriers during recognition in two prefrontal regions; 
the right VLPFC and DLPFC. The translocation appears to modulate PFC function during 
episodic memory, which is consistent with the critical role of this region in the 
pathophysiology of psychosis. 
 
5.5.4.1.1 Inferior frontal gyrus (VLPFC) 
The left inferior prefrontal cortex has been shown to be involved in the encoding of verbal 
and nonverbal information, the implementation of memory strategies (Simons and Spiers, 
2003), and in the maintenance of successfully retrieved information (Badre and Wagner, 
2002, Petrides, 2002). Whereas, the right inferior frontal gyrus has been shown to be 
involved in the effortful process of recognition, but not necessarily in successful memory 
recognition (Bremner et al., 2004). Further research has found evidence of a material-
specific effect during episodic memory, reporting that activation in this region is left 
lateralized when verbal stimuli is used, whereas visuo-spatial stimuli is more likely to result 
in right VLPFC activity (Wagner et al., 1998a, Golby et al., 2001). This may support the 
current finding in the right VLPFC in translocation carriers during recognition, as the 
current task is simply measuring memory recognition processing (i.e. did not distinguish 





between correct and incorrect responses), and was using non-verbal stimuli. There is also 
evidence that the VLPFC is involved in explicit encoding strategies as the use of such 
strategies has shown to engage this region and dramatically improve memory recognition 
(Ranganath et al., 2008). 
 
5.5.4.1.2 Middle frontal gyrus (DLPFC) 
Several lines of research suggest that the DLPFC is crucial for different memory processes 
including episodic and working memory. Research supports the idea that the DLPFC 
contributes to episodic long term memory formation through its role in working memory 
organization (Blumenfeld and Ranganath, 2006). Evidence suggests that there may be a 
hemispheric asymmetry of activation during episodic memory processes with greater 
involvement of the left DLPFC during encoding and greater activation in the right 
hemisphere during the recognition phase (Tulving, 1985), whereas other studies have 
reported bilateral activation of the DLPFC (Schmidt et al., 2002). Hemispheric activation 
may also depend on task complexity as activation is usually greater in the right middle 
frontal gyrus for more simple tasks, with additional recruitment of the left hemisphere for 
more complex designs (Achim and Lepage, 2005). These findings may provide support for 
the right lateralised DLPFC results during recognition in carriers, as the current task was 
relatively simple. 
 
5.5.4.1.3 Effect of DISC1 on PFC function 
Previous research has provided evidence to suggest that DISC1 has an influence on PFC 
functioning. Prata et al. (2008) used fMRI during a verbal fluency task, a standard measure 
of prefrontal activation, to test the influence of DISC1 on PFC function in healthy controls 





(Prata et al., 2008). They found that Ser homozygotes demonstrated less efficient PFC 
activation, particularly in the middle and superior frontal gyri. In a later study the same 
authors examined the influence of this polymorphism in patients with schizophrenia and 
bipolar disorder, however found no effect on PFC activation. The authors interpret the 
absence of an observable effect in the patient sample as an indication of underlying 
interactions between DISC1 genotype and a multitude of other risk genes that have been 
implicated in schizophrenia together with potential interactions with unknown genetic 
factors. A study investigating the effect of the Ser704Cys polymorphism on brain 
morphology also found that Cys carriers have larger superior frontal volumes, but again 
only in health controls (Takahashi et al., 2009). 
 
A recent study examined the effect of the same DISC1 polymorphism on PFC function, 
with Cys allele carriers considered at-risk (Opmeer et al., 2015). The Cys allele has 
previously been associated with affective disorders including depression (Hashimoto et al., 
2006). This study used a visuospatial planning task in healthy controls and patients with an 
affective disorder, and found a differential effect of DISC1 on PFC activation depending 
on the presence of psychopathology. Controls with the risk Cys allele demonstrated lower 
activation in the DLPFC and ACC. This effect was reversed in patients with anxiety, 
whereas depressive patients showed no effect of genotype. 
 
A recent study by Brauns et al. (2011) investigated the effects of another DISC1 SNP 
Leu607Phe, and found that neural activity in the DLPFC during a working memory task 
was increased in Phe allele carriers (Brauns et al., 2011). The Phe allele has been previously 
associated with schizophrenia (Cannon et al., 2005, Hodgkinson et al., 2004). The authors 





interpreted this increased activity as cortical inefficiency, suggesting that risk carriers need 
to recruit additional neural resources to perform at the same level as those without the risk 
allele.  
 
As discussed, previous research has investigated the effect of various DISC1 
polymorphisms on brain structure and function. The literature is however mixed and shows 
different effects of DISC1 genotype depending on the sample studied e.g. controls or 
patients, the imaging paradigm used, or the genotype considered ‘at-risk’. For example 
some studies consider the Ser allele the risk-variant as it has been shown to be over 
transmitted in patients (Callicott et al., 2005), whereas others suggest individuals 
homozygous for the Cys allele have increased susceptibility to schizophrenia (Qu et al., 
2007). 
 
Research has identified that the same DISC1 allele may display alternate risk or protection 
for schizophrenia, suggesting that the effect of a specific susceptibility gene is dependent 
not only on the existence of one risk variant on the gene, but also on the presence or absence 
of other risk variants within the same gene (Hennah et al., 2009). This demonstrates the 
complex nature of gene interactions and the need to take other genetic and environmental 
factors into consideration that might mediate the phenotypic consequence of DISC1 and 
risk for schizophrenia. However the effect of genotype variation in DISC1 SNPs on brain 
structure and function suggests that the DISC1 gene is at least partly involved in the 
neurobiology of schizophrenia (Takahashi et al., 2009). The effect of the DISC1 
translocation on functional imaging measures has only recently been investigated as part of 





the SFMHS. We therefore do not yet know the mechanism of this effect and it is also likely 
to be related to complex gene-gene and gene-environment interactions.  
 
5.5.4.1.4 Prefrontal activation in patients 
A recent quantitative meta-analysis of functional neuroimaging studies of episodic memory 
in schizophrenia found that deficits were most consistently associated with dysfunction in 
the PFC (Ragland et al., 2009). This review found that patients demonstrated significantly 
less prefrontal activation in dorsolateral and ventrolateral regions during both encoding and 
recognition. These findings are supported by another meta-analysis examining fMRI 
studies of executive function in schizophrenia showing disruption of a fronto-cingulate 
network including reduced activation in the bilateral DLPFC and right VLPFC 
(Minzenberg et al., 2009). There is further meta-analytic evidence that the VLPFC is a key 
region in distinguishing between patients and controls during episodic memory processing, 
however once again patients usually show reduced activation (Achim and Lepage, 2005).  
There are mixed findings of hyper and hypo-frontality during episodic memory tasks in 
patients with schizophrenia. It has been suggested that low task demand is associated with 
increased PFC activation in patients because the task is within their ability, however 
requires recruitment of more resources to achieve a similar level of accuracy to healthy 
controls (Manoach, 2003). The task used in this study appeared to be relatively easy and 
required low cognitive demand. All participants included in the analysis achieved a 
minimum of 75% accuracy during encoding and 70% during recognition. It may be the case 
that the increased PFC activation in the translocation carrier group in the current results 
reflects compensatory over-activation when viewing neutral scenes. 
 





The neural underpinnings of episodic memory in bipolar disorder are still uncertain 
however several studies have found both dorsal and ventral PFC dysfunction across a range 
of tasks (Frangou et al., 2008). There are inconsistent findings regarding PFC activation in 
patients with bipolar disorder. Some studies show hypoactivation (Hamilton et al., 2009, 
Townsend et al., 2010), whereas others have found hyperactivation (Adler et al., 2004, 
Monks et al., 2004). A recent study examining working memory in euthymic patients 
showed an increase in activation in the right middle frontal gyrus compared to healthy 
controls (Dell’Osso et al., 2015).  
 
Increased VLPFC activity has been reported in patients with bipolar disorder. Robinson et 
al. (2008) examined neural activity during an affective face-matching task in euthymic 
bipolar disorder (Robinson et al., 2008). They found that patients showed hyperactivation 
in inferior prefrontal regions compared to healthy controls. Another study also found 
increased activation in the right VLPFC in euthymic patients during an emotional stroop 
task (Blumberg et al., 2003b). Furthermore, there was a lateralization difference that related 
to mood state. Elevated mood was associated with right hemisphere lateralization whereas 
depression was linked to the left hemisphere. Results of these studies support a trait-related 
disruption of PFC activity in bipolar disorder. 
 
5.5.4.2 Temporal regions 
Translocation carriers showed increased activation in the superior temporal gyrus and 
fusiform gyrus during recognition. Studies have found an association between the superior 
temporal gyrus and DISC1 genotype. Ser homozygotes have been found to show an 
accelerated rate of cortical thinning in temporal regions including the superior temporal 





gyrus (Raznahan et al., 2011). Reduced cortical thickness in this region has also been 
reported in relation to another DISC1 SNP (rs1322784) (Brauns et al., 2011). These 
findings suggest a relationship between DISC1 genotype and cortical development in the 
superior temporal gyrus.  
 
Neuroimaging studies have found that patients with schizophrenia demonstrate greater 
activation in the superior temporal gyrus in response to visual working memory tasks, 
reflecting a failure to deactivate this region compared to controls (Walter et al., 2007). 
Abnormal fronto-temporal connectivity between the superior temporal and frontal cortex 
has also been implicated in schizophrenia (Lawrie et al., 2002). Further to these findings, 
first episode patients and individuals with an ‘at risk mental state’ for psychosis have also 
shown temporal lobe dysfunction and abnormal functional connectivity during working 
memory but to a lesser extent than patients (Crossley et al., 2009). These findings suggest 
that the superior temporal gyrus may be involved in the neurobiology of psychosis. 
 
4.5.4.3 Anterior cingulate cortex 
Activation in the anterior cingulate was also found to be increased in translocation carriers 
during recognition. Both groups showed a pattern of deactivation in this region, therefore 
the between-group finding reflects less deactivation in the carriers compared to non-
carriers. Research suggests that the ACC plays a role in memory and cognitive control, and 
imaging studies indicate a prominent role for the ACC in episodic memory recognition 
(Paus et al., 1998, Lepage et al., 2000, Weis, 2004). Herrmann et al. (2001) found an 
anterior cingulate-prefrontal activation pattern during a memory retrieval task requiring the 
control of interfering information, indicating that the control of semantic interference in 





episodic memory retrieval selectively engages specific frontal regions (Herrmann et al., 
2001). 
 
Several studies have reported effects of DISC1 genotype on the structure and function of 
the cingulate cortex, including the ACC. Hashimoto et al. (2006) studied healthy controls 
to investigate the impact of the Ser704Cys SNP, reporting decreased ACC grey matter 
volume in Cys homozygotes. The Cys allele has been associated with MDD, and decreased 
ACC volume has also been reported in patients and individuals with a family history of 
depression (Hashimoto et al., 2006). The Ser allele has also been associated with abnormal 
structure in this region, with a recent study reporting accelerated cortical thinning in the 
left ACC in healthy Ser carriers (Raznahan et al., 2011). The Leu607Phe SNP has also been 
implicated in the structure of the ACC. Szeszko et al. (2008) found an association between 
Phe carriers and reduced grey matter in the ACC, in both a sample of healthy controls and 
patients with schizophrenia (Szeszko et al., 2008). A recent study by Chakirova et al. (2011) 
found an effect of a different DISC1 risk variant (rs821633) on activation in the cingulate 
gyrus (Chakirova et al., 2011). Risk allele carriers showed reduced activation in this region 
from a sample of patients with bipolar disorder. These findings provide evidence that 
variation in the DISC1 gene may affect the structure and function of the ACC. 
 
The ACC is important in the pathophysiology of both schizophrenia and bipolar disorder 
(Adams and David, 2007, Brooks et al., 2010). Several studies have reported 
underactivation of the ACC in patients with schizophrenia (Schlosser et al., 2008, Garrity 
et al., 2007, Whalley et al., 2006), whereas overactivation in these regions has been 
consistently demonstrated in patients with bipolar disorder (Cerullo et al., 2009). The 





following chapter (chapter 6) will discuss the ACC in relation to schizophrenia and bipolar 
disorder in greater depth.  
 
4.5.4.4 Cerebellum  
The current results demonstrate increased activity in translocation carriers during 
recognition in the left posterior lobe of the cerebellum. The cerebellum has previously been 
implicated in episodic memory processes and cerebellar activity has frequently been found 
during recognition (Cabeza et al., 2002, Fliessbach et al., 2007, Weis, 2004).  
 
DISC1 is widely expressed in the brain in several regions including the cerebellum (Chubb 
et al., 2008). Chakirova et al. (2011) found an interaction between genotype and group 
status in the left cerebellum, during a sentence completion task. In patients with 
schizophrenia, risk allele carriers showed greater activation in the cerebellum, whereas in 
the control group risk status was associated with decreased activation (Chakirova et al., 
2011). These results illustrate the different effect SNPs can have depending on unknown 
underlying genetic and environmental factors. Carless et al. (2011) also found an effect of 
another DISC1 SNP (rs16854954) on left cerebellum volume in a large family based study 
in individuals without psychiatric illness (Carless et al., 2011).  
 
Meta-analyses investigating episodic memory deficits in schizophrenia have also identified 
the cerebellum amongst the most extensive difference between patients and controls, with 
increased activation usually in controls (Achim and Lepage, 2005, Ragland et al., 2009). 
However, the specific functional mechanisms underlying the contribution to cognition and 
memory by the cerebellum remain to be resolved. Evidence suggests that a network 





between the PFC and cerebellum, linked through synapses in the thalamus, plays a crucial 
role in coordinating motor and cognitive functions (Andreasen et al., 1998, Andreasen et 
al., 1999). Abnormalities in these regions provide support for disruption to a frontocortical–
thalamic cerebellar circuit in schizophrenia. There is also recent evidence that the DISC1 
Ser704Cys polymorphism influences the thalamic-prefrontal circuitry (Liu et al., 2013a). 
As highlighted in this discussion, there is evidence that components of this network are 
involved in cognitive functions that are key for episodic memory recognition, including the 
DLPFC, the ACC and the cerebellum. The current results also found significant group 
differences in these regions, however did not however find activation in the thalamus. 
 
The cerebellum also appears to be implicated in the pathophysiology of bipolar disorder. 
Studies have reported structural deficits in posterior cerebellar regions (Kim et al., 2013). 
The cerebellum has also been shown to play a role in emotional processing and regulation, 
which is implicated in bipolar disorder (Hoppenbrouwers et al., 2008). However, a recent 
study comparing cerebellar volume in schizophrenia and bipolar disorder with and without 
psychotic features found that reduction in cerebellar cortical volume was specific to 
schizophrenia (Laidi et al., 2015). 
 
5.5.5 Correlation analyses 
Exploratory correlation analyses were also performed to investigate whether abnormalities 
involving episodic memory processing circuitry were associated with clinical symptoms. 
There was a significant negative correlation between YMRS score and activation in the left 
ACC in the carrier group during recognition. Relatively few imaging studies have focused 
on symptoms of mania in mood disorders. Studies have reported activation differences in 





this region, however contrary to the current results, they tend to report increased activation 
of the ACC associated to manic symptoms (Blumberg et al., 2000, Goodwin et al., 1997, 
Whalley et al., 2009). However, it is important to note that manic symptoms in our current 
sample were relatively low in all subjects. 
 
In the non-carriers there was a significant negative correlation between HDRS scores and 
activation in the right middle frontal gyrus during recognition. Findings from fMRI studies 
suggest that there is decreased DLPFC activation in patients with depression (Blumberg et 
al., 2003b). This finding is in line with previous studies. Whalley et al. (2009) investigated 
emotional memory during fMRI in patients with schizophrenia and bipolar disorder, and 
associations between activation levels and symptom severity across the disorders. This 
study found a negative correlation between depression scores on the HDRS and activation 
in the DLPFC, mainly driven by the bipolar group (Whalley et al., 2009).  
 
Hypofrontality has been reported in depression during resting state activity, primarily in 
the DLPFC (Koenigs and Grafman, 2009, Galynker et al., 1998). Previous research on 
bipolar depression has been less consistent but has also reported decreased DLPFC 
activation, with some evidence of a negative relationship between activation and measures 
of depression (Brooks et al., 2009b).  Further research has found that patients with 
depression tend to show greater activation of the DLPFC during tests of working memory 
and cognitive control when performance is matched to controls (Harvey et al., 2005). This 
is assumed to reflect the need for greater recruitment of resources in this region to maintain 
a similar level of performance. This may be the case in the current findings demonstrating 
increased activation of the DLPFC in the translocation carrier group. 





The correlations conducted in the family must be interpreted with caution due to small 
group numbers and the presence of outliers, in particular one individual in the carrier group 
who scored substantially higher on all clinical measures. Outliers were not removed from 
the analysis due to small numbers and nonparametric statistics were performed to account 
for this where possible.  
 
Overall, differences in activation were observed between carriers and non-carriers in 
several regions during encoding and recognition despite similar behavioural performance 
on an episodic memory task. Association with manic and depression scores within groups 
were also reported indicating different mood states may be associated with different 
pathophysiological processes. 
 
5.5.6 Polygenic risk score 
There was no significant difference between carriers and non-carriers in terms of their PRS 
for schizophrenia, bipolar disorder or MDD. This suggests that it is the translocation that 
is causing differences in activation between groups and not simply an increased polygenic 
liability to psychiatric illness. PRS data was not available for patients and controls in the 
current sample so it could not be investigated whether the family members (carriers and 
non-carriers) have an increased PRS compared to controls.  
 
Partial correlations, controlling for the number of risk variants scored for each individual, 
were also performed to investigate the relationship between polygenic risk and imaging 
findings. There were no significant correlations between polygenic risk and imaging during 
encoding. When looking at the carrier group alone there was a significant positive 





correlation between activation in the left ACC and PRS for bipolar disorder, and between 
activation in the right superior temporal gyrus and PRS for depression. There were no 
significant correlations in the non-carrier group. 
 
There were only significant correlations when examining the carrier group alone. 
Therefore, it could be the effect of increased polygenic risk in addition to the presence of 
the translocation that is influencing the relationship between PRS and imaging findings. 
Previous research on polygenic risk has suggested that genetic risk factors not captured by 
PRS, for example the presence of rare variants, could influence the relationship between 
polygenic risk and brain function (Whalley et al., 2015b). 
 
Previous research has used this polygenic approach and found increased activation of 
limbic regions to be associated with increased polygenic risk for bipolar disorder, for 
example in the ACC (Whalley et al., 2012a). The ACC has been implicated in bipolar 
disorder and as will be demonstrated in the following results chapter, it is a key region 
found to be over activated in patients with bipolar disorder during the current episodic 
memory task.  
 
5.5.7 Strengths and limitations 
There are several limitations to the current findings. Firstly, the sample size was small for 
both groups, which may have resulted in insufficient power to detect significant effects. 
Low statistical power also reduces the probability that a statistically significant finding 
actually mirrors a true effect (Button et al., 2013). The age of the translocation carrier group 
was significantly higher than the non-carrier group and was therefore entered as a covariate 





in the second-level analysis, however it is still possible that the current findings are due to 
the effects of age. However, the low number and age of participants was unavoidable due 
to the nature of the family being studied, as cases occur infrequently and are often difficult 
to recruit. The unique nature of the family being studied and that no research has previously 
investigated the effect of the t(1;11) translocation on neuroimaging measures, arguably 
outweighs such methodological limitations. The current findings of this work are novel and 
provide evidence to suggest that the translocation does impact on neuroimaging measures, 
despite potential confounding factors.  
 
Contrary to the hypothesis, and to previous studies investigating DISC1 allelic variation 
using the same memory task (Callicott et al., 2005, Di Giorgio et al., 2008), the current 
results did not find an influence of the translocation on hippocampal activation during 
episodic memory. This may have been due to several methodological limitations, or may 
reflect the true absence of an effect of the translocation in this region. Activation in the 
hippocampus was only found within groups during both encoding and recognition when a 
SVC in the hippocampus was applied. Therefore, it is possible that the amplitude of neural 
responses in the groups in the hippocampus may not have been sufficient to evoke 
detectable differences in hemodynamic response between groups (Sheth et al., 2004). 
 
A lack of findings in the hippocampus has also been reported in other studies. Ragland et 
al. (2009) did not find consistent evidence for altered hippocampal activity in their 
quantitative meta-analysis of functional neuroimaging studies of episodic memory in 
schizophrenia (Ragland et al., 2009). A further study did not find an effect of the Ser704Cys 
polymorphism on hippocampal activation during episodic memory in healthy participants 





(Opmeer et al., 2015). fMRI studies examining associations between DISC1 
polymorphisms, including Ser704Cys and Leu607Phe, with hippocampal activation have 
provided inconsistent results (Duff et al., 2013). There are further limitations regarding the 
analysis and task used however these will be discussed in the final chapter. 
 
5.5.8 Conclusion  
In summary, this chapter presents the first evidence of functional alterations during 
encoding and recognition in association with the DISC1 t(1;11) translocation, in brain 
regions that are known to be affected in patients with major psychiatric disorders. Many of 
these brain regions have also been shown to be associated with genetic variation in DISC1 
polymorphisms. Primarily, translocation carriers showed greater activation in fronto-
temporal regions compared to non-carriers. This may reflect the need for carriers to recruit 
additional neural resources to perform at the same level as those without the translocation. 
Activation in these regions during recognition was also correlated to polygenic risk for 
bipolar disorder and depression, and to symptom measures of mania and depression. There 
were no correlations to psychosis related symptoms or PRS for schizophrenia. As will be 
discussed in the final synthesis chapter, patients with schizophrenia and bipolar disorder, 
and their unaffected relatives, show episodic memory related neural abnormalities in 
prefrontal and temporal regions. The current findings of this work are novel and provide 
insight into the potential effect of the translocation in episodic memory related brain 
activation. However as previously discussed, results must be considered in light of potential 
confounding factors in particular the age difference between groups and the affective 
diagnoses and symptoms present in the carrier group.  
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Chapter 6: Functional magnetic resonance imaging comparison of controls and 
patients 
This chapter will present the neuroimaging findings in healthy controls, patients with 
schizophrenia and patients with bipolar disorder, in order to look at differences in activation 
during encoding and recognition between groups. This sample of controls and patients was 
included to allow the comparison of having a psychiatric disorder to the effects of the 
t(1;11) translocation, without the need for direct comparisons between family members and 
patients, which would be confounded by relatedness within the family. 
 
6.1 Demographic Details 
Demographic and clinical data are summarized in table 10. The final fMRI sample 
comprised of 40 healthy controls and 41 patients (30 with schizophrenia, 11 with bipolar 
disorder). There were no significant differences between the groups in terms of age, gender 
or current (WASI) and premorbid (NART) IQ (all p > 0.05) however they did differ on 
PANSS total score, negative symptoms and positive symptoms as expected. PANSS 
measures were significantly higher in both patient groups compared to healthy controls 
(controls versus schizophrenia U = 89, p < 0.001, controls versus bipolar disorder U = 60, 
p < 0.001), however there was no significant difference between patients with 
schizophrenia and bipolar disorder. There were also significant differences between groups 
on the YMRS and HDRS (p < 0.05), again higher in both patient groups compared to 
healthy controls, however no significant difference between patient groups. GAF scores 
were significantly different between all groups with controls scoring highest, followed by 
patients with bipolar disorder, and patients with schizophrenia scored significantly lower 





(controls versus schizophrenia U = 21, p < 0.001, controls versus bipolar disorder U = 14, 
p < 0.001, schizophrenia versus bipolar disorder U = 58.5, p = 0.021). 
 
Table 10: Demographics and clinical measures in controls and patients 







Demographic and Clinical Measures 
Mean age (years) (SD) 38 (14.47) 35.83  (10.25) 42.91 (13.67) χ
2 = 1.47, 0.480* 
Gender (M:F) 11:9 11:4 8:3 χ2 = 2.91, 0.233** 
Mean NART (SD) 
111.24 (7.47) 109.17 (10.86) 114.9 (6.33) 
χ2 = 2.18, 0.337* 
 
Mean WASI score (SD) 
114.89 (11.91) 104.29 (17.85) 110.0 (15.74) 
χ2 = 5.72, 0.057* 
 
Mean PANSS total 
score (SD) 
31.4 (3.99) 53.5 (16.95) 45.5 (15.71) χ
2 = 48.85, <0.001* 
Mean PANSS positive 
score 
(SD) 
7.2 (0.72) 13.2 (5.48) 10.2 (2.57) χ
2 = 41.7, <0.001* 
Mean PANSS negative 
score  
(SD) 
7.06 (0.24) 12.97 (5.75) 11.2 (6.48) χ
2 = 41.7, <0.001* 
Mean YMRS score 
(SD) 
0.13 (0.79) 2.03 (3.17) 2.55 (2.54) χ
2 = 31.72, <0.001* 
Mean HDRS score 
(SD) 
0.8 (2.93) 8.37 (8.29) 8.18 (8.36) χ
2 = 34.28, <0.001* 
Mean GAF score (SD) 87.58 (7.89) 48.48 (17.68) 62.89 (17.89) χ




- 414.14 (335.08) 152.27 (152.27) U = 79, 0.011* 
*non parametric test used (Mann Whitney U/Kruskal-Wallis) ** Chi square 
Positive and negative symptom scale (PANSS), National adult reading test (NART), Wechsler Abbreviated 
Scale of Intelligence (WASI), Young mania rating scale (YMRS), Hamilton depression rating scale (HDRS) 
Significant results highlighted in bold 
 





6.2 Medication Status 
From the subjects included in the analysis, twenty-seven patients with schizophrenia and 
four patients with bipolar disorder were treated with antipsychotic medication, which was 
examined by converting different antipsychotic drug doses into chlorpromazine equivalents 
(CPZE). There was a significant difference between patients with schizophrenia and bipolar 
disorder in terms of CPZE (p = 0.011), with patients with schizophrenia taking greater 
levels of antipsychotic medication (table 10). 
 
In the schizophrenia group, antipsychotic medication included olanzapine, clozapine, 
amisulpride, risperidone, depixol, clopixol, stelazine, chlorpromazine, aripiprazole and 
quetiapine. Three patients with schizophrenia were not on antipsychotic medication, 
however two of these individuals were on a mood stabilizer (carbamazepine) or anti-
depressant (fluoxetine), and one was not taking any medication. In the bipolar group, eight 
were taking a mood stabilizer (valproate, lithium or lamotrigine), and four individuals were 
taking antipsychotic medication (three on olanzapine and one on modecate). One individual 
was also taking an anti-depressant in addition to a mood stabiliser and antipsychotic. Two 
patients with bipolar disorder were not taking any medication. 
 
6.3 Episodic memory task performance  
Episodic memory task performance data are shown in table 11 and figure 6.1. Kruskal-
Wallis nonparametric tests revealed that there were no significant differences between the 
groups in terms of their performance (% correct) on encoding (p = 0.659) and recognition 
conditions (p = 0.081). Mean reaction time (seconds) across the whole experiment 
(encoding and recognition phases) was compared between the groups. A one-way ANOVA 





found a significant difference between groups (F(2,78) = 4.46, p = 0.015) and post-hoc 
Bonferroni corrections revealed that this difference was between controls and patients with 
schizophrenia (p = 0.012), with patients taking longer to respond (figure 6.2). 
 
 
Table 11: Episodic memory performance in controls and patients 








Mean encoding % 
correct (SD) 95.94 (4.27) 91.39 (14.05) 
95.84 
(3.71) 
χ2 = 0.833, 0.659* 
 
Mean recognition  % 
correct (SD) 91.77 (9.9) 82.77 (18.53) 
92.49 
(8.74) 
χ2 = 5.035, 0.081* 
 
 
Mean reaction time 
(sec) 
 (SD) 
1.12 (0.18) 1.26 (0.22) 1.20 (0.24) 
F = 4.46, 0.015 
con vs. scz, 0.012 
*non-parametric test used (Kruskal-Wallis) 
Controls (con), patients with schizophrenia (scz) 
 






Figure 6.1: Episodic memory performance in controls and patients  
Mean % of correct responses during encoding and recognition in healthy controls, patients 
with schizophrenia and bipolar disorder (error bars: 95% CI). 
 






Figure 6.2: Reaction time in patients and controls  
Mean reaction time (seconds) across the episodic memory paradigm (encoding and 
recognition phases) in controls and patients (error bars: +/- 1 SD). 
 
fMRI results 
For the imaging results, within group activations for encoding and recognition will be 
presented for each group in turn (controls, patients with schizophrenia and patients with 
bipolar disorder). Between group results will then be reported for encoding and recognition 
for the following group comparisons; controls vs. schizophrenia, controls vs. bipolar 
disorder, and schizophrenia vs. bipolar disorder. Statistical maps were thresholded at a level 
of p = 0.001 uncorrected (unless indicated at a level of p = 0.005) and regions were 
considered significant at p < 0.05 cluster level corrected for multiple comparisons across 
the whole brain volume. Brain regions were visualised using MANGO and images from 
SPM are displayed. Kruskal-Wallis nonparametric tests revealed that there were no 





significant differences between the groups in terms of average motion per TR (mm) in the 
scanner (p = 0.11) (table 12). 
 
Table 12: Mean motion per TR (mm) in patients and controls 







Mean motion per TR 
(mm) (SD) 
0.195 (0.07) 0.260 (0.14) 0.264 (0.14) χ
2 = 4.4, 0.11* 
*non-parametric test used (Kruskal-Wallis) 
 
 
6.4 Task-related activation - within group results 
Table 13 lists the regions that were significantly activated during the encoding stage of the 
task and table 14 lists the areas of activation during recognition, both within each group. 
Figures 6.3 and 6.4 illustrate within group activations during encoding and recognition, 
respectively. For results of large clusters the threshold was set to p < 0.0001 to define more 




During encoding controls showed significant activation compared to baseline in a large 
cluster with the peak at the left cerebellum (-18, -79, -8, p < 0.001). This result encompassed 
multiple regions including frontal cortices (including DLPFC and VLPFC), bilateral 
activation in the hippocampal formation (hippocampus and parrahippocampus), parietal 
cortices, and other structures including the cingulate gyrus, insula, thalamus, fusiform 
gyrus and cerebellum (see figure 6.3a). Several of these regions form a distributed network 





that is crucial for visuospatial information processing (Di Giorgio et al., 2008, Bertolino et 
al., 2006). 
 
6.4.1.2 Patients with schizophrenia 
During encoding patients with schizophrenia showed significant activation compared to 
baseline in a large region with the peak at the right cuneus (9, -94, 10, p < 0.001). This 
cluster encompassed many regions including frontal lobes (middle, inferior, superior and 
medial), inferior/superior parietal, bilateral insula, caudate, thalamus, parrahippocampus 
and precuneus (see figure 6.3b). 
 
6.4.1.3 Patients with bipolar disorder 
During encoding compared to baseline, patients with bipolar disorder showed significant 
activation in a large cluster with the peak at the right cerebellum (24, -52, -14, p < 0.001) 
(see figure 6.3c). This cluster encompassed many regions including bilateral hippocampus, 
thalamus, fusiform gyrus, posterior cingulate and insula. Other significant results included 













Table 13: Within group activations in patients and controls during encoding   
p value (cluster-
level) 
ke Z Peak Height 
(x, y, z) 
Peak voxel location, 
Brodmann area 
Encoding > Baseline     
Controls (n=40) 
<0.001 26310 inf -18, -79, -8 Peak L cerebellum 
Schizophrenia (n=30) 
<0.001 26483 inf 9, -94, 10 Peak R cuneus, 17 
Bipolar disorder (n=11) 
<0.001 11191 6.17 24, -52, -14 Peak R cerebellum, 
culmen 
0.003 119 4.41 -39, -34, 34 L inferior parietal, 40 
0.012 92 4.40 48, 44, 10 R middle frontal, 46 
0.002 137 4.27 45, 11, 22 R inferior frontal. 9 
0.029 75 3.88 -6, 11, 46 L cingulate, 24 
<0.001* 473 4.20 24, -1, 64 R middle frontal, 6 
*thresholded at p=0.005 uncorrected 
Regions were considered significant at p < 0.05 cluster level corrected for multiple comparisons 

















(a) controls             (b) patients with schizophrenia 
 
(c) patients with bipolar disorder  
 
Figure 6.3: Within group analysis in controls and patients for encoding > baseline 
Encoding > baseline analysis within groups in (a) controls (n = 40), (b) patients with 
schizophrenia (n = 30) and (c) patients with bipolar disorder (n = 11). Sagittal, axial and 









6.4.2 Recognition  
6.4.2.1 Controls 
During recognition there was significant activation in a large cluster with a peak at the left 
middle occipital gyrus (-12, -91, 19, p < 0.001). This region of significant activation 
included frontal (medial, superior, inferior, middle gyrus, cingulate gyrus), temporal 
(bilateral thalamus, parahippocampus/hippocampus, fusiform), parietal (bilateral superior, 
inferior gyrus) precuneus and caudate, in contrast to baseline (see figure 6.4a).  
 
6.4.2.2 Patients with schizophrenia 
During recognition patients showed significant activation in a large cluster with the peak 
at the right lingual gyrus in the occipital lobe (3, -88, 4, p < 0.001). This result included 
several regions associated with the task including middle, medial and inferior frontal, 
inferior/superior parietal cortices, occipital lobe, parrahippocampus, cingulate gyrus, 
insula, thalamus, fusiform gyrus and precuneus. There was also another significant cluster 
at the left precentral gyrus (-39, 2, 31, p < 0.001) (see figure 6.4b). 
 
6.4.2.3 Patients with bipolar disorder  
During recognition patients showed significant activation with a peak at the left cerebellum 
(-33, -52, -20, p < 0.001) encompassing superior/inferior frontal gyrus, insula and 
precentral gyrus (see figure 6.4c). Other significant results were in a large cluster with peak 
at the right middle frontal (51, 32, 25, p < 0.001), which included the left middle frontal, 
inferior parietal, left claustrum and right caudate (see table 14). 
 
 





Table 14: Within group activations in patients and controls during recognition  
p value (cluster-
level) 
ke Z Peak Height 
(x, y, z) 




    
Controls (n=40) 
<0.001 25721 inf -12, -91, 19 Peak L middle occipital 
gyrus, 18 
Schizophrenia (n=30) 
<0.001 14563 inf 3, -88, 4 Peak  R lingual gyrus, 
occipital lobe, 18 
<0.001 
331 5.23 -39, 2, 31 
L precentral gyrus, frontal 
lobe, 6 
Bipolar disorder (n=11) 
<0.001 8896 6.01 -33, -52, -20 L cerebellum, culmen 
<0.001 1173 4.69 51, 32, 25 R middle frontal, 9 
0.010 94 4.36 -45, -34, 37 L inferior parietal, 40 
<0.001 535 4.20 -36, 5, 55 L middle frontal, 6 
<0.001 176 4.09 -27, 23, -5 L Claustrum, sub-lobar 
0.011 92 3.81 15, 11, 16 R caudate body, sub-
lobar 
Regions were considered significant at p < 0.05 cluster level corrected for multiple comparisons 
















(a) controls      (b) patients with schizophrenia  
 
(c) patients with bipolar disorder 
 
Figure 6.4: Within group analysis in controls and patients for recognition > baseline 
Recognition > baseline analysis within groups in (a) controls (n = 40), (b) patients with 
schizophrenia (n = 30) and (c) patients with bipolar disorder (n = 11). Sagittal, axial and 










6.5 Between-group results  
Table 15 shows the group comparisons between controls, patients with schizophrenia and 
patients with bipolar disorder, during memory encoding and recognition. This section will 
report encoding and recognition results in turn for the following group comparisons; 
controls vs. schizophrenia, controls vs. bipolar disorder, schizophrenia vs. bipolar disorder 
and the patient group as a whole vs. controls. 
 
Table 15: Between group activations in patients and controls during encoding and 
recognition  
p value (cluster-level) ke Z Peak Height (x, y, z) Peak voxel location, 
Brodmann area 
Encoding > Baseline     
Schizophrenia > controls  
<0.001 567 4.89 39, -34, 52 R inferior parietal lobe, 40 
<0.001 277 4.46 -57, -31, 34 L inferior parietal lobe, 40 
All patients > controls  
<0.001 383 5.09 -57, -31, 34 L inferior parietal lobe, 40 
<0.001 508 4.75 39, -34, 52 R inferior parietal lobe, 40 
0.034 115 4.78 -54, -73, 7 L inferior temporal lobe, 37 
Recognition > Baseline     
Control > schizophrenia  
0.006 206 4.44 6, 20, 10 R caudate, anterior cingulate, 33 
Bipolar disorder > controls 
0.018* 324 4.53 -24, 29, 7 L caudate, anterior cingulate 33, 
insula 13, inferior frontal lobe 
45/46 
Bipolar disorder > schizophrenia   
0.012 108 4.92 15, 14, 16 R caudate, anterior cingulate, 33 
*thresholded at p=0.005 uncorrected (regions were considered significant at p < 0.05 cluster level 
corrected for multiple comparisons across the whole brain volume) 
For the encoding > baseline contrast, there were no significant results when comparing controls and patients 
with bipolar disorder. For the recognition > baseline contrast, there were no significant results when 
comparing controls and all patients combined. 





6.5.1 Controls vs. patients with schizophrenia  
6.5.1.1 Encoding 
During encoding, patients with schizophrenia demonstrated increased activation bilaterally 
in the inferior parietal lobe compared to healthy controls (39, -34, 52, p < 0.001 in right 
hemisphere, -57, -31, 34, p < 0.001 in left hemisphere). Patients did not show any regions 
with decreased BOLD responses compared to healthy controls.  
 
(a)       (b) 
 
Figure 6.5: Between group result for encoding > baseline contrast in patients with 
schizophrenia > controls 
(a) Result shows area of greater activation in patients with schizophrenia compared to 
controls in bilateral inferior parietal lobe (p < 0.001). Maps thresholded at p = 0.001 
uncorrected. Crosshair position at right IPL, x = 39, y = -34, z = 52. Image from SPM 
(b) Extracted values from peak voxel at inferior parietal lobe in left (-57, -31, 34) and right 









6.5.1.2 Recognition  
During recognition controls showed increased activation of a region including the right 
caudate and anterior cingulate compared to patients with schizophrenia (6, 20, 10, p = 
0.006). Patients did not show any significant regions of increased activation.  
 
 
Figure 6.6: Between group result for recognition > baseline contrast in controls > patients 
with schizophrenia 
Result shows greater activation in healthy controls in a region encompassing the caudate 
and anterior cingulate (p = 0.006), compared to patient with schizophrenia. Maps 












6.5.2 Controls vs. patients with bipolar disorder 
6.5.2.1 Encoding 
Patients with bipolar disorder showed no significant differences in activation compared to 
healthy controls during the encoding phase of the task.  
 
6.5.2.2 Recognition  
During recognition patients demonstrated increased activation in a region encompassing 
the left caudate and anterior cingulate, extending to inferior frontal lobe and insula (-24, 




Figure 6.7: Between group result for recognition > baseline contrast in patients with bipolar 
disorder > controls  
Result shows greater activation in patients with bipolar disorder in a region encompassing 
the caudate and anterior cingulate (p = 0.018), compared to healthy controls. Maps 
thresholded at p = 0.005 uncorrected. Crosshair position at left caudate: x = -24, y = 29, z 
= 7).  
 
 





6.5.3 Schizophrenia vs. bipolar disorder 
6.5.3.1 Encoding 
When comparing the two patient groups, there were no significant differences during the 
encoding phase.  
 
6.5.3.2 Recognition  
During recognition there was a significant difference between patient groups, with patients 
with bipolar disorder showing increased activation in the right caudate extending to the 




Figure 6.8: Between group result for recognition > baseline contrast in patients with bipolar 
disorder > patients with schizophrenia  
Result shows greater activation in patients with bipolar disorder in a region encompassing 
the caudate and anterior cingulate (p = 0.012), compared to patients with schizophrenia. 
Maps thresholded at p = 0.001 uncorrected. Crosshair position, right caudate: x = 15, y = 










Figure 6.9: Extracted values from peak voxel of activation in the right caudate during 
recognition across groups 
Extracted values from peak voxel in right caudate (15, 14, 16) in controls, patients with 

















6.5.4 Patient group as a whole vs. controls 
To further investigate the between group results, differences between healthy controls and 
the patient groups combined (participants with schizophrenia and bipolar disorder) were 
examined to investigate overall effects of illness. There were no significant results during 
recognition, however during encoding the patient group showed an area of greater 
activation in bilateral inferior parietal lobe (this result seems to be driven by the patients 
with schizophrenia), and also in the left inferior temporal gyrus (-54, -73, 7, t = 4.78, z = 




Figure 6.10: Between group result for encoding > baseline contrast in patient group as a 
whole > controls 
Result shows greater activation in all patients (with schizophrenia and bipolar disorder) in 
the left inferior temporal gyrus (p = 0.034), compared to controls. Maps thresholded at p = 










6.5.5 Post-hoc ROI analysis: hippocampus 
Based on prior reports regarding hippocampal involvement in episodic memory, SVCs 
were applied for the hippocampus using the WFU PickAtlas software, however no 
significant hippocampal results were found.  
 
6.5.6 Correlation analyses 
Data was extracted from SPM for the peak voxel of activation for each significant between 
group result (as displayed in table 15) and then correlated against medication status and 
clinical measures using SPSS. Pearson correlations were performed as the data was 
normally distributed. All correlation analyses were computed for each subject group 
independently to avoid confounding the effects of group differences on correlation 
strengths. Correlation results are presented with and without correction for multiple 
comparisons (P-values were corrected using the FDR procedure and considered significant 
when pFDR ≤ 0.05). 
 
6.5.6.1 Effects of antipsychotic medication 
Any significant differences between patients and controls were investigated by relating 
functional activation to antipsychotic medication dose (chlorpromazine equivalents). 
During encoding, there was a significant positive association of moderate effect between 
CPZE and peak activation in the left inferior parietal lobe in the schizophrenia group (r = 
0.406, p = 0.026, n = 30), however this did not survive FDR correction, pFDR > 0.05. There 
were no statistically significant correlations between antipsychotic medication status and 
fMRI group results during recognition (all p > 0.05) (table 16). 
 





6.5.6.2 Effects of psychopathology 
Whether any differences between groups were associated with psychopathology was 
evaluated by looking at the relationships between functional activation and symptom 
severity ratings; PANSS total score, PANSS positive, PANSS negative, YMRS and HDRS. 
 
Table 16: Correlations between clinical variables and significant between group 
activations during encoding and recognition  
 Encoding – L inferior 
parietal lobe 
Schizophrenia group  
(n = 30) 
Recognition – caudate 
Schizophrenia group 
 (n = 30) 
Recognition – caudate 
Bipolar disorder group  
(n = 11) 
PANSS total p = 0.071, r = -0.335 p = 0.151, r = -0.269,  p = 0.188, r = 0.453,  n = 10 
PANSS positive p = 0.512, r = -0.125 p = 0.825, r = -0.042 p = 0.034, r = 0.669, n = 10 
(pFDR not sig) 
PANSS negative p = 0.249, r = -0.271 p = 0.035, r = -0.387 
(pFDR not sig) 
p = 0.155, r = 0.486, n = 10 
HDRS p = 0.020, r = -0.421 
(pFDR not sig) 
p = 0.495, r = -0.130 p = 0.607, r = 0.175, n = 11 
YMRS p = 0.060, r = -0.347 p = 0.916, r = 0.020 p = 0.166, r = 0.449, n = 11 
Medication status 
(CPZE) 
p = 0.026, r = 0.406 
(pFDR not sig) 
p = 0.190, r = -0.246 p = 0.311, r = 0.337, n = 11 


















During encoding there was a moderate negative correlation between activation in the left 
inferior parietal lobe and scores on the HDRS in the schizophrenia group (r = -0.421, p = 
0.020, n = 30) i.e. those with greater depressive symptoms showed decreased activation of 
the inferior parietal lobe (figure 6.11). However, this result did not survive FDR correction, 
pFDR > 0.05. This result was derived from the schizophrenia > controls contrast during 
encoding, so there is no corresponding result in the bipolar group. 
 
 
Figure 6.11: Scatterplot of activation in the left inferior parietal lobe and HDRS score 
during encoding for patients with schizophrenia 
Significant negative correlation between Hamilton Depression Rating Scale scores and 
activation in the left inferior parietal lobe during the encoding versus baseline contrast in 
patients with schizophrenia (not FDR corrected). 
 






During recognition there were two significant correlations. There was a weak negative 
correlation between activation in the right caudate and PANSS negative scores in the 
schizophrenia group (r = -0.387, p = 0.035, n = 30). This correlation was not significant in 
the bipolar group (p = 0.155). A test of the interaction was also performed and was non-
significant (p = 0.249) (figure 6.12). 
In the bipolar group activation in the right caudate was strongly positively correlated with 
PANSS positive scores (r = 0.669, p = 0.034, n = 10), whereas this was not significant in 
the schizophrenia group (p = 0.825). A test of the interaction was also performed and was 
non-significant (p = 0.321) (figure 6.13).  
All other correlations with symptom measures were non-significant (all p > 0.05). It should 
also be noted that neither of these correlations survived FDR correction, pFDR > 0.05 
 






Figure 6.12: Scatterplot of activation intensity in the right caudate and PANSS negative 
symptoms score during recognition for patients with schizophrenia and bipolar disorder 
Significant negative correlation between PANSS negative symptom scores and activation 
in the right caudate during the recognition versus baseline contrast in patients with 
schizophrenia (not FDR corrected). Patients with greater negative symptoms showed 
lower activation of this region. 
 
 






Figure 6.13: Scatterplot of activation intensity in the right caudate and PANSS positive 
symptoms score during recognition for patients with bipolar disorder and schizophrenia 
Significant positive correlation between PANSS positive symptom score and activation in 
the right caudate during the recognition versus baseline contrast in patients with bipolar 
disorder (not FDR corrected). Patients with higher negative symptoms showed greater 














6.6.1 Summary of findings 
This experiment used fMRI to investigate the BOLD response during an episodic encoding 
and recognition memory task in a sample of healthy controls and patients with 
schizophrenia and bipolar disorder. Compared to healthy controls, patients with 
schizophrenia demonstrated increased activation during encoding in the inferior parietal 
lobe bilaterally, and decreased activation of the anterior cingulate and caudate nucleus 
during recognition. Patients with bipolar disorder showed no differences compared to 
controls during encoding, and increased activation during recognition in a region 
encompassing the caudate and anterior cingulate, extending to inferior frontal lobe and 
insula. Patients with bipolar disorder also showed increased activation in the same region, 
encompassing the ACC and caudate, compared to patients with schizophrenia. 
 
6.6.2 Encoding results 
6.6.2.1 Inferior parietal lobe 
Patients with schizophrenia showed greater activation than controls bilaterally in the 
inferior parietal lobe. Although the literature suggests that the most common regions 
activated during episodic memory are in prefrontal and medial temporal lobes, memory 
processing also involves several other brain regions including the parietal lobes (Wagner 
et al., 2005). The parietal cortex, the inferior parietal lobe in particular, is relevant in the 
neurobiology of schizophrenia with structural deficits reported in patients (primarily 
reductions in volume however results are inconsistent) (Torrey, 2007). Patterns of abnormal 
activation in this region have also been demonstrated during various cognitive processes, 
for example, hypoactivation of the parietal lobe during working memory has been found in 





patients with schizophrenia and has been associated with poorer performance (Menon et 
al., 2001a).  
 
The parietal lobe has been shown to support the frontal lobe in the storage and retrieval of 
information (Jonides et al., 1998), and forms connections with the frontal lobe (Seltzer and 
Pandya, 1984). There is also evidence to suggest that functional and structural 
abnormalities related to schizophrenia may begin in the parietal lobe and progress to frontal 
regions, suggesting that these alterations may occur early in the course of the illness (Yildiz 
et al., 2011). Prefrontal-parietal networks are also involved in several cognitive processes 
including working memory (Deserno et al., 2012) and episodic memory recognition (Weiss 
et al., 2009). 
 
The parietal lobe has also been implicated in studies with individuals at high genetic risk 
of schizophrenia. Studies have shown altered activation of the parietal lobe in relation to 
several cognitive tasks such as increased activation during a verbal fluency task (Whalley 
et al., 2004), increased activation during working memory (Callicott et al., 2003) and 
decreased activation during spatial working memory in high risk individuals (Keshavan et 
al., 2002).  
 
During encoding there was a significant negative correlation of moderate effect between 
activation in the left inferior parietal lobe and scores on the HDRS in the schizophrenia 
group i.e. patients with higher depressive scores showed lower activation in this region. 
This is in line with previous findings, for example Whalley et al. (2009) found a negative 
correlation between depression scores and activation in the same region during an 





emotional memory task (Whalley et al., 2009).  
 
Dysfunction of the left inferior parietal cortex has been found in patients with schizophrenia 
and depression (Müller et al., 2013). The inferior parietal lobe has also been shown to play 
a role in attentional processing, and patients with depressive symptoms exhibit greater 
activation in this region in response to negative stimuli (Canli et al., 2004), whereas the 
current task used non-emotive neutral stimuli. This finding suggests that there is an 
association between depressive symptoms and disrupted episodic memory encoding in 
patients with schizophrenia. 
 
Any significant differences between patients and controls were investigated by relating 
significant between group activations to antipsychotic medication. There was no evidence 
of any effect of medication on brain activation in the regions of interest except for a 
moderate positive correlation between antipsychotic dose and left inferior parietal 
activation during encoding in the schizophrenia group (p = 0.026). This finding may 
represent an effect of antipsychotic medication rather than a true difference between 
groups. However, this association was only found in the left hemisphere and not in the 
significant result from the right hemisphere, and did not survive FDR correction 
procedures.  
 
The current results provide support for an association between schizophrenia and altered 
activity in the inferior parietal lobe during episodic memory encoding. Despite research 
supporting an important role of this region in schizophrenia, the inferior parietal lobe has 
not received as much attention in the literature compared to other areas such as the PFC 





and hippocampus, and perhaps deserves more investigation to establish the role it plays in 
this disorder.  
 
6.6.2.2 Patient group as a whole 
To further investigate the between group results, differences between healthy controls and 
the patient groups combined (participants with schizophrenia and bipolar disorder) were 
examined to investigate overall effects of illness. This was done in order to reflect the range 
of conditions that the t(1;11) translocation has been associated with (Craddock and Owen, 
2010) and is in line with current approaches that look to investigate mental disorders not 
constrained by DSM diagnostic categories (Insel et al., 2010). During encoding the patient 
group showed an area of greater activation bilaterally in the inferior parietal lobe (this result 
seems to be driven by the patients with schizophrenia), and an additional result in the left 
inferior temporal gyrus. 
 
Neuroimaging studies have found that the inferior temporal gyrus is involved in visual 
mental imagery (Cabeza et al., 2004) and selectively responds to task-relevant visual 
stimuli (Hamamé et al., 2012). Functional deficits in these cognitive processes have been 
reported in patients with schizophrenia (Tek et al., 2002), alongside evidence of grey matter 
volume reductions in bilateral inferior temporal gyrus in patients with chronic 
schizophrenia (Onitsuka et al., 2014). There is also limited evidence of decreased grey 
matter volume in this region in patients with bipolar disorder (Farrow et al., 2005). A 
further study found deficits in left inferior temporal grey matter that were related to an 
increased genetic liability to schizophrenia but not bipolar disorder (McIntosh et al., 2006). 





These findings suggest that this region appears to play a role in the pathophysiology of 
schizophrenia. 
 
6.6.3 Recognition results 
6.6.3.1 Patients with schizophrenia 
Compared to healthy controls and patients with bipolar disorder, patients with 
schizophrenia demonstrated decreased activation in a region encompassing the caudate 
nucleus and ACC during recognition. During recognition in the contrast examining bipolar 
disorder > schizophrenia, there was a negative correlation between PANSS negative 
symptom scores and right caudate activation in the schizophrenia group. 
 
6.6.3.2 Anterior cingulate cortex 
The ACC is implicated in the neurobiology of schizophrenia with structural deficits such 
as reduced volume reported in patients (Galderisi et al., 2008, Zetzsche et al., 2007, Narr 
et al., 2005, Haznedar et al., 2004). The ACC has been found to be differentially activated 
in response to a range of neuropsychological tasks (Haznedar et al., 1997, Dolan et al., 
1995, Hofer et al., 2014) and studies have found both hyper and hypo activation of this 
region. In line with the current findings, several studies have reported underactivation of 
the ACC in patients with schizophrenia (Schlosser et al., 2008, Garrity et al., 2007, Whalley 
et al., 2006). A review of activation deficits during episodic memory in schizophrenia found 
that during recognition, reduced activation in the right ACC was amongst the most 
extensive differences between patients and controls (Ragland et al., 2009).  
 





The ACC has been hypothesised to be involved in the recognition of newly learned 
information (Meunier et al., 1997) and has been proposed to play an important role in 
executive control (D'Esposito et al., 1995). The ACC has also been associated with several 
cognitive processes including amplification of task relevant stimuli (Egner and Hirsch, 
2005), and resolving conflict during information processing (Van Veen and Carter, 2002). 
Therefore, failure to activate this region in the patient group could reflect an attentional 
deficit or executive functioning difficulties (Hofer et al., 2014). 
 
The cingulate cortex has extensive connections between core limbic structures such as the 
amygdala and frontal regions such as the PFC, as part of a fronto-limbic system that is 
crucial for successful execution of internally generated, task-oriented actions (Szeszko et 
al., 2008). Fronto-limbic connectivity also plays a key role in the pathophysiology of 
schizophrenia (Bilder and Degreef, 1991). Using a verbal version of the current task, a 
recent study found decreased activation in the cingulate cortex during recognition in 
individuals at high genetic risk for schizophrenia due to the presence of the high risk variant 
of the BDNF val66met polymorphism (Baig et al., 2010). 
 
A study by Hofer et al. (2014) investigated patterns of brain activity during episodic 
encoding and recognition of words in unmedicated patients during an acute episode of 
schizophrenia compared to healthy controls. During word recognition, reduced activation 
was found in the patient group in the DLPFC and limbic/paralimbic regions including the 
ACC and insula (Hofer et al., 2014). These results provide support for a difference between 
patients with schizophrenia and healthy controls during recognition even when patients are 





not prescribed antipsychotic medication. The current findings in this region during 
recognition were not correlated with antipsychotic medication doses. 
 
6.6.3.3 Caudate 
Reduced activation was found during recognition in the caudate nucleus in patients with 
schizophrenia. The caudate, along with the putamen and nucleus accumbens, is part of the 
striatum, which is a component of the basal ganglia. The basal ganglia has increasingly 
been shown to be involved in several cognitive functions, with the caudate playing an 
important role in the planning and execution of strategies required for goal-directed 
behaviours (Grahn et al., 2008). The caudate also plays a role in learning and memory, 
specifically in stimulus-response associations, as evidence by lesion and neurobehavioural 
studies in animals, and neurodegenerative diseases and neuroimaging in humans (Packard 
and Knowlton, 2002). Research has also demonstrated deficits in basal ganglia activation 
in patients with schizophrenia during a motor sequencing task (Menon et al., 2001b). 
 
Koch et al. (2008) examined working memory retrieval during fMRI and found that patients 
with schizophrenia revealed decreased activation in the caudate bilaterally and the ACC 
compared to controls, when matched for performance (Koch et al., 2008). The authors 
interpret the finding of hypoactivation in these regions as a result of impaired general 
cognitive rather than motor processes in patients, due to the fact that results were still 
detectable after matching for performance. The caudate and the ACC have both been linked 
with impaired cognitive control (Postuma and Dagher, 2006, Egner and Hirsch, 2005), and 
disturbances in the function of these regions have been reported in several psychiatric 
disorders including schizophrenia.  





One study found that the basal ganglia and medial temporal lobe memory systems may 
compete with each other during declarative memory processing (Poldrack et al., 2001). 
This study found that activation in the caudate nucleus and medial temporal lobe was 
negatively correlated within subjects. Further to this, learning appeared to be dependent on 
MTL structures during the early stages of learning whereas individuals relied on the 
striatum with increased training.  
 
Caudate volume reduction in patients with schizophrenia has been found, however it is not 
consistently reported (Ebdrup, 2010). Caudate reduction has also been demonstrated in the 
offspring of patients with schizophrenia, which may represent a measure of familial risk of 
psychosis (Rajarethinam et al., 2007). However, other studies have reported no difference 
in caudate volume in at risk individuals (Lawrie et al., 2001). Findings in the literature are 
inconsistent however appear to report that reduced caudate volume is likely to be associated 
with the pathophysiology of schizophrenia. However, enlarged caudate size is typically 
related to antipsychotic medication exposure, which may explain findings of increased 
volume size in chronically treated patients with schizophrenia (Lang et al., 2014). It is likely 
that medication can induce alterations in the striatum as medicated patients with a first 
episode of psychosis have shown greater reductions in caudate size compared to patients 
with chronic schizophrenia treated with antipsychotics (Ellison-Wright et al., 2008). The 
current finding of reduced activation in the caudate in patients during recognition was not 
correlated with medication dose, suggesting that this finding is not due to antipsychotic 
medication dose in the patient group. However, it cannot be entirely dismissed that the 
caudate hypoactivation is a result of the antipsychotic medication that patients received. 
 





A recent study was able to categorize individuals into schizophrenia and control groups 
using a measure of hemispheric specialization (altered brain asymmetry) of the caudate 
nucleus with an accuracy rate of 74% (Mueller et al., 2015). The authors highlight the 
importance of caudate connectivity and asymmetry, and suggest that this could serve as a 
potential endophenotype of schizophrenia. 
 
The current results found that patients with schizophrenia with greater negative symptoms 
on the PANSS demonstrated lower activation of the right caudate. Previous research has 
found an association between the caudate and negative symptoms. Young et al. (1991) 
found that patients with marked negative symptoms had a bilateral reduction in the caudate 
nucleus (Young et al., 1991). On the other hand, increased caudate volume has been 
associated with greater severity of negative symptoms in patients treated with antipsychotic 
medication (Gur et al., 1998). Another study investigating medication-naïve patients found 
that all items on the negative subscale of the PANSS were negatively correlated with 
regional blood flow in several regions including the basal ganglia and cingulate (Sabri et 
al., 1997). 
 
The current finding in the right caudate extended to the ACC. The ACC has been shown to 
be involved in the development of negative symptoms in patients (Cascella et al., 2010). A 
recent review by Bersani et al. (2014) suggested that hypoactivity of the cingulate cortex, 
in particular the ACC, is related to negative symptoms such as social withdrawal in patients 
with schizophrenia (Bersani et al., 2014). Volume reduction in the ACC has also been 
shown to be more pronounced in patients with greater negative symptoms (Preuss et al., 
2010). 





6.6.3.4 Fronto-striatal network 
Disruption of a fronto-striatal network, including both the caudate and ACC, appears to 
contribute towards negative symptoms such as apathy and lack of motivation (Cummings, 
1993). Altered function of fronto-striatal circuitry is a key finding in schizophrenia, with 
reports of increased (Salvador et al., 2010) and decreased fronto-striatal connectivity 
(Welsh et al., 2010). fMRI studies have demonstrated altered fronto-striatal activity in 
patients undergoing various cognitive tasks, for example during working memory 
performance (Quidé et al., 2013). Fronto-striatal dysfunction has also been found in the 
unaffected siblings of individuals with schizophrenia during reward processing (de Leeuw 
et al., 2015). This study found reduced activation in this circuit in siblings compared to 
controls, which correlated with the degree of sub-clinical negative symptoms including lack 
of motivation and apathy. These findings support a genetic vulnerability for fronto-striatal 
functioning in schizophrenia  
 
The results found that patients with schizophrenia showed decreased activation in a region 
including the caudate and ACC during recognition, and those with increased negative 
symptoms showed an even greater reduction in this region. Therefore negative symptoms 
in schizophrenia may be associated with reduced activity in the caudate and ACC. 
 
6.6.3.5 Patients with bipolar disorder 
The current results demonstrated overactivation of a region including the caudate nucleus 
and ACC, extending to inferior frontal (VLPFC) and insula in patients with bipolar disorder 
compared to healthy controls during recognition. Patients with bipolar disorder also showed 
increased activation in the caudate and ACC compared to patients with schizophrenia. 





During recognition in the contrast examining bipolar disorder > schizophrenia, there was a 
positive correlation between PANSS positive symptom scores and right caudate activation 
in the bipolar group.  
 
6.6.3.6 Anterior limbic network 
It has been proposed that bipolar disorder arises from disruption in an anterior limbic 
network consisting of VLPFC areas with connections to limbic regions including the 
amygdala, insula and ACC (Strakowski, 2012, Strakowski et al., 2004). A pattern of 
overactivation in these regions has been consistently demonstrated in patients with bipolar 
disorder (Cerullo et al., 2009) and the current findings are in line with previous research. 
These regions are involved in emotion regulation and a dysfunction of this network results 
in a susceptibility to mood disruptions as evident in patients with bipolar disorder (Whalley 
et al., 2011). This hypothesis proposes that the overactivation in this brain network is 
persistent and leaves individuals at risk for mood and cognitive dysfunction, even during 
the euthymic state (Strakowski et al., 2004). 
 
Overactivation of emotion-processing regions including the ACC, thalamus and insula has 
also been found in individuals at high genetic risk for bipolar disorder (Whalley et al., 
2015c). This suggests that these abnormalities are not confounded by long-term illness or 
medication. In addition to functional deficits, structural abnormalities of the ACC have also 
been demonstrated, including increased size of this region in patients with bipolar disorder 
(Javadapour et al., 2007). 
 





The majority of existing research has employed emotional tasks in order to investigate 
emotional brain circuitry in bipolar disorder, however overactivation in such regions has 
been demonstrated using neutral stimuli (Strakowski et al., 2004, Gruber et al., 2010). The 
task used in the current experiment was a non-emotional paradigm and patients still 
demonstrated this pattern of overactivation, suggesting that patients may attach greater 
emotional valence to neutral stimuli, in comparison to healthy controls or patients with 
schizophrenia. 
 
Most studies investigating episodic memory in bipolar disorder have focused on verbal 
tasks however episodic memories are often stored as visual images (Conway, 2009), 
therefore the current experiment specifically targeted non-verbal encoding and recognition. 
In line with the current results, a recent study by Oertel-Knochel et al. (2014) found a 
disruption of primarily left fronto-temporal-parietal brain regions including ACC in 
patients with bipolar disorder during a non-verbal episodic memory task (Oertel-Knochel 
et al., 2014).  
 
6.6.3.7 Caudate  
The current findings also showed increased activation during recognition in the caudate 
nucleus in patients with bipolar disorder. Increasing evidence suggests that the 
neurobiology of bipolar disorder is associated with structural and functional abnormalities 
in the caudate (Shahana et al., 2011). Structural imaging studies generally show increased 
caudate volume in patients compared to controls (DelBello et al., 2004), however findings 
in the literature are contradictory. A recent study found that right caudate volume was 
reduced in bipolar subjects compared to healthy controls (Beyer et al., 2004), whereas 





patients with schizophrenia only show a modest volume reduction (Tayebani et al., 2014). 
There is also evidence of increased caudate volume in individuals at high risk for bipolar 
disorder, with these individuals showing comparable caudate size to patients (Hajek et al., 
2009). Another study of monozygotic twins found that the caudate was larger in both 
affected and unaffected twins of bipolar disorder compared to healthy comparison twins 
(Noga et al., 2001). 
 
Functional abnormalities in the caudate of patients with bipolar disorder have also been 
reported. In line with the current findings, previous research has found increased activity 
in the left caudate, associated with mania in bipolar disorder (Blumberg et al., 2000). 
Further functional imaging studies have also found increased caudate activity in patients 
during affective tasks (Chang et al., 2004, Wessa et al., 2007).  
 
The caudate receives projections from other structures including the ACC, amygdala and 
prefrontal regions including the DLPFC (Blumberg et al., 2000). The known structural 
connectivity between these regions suggests that increased activity occurs within the 
context of a prefrontal-striatal-thalamic network that is modulated by limbic structures and 
is central to emotional processing (Ong et al., 2012). Overall, the current results support 
the hypothesis that patients with bipolar disorder demonstrate dysfunction of the anterior 
limbic network that includes the ACC and caudate.  
 
The current findings showed that patients with bipolar disorder who had higher positive 
symptom scores on the PANSS demonstrated greater activation of the right caudate. 
Previous research in patients with bipolar disorder has found an association between 





increased caudate and ACC activation in bipolar mania (Blumberg et al., 2000, Whalley et 
al., 2009). A significant correlation in this region with mania scores on the YMRS was not 
found as might have been expected. It could be argued however that many of the positive 
items on the PANSS e.g. conceptual disorganization (loose associations, disorganized 
thinking), excitement (hyperactivity reflected in accelerated motor behaviour) and hostility, 
appear to overlap with measures of mania on the YMRS e.g. language/thought disorder 
(tangentiality), increased motor activity and irritability/disruptive behaviour, however this 
is only speculative.  
 
The current finding in the right caudate extended to the ACC. Positive symptoms have been 
associated with increased activation of the ACC (Assaf et al., 2006, Lahti et al., 2006) and 
significant activation in the ACC has been observed during auditory hallucinations 
(Silbersweig et al., 1995, Cleghorn et al., 1990). Decreased ACC volume has also been 
observed in patients and this has been correlated with positive symptom severity (Choi et 
al., 2005). Around 50% of patients with bipolar disorder experience psychotic symptoms 
at some point (Keck et al., 2003) and research has begun to explore the neurocognitive 
profiles of nonpsychotic and psychotic bipolar disorder. A recent study was able to 
distinguish between nonpsychotic and psychotic bipolar disorder by examining ventral 
ACC connectivity, concluding that patients with bipolar disorder with psychosis showed a 
more similar pattern of connectivity to patients with schizophrenia (Anticevic et al., 2014). 
 
The current findings suggest that patients with bipolar disorder show increased activation 
in a region encompassing the caudate and ACC during recognition, and those with 
psychotic symptoms show even greater activation in this region. Therefore psychotic 





symptoms in bipolar disorder may be associated with heightened activity in these regions. 
 
6.6.4 Limitations 
There are several limitations of the current findings. Unavoidably, the majority of patients 
were on medication at the time of scanning. As discussed in chapter 1, antipsychotic 
medications have been shown to affect the BOLD signal during performance of a variety 
of cognitive paradigms. Ideally drug free patients would have been recruited however these 
are rare, unrepresentative of the wider psychiatric population, and if unmedicated may not 
have been able to comply with experimental procedures, particularly the fMRI task. 
Therefore, antipsychotic medication status in the patient groups was noted and was 
converted into chlorpromazine equivalents, to compare different types of medication 
together. Medication effects were then explored by performing correlations between 
antipsychotic medication and any significant results between patients and controls. No 
significant medication effects were seen to impact on the main findings, however this 
cannot be entirely ruled out. Further to this, duration of illness was not recorded for the 
patients included in this study, and as discussed previously, this may have influenced the 
current results.  
 
Contrary to the hypothesis, the current results did not find between group differences in 
medial temporal lobe structures such as the hippocampus. Previous studies have shown the 
hippocampus is central to memory function and have reported differences in activation 
between patients with schizophrenia and bipolar disorder (Hall et al., 2010).  The task used 
in the current study had a relatively low cognitive demand and may not have elicited a 
substantial neural response in this region to evoke differences in hemodynamic response. 





The hippocampus is involved in several aspects of memory processing including relational 
binding (Stolz et al., 2012) and shows greater activation when individuals are required to 
encode multiple items and bind them to form a representative memory (Davachi and 
Wagner, 2002). The current task only involved one single visual input and did not require 
individuals to use relational binding, which may explain the lack of results in the 
hippocampal region. There are further limitations regarding the analysis and task used 
however these will be discussed in the final chapter of this thesis. 
 
6.6.5 Conclusion 
In conclusion, the episodic memory paradigm produced activation differences between 
patients with schizophrenia and bipolar disorder in the ACC and caudate during recognition 
that were evident despite similar behavioural performance. Correlations between positive 
and negative symptoms on the PANSS and activation in this region were also found. These 
findings add to previous research suggesting that there may be distinct neurobiological 
substrates associated with each disorder.  
 
Furthering the understanding of common and distinct pathophysiologies associated with 
schizophrenia and bipolar disorder may help to biologically classify psychiatric illness in 
the future, rather than relying on current diagnostic classification systems based on clinical 
characteristics such as DSM-5. Further to this, enhancing our understanding of the 
underlying biological causes of cognitive deficits in psychosis may also aid the 
development of treatment options including pharmacological agents or cognitive 
remediation.  
 


































































Chapter 7: Synthesis  
This chapter will provide an overall summary and discussion of the key results presented 
in this work. It will also discuss the implications of these findings, limitations and strengths 
of the experiment and analyses performed, and considerations for future research. 
 
7.1 Overall summary of findings  
The primary aim of the study described in this thesis was to investigate functional activation 
during an episodic memory paradigm in individuals with and without the DISC1 t(1;11) 
translocation, to examine the impact of this translocation. A parallel study was also 
performed to examine differences between controls and patients with schizophrenia or 
bipolar disorder. The recruitment of the patient and healthy control groups allowed the 
comparison of the effects of the t(1;11) translocation to the effects of a having a psychotic 
illness, while minimising key confounds. Four groups of participants, 19 family members 
(8 with the translocation, 11 without), 30 patients with schizophrenia, 11 patients with 
bipolar disorder and 40 healthy controls underwent a functional MRI encoding and 
recognition paradigm and provided useable data. 
 
During encoding of neutral scenes, family members with the translocation showed greater 
activation of the left posterior cingulate, right fusiform gyrus and right superior frontal 
gyrus compared to non-carriers. During recognition, carriers showed greater activation in 
prefrontal regions (DLPFC and VLPFC), the anterior cingulate, and temporal regions 
(fusiform gyrus, and superior temporal gyrus). For both contrasts, no regions were found 
to be more active in unaffected family members than in translocation carriers. There were 





no significant differences between the groups in terms of their performance on encoding 
and recognition conditions. 
 
Compared to healthy controls, patients with schizophrenia demonstrated increased 
activation during encoding in the inferior parietal lobe bilaterally, and decreased activation 
in a region encompassing the caudate nucleus and ACC during recognition. Patients with 
bipolar disorder showed no difference in activation compared to controls during encoding, 
and increased activation during recognition in a region encompassing the caudate and 
anterior cingulate, extending to the inferior frontal lobe and insula. There was also a 
significant difference between patients with schizophrenia and bipolar disorder during 
recognition, with bipolar disorder again showing increased activation in the caudate 
extending to the ACC. There were no differences between groups in terms of their episodic 
memory performance.  
 
7.2 Family studies and rare variants  
The segregation of the t(1;11) translocation with schizophrenia, bipolar disorder and MDD 
(St Clair et al., 1990) suggests that disruption of the DISC1 gene is likely to be a risk factor 
for major psychiatric illness. Studying the effects of this translocation can help to identify 
the disease pathways that are affected by DISC1 and inform how DISC1 mediates its effects 
on psychopathology through endophenotypes such as brain function.  
 
Single-family studies with multiply affected individuals are important for the study of 
genetically complex and common disorders such as schizophrenia and bipolar disorder, as 
they allow for the investigation of rare variants. DISC1 is a prime example of the ‘common 





disease; rare variant’ hypothesis. Rare variants have a large effect on underlying biology 
compared to common variants that have relatively weak impact but result in illness due to 
their cumulative presence. It is also plausible that variants with the largest effect sizes will 
be those that have important functional consequences (Cirulli and Goldstein, 2010). Rare, 
family-specific genetic variants may also have a particularly important role in elucidating 
the neurobiology of major psychiatric disorders, due to reduced genetic complexity within 
families and greater penetrance on endophenotypes such as brain function (Whalley et al., 
2015a). Recent findings from the Schizophrenia Working Group of the Psychiatric 
Genomics Consortium large scale GWAS found an overlap between genes affected by rare 
variants and more common loci (Ripke et al., 2014). These findings suggest that studies of 
rare genetic variants, even though specific to small groups, will be informative for illness 
more widely. 
 
A disadvantage of studying family-specific mutations is that findings may be specific to 
one family and thus lack generalisability to the disease itself. However, insights from rare 
cases and family studies have provided invaluable insights into other complex disorders 
such as Alzheimer’s disease (Bertram et al., 2010). A major incentive for studying risk 
factors for major mental illness is hopefully to identify and develop more effective 
treatment options. Studying rare variants such as DISC1 may help to identify disease 
pathways that may be viable drug targets to help alleviate the symptoms of psychiatric 
disorders.  
 





7.3 Evidence against DISC1 
Despite the evidence discussed for an association between DISC1 and schizophrenia, the 
role of this gene has recently been challenged (Sullivan, 2013, Farrell et al., 2015). There 
is conflicting evidence regarding the association of common variants in DISC1 with 
schizophrenia. For example, a recent meta-analysis using data collected from 10 candidate 
gene studies and three GWAS found no evidence that common variants at the DISC1 locus 
were associated with schizophrenia (Mathieson et al., 2012). SNPs in the DISC1 gene were 
also not highlighted in the latest psychiatric genomics consortium study (Ripke et al., 
2014). There are currently no results demonstrating genome-wide levels of significance for 
DISC1 and recent GWAS data has failed to find evidence of DISC1 for any major 
psychiatric disorder (Ripke et al., 2011, Sklar et al., 2011). GWAS help to identify 
susceptibility loci that are common in the general population, but exert only small risk 
effects. Individually these risk variants only account for a small proportion of the 
heritability of psychiatric disorders, with the remaining heritability likely to be accounted 
for by other genetic factors including rare variants. The GWAS approach is neither powered 
nor designed for the detection of rare risk alleles and this is the case even for variants with 
high penetrance and impact (Bertram et al., 2010). The failure of a gene to achieve the 
genome-wide significance threshold should not necessarily be interpreted as rejection of a 
genetic hypothesis, as it may still be genuinely contributing to the aetiology of the disease 
(Lee et al., 2012a). DISC1 has strong independent evidence from other sources including 
convergent biological support for its involvement in major psychiatric disorders (Chubb et 
al., 2008, Porteous et al., 2006), and is amongst the most strongly associated genes in 
schizophrenia and bipolar disorder. Studies have also highlighted the importance of DISC1 
at different stages of neurogenesis such as neuronal proliferation, differentiation and 





migration (Porteous et al., 2006, Mao et al., 2009, Brandon and Sawa, 2011, Porteous et 
al., 2011), reflecting the diversity of potential roles of DISC1 and its importance to overall 
brain function. 
 
7.4 SFMHS multimodal imaging results 
Recent yet-to-be published work by colleagues using data from the SFMHS have found 
differences between carriers and non-carriers using multimodal imaging. These findings 
include reduced left superior temporal sulcus cortical thickness and reduced right superior 
frontal gyrification index in carriers. Carriers also demonstrated reductions in glutamate 
concentrations in the right DLPFC. fMRI results from an n-back working memory task 
have found increased activation in the caudate nucleus in carriers (Lawrie et al., In Press). 
As with the current results, no differences have been found on measures of cognition, 
suggesting that the translocation may have a more measurable impact upon the intermediate 
neural systems level, supporting the endophenotype approach. 
 
The current results also found differences in the aforementioned regions, including 
increased activation in carriers the right DLPFC and right superior frontal gyrus. Findings 
in the current patient sample also reported abnormal activity in the caudate nucleus, as 
reported in carriers during the working memory task. It is reassuring that there is an overlap 
between the current fMRI results and the wider imaging findings from the SFMHS. 
Combined, these findings suggest that the t(1;11) translocation is associated with a range 
of clinical outcomes in the family, but may have a more homogeneous effect on imaging 
measures. However, the current fMRI results from this thesis only included carriers with 
affective psychopathology, whereas participants included in the wider SFMHS included 





carriers with a range of diagnoses. Therefore, a logical inference based on the different 
imaging modalities is not straightforward and warrants further investigation. 
 
7.5 Translocation carriers vs. patient sample 
In the current results, patients with bipolar disorder showed a pattern of overactivation in a 
region including the ACC and VLPFC during recognition when compared to healthy 
controls. Overactivation in these structures was also observed during recognition in 
translocation carriers. These findings are in line with previous research suggesting that 
bipolar disorder arises from disruption in a fronto-limbic network consisting of VLPFC 
areas with connections to limbic regions including the amygdala, insula and ACC 
(Strakowski, 2012, Strakowski et al., 2004). A pattern of overactivation in these regions 
was found in the current patient sample and has been consistently demonstrated in patients 
with bipolar disorder (Cerullo et al., 2009, Wessa et al., 2007, Chang et al., 2004). Several 
studies have also found abnormal connectivity within a fronto-limbic pathway that may be 
an imaging marker in patients with bipolar disorder (Anand et al., 2009, Chepenik et al., 
2010, Öngür et al., 2010, Chai et al., 2011). There is also evidence of hyperactivation of 
the VLPFC in bipolar disorder (Robinson et al., 2008, Blumberg et al., 2003b). It has been 
proposed that the overactivation in this brain network is persistent and leaves individuals 
at risk for mood and cognitive dysfunction, even during the euthymic state (Strakowski et 
al., 2004). 
 
In the current results, patients with schizophrenia showed reduced activation during 
memory recognition in a region encompassing the ACC and caudate, compared to both 
controls and patients with bipolar disorder. The current findings support previous studies 





suggesting overactivation of fronto-limbic and striatal structures including the ACC and 
caudate in bipolar disorder (Wessa et al., 2007), and a relative underactivation in 
schizophrenia (Koch et al., 2008). Therefore, family members with the translocation 
appeared to demonstrate a more similar pattern of overactivation during recognition to 
patients with bipolar disorder, compared to schizophrenia. This may reflect the fact that 
most diagnoses in the carriers were of an affective disorder rather than a schizophrenia-
related psychosis, and may be due to the presence of symptoms in the carriers rather than a 
direct effect of the translocation. Compared to recognition, there was no overlap in findings 
between family members and patients during the encoding phase of the task. It would also 
be of interest to understand the results in relation to depression, which was diagnosed in 4 
of the carriers (2 with recurrent and 2 with single episode depression), and in hindsight a 
comparison group of patients with depression would have been of interest to include. 
 
7.6 Overlap between schizophrenia and bipolar disorder 
Bipolar disorder and schizophrenia are historically considered two distinct disorders but 
convergent genetic, neuroimaging and clinical evidence indicates both overlap and 
discontinuity between them. Diagnostic classifications based on clinical presentation of 
symptoms, such as the DSM, enable reliable diagnosis but do not neatly align with 
neuroimaging and genetic evidence. Therefore, current diagnostic categories may not 
reflect the underlying pathophysiology of psychiatric disorders, and this may limit their 
ability to deliver novel therapeutic approaches (Insel et al., 2010). Functional neuroimaging 
offers a tool to explore the underlying neurobiological processes of these disorders in order 
to establish if there are illness-specific features, ultimately to inform diagnosis and 
treatment options.  





The neuroimaging literature that compares schizophrenia and bipolar disorder is extensive. 
Recent reviews of studies directly comparing both disorders using fMRI conclude that in 
tasks involving emotion, reward and memory, overactivation is generally seen in MTL 
structures or limbic regions in bipolar disorder compared to schizophrenia (Whalley et al., 
2012b, Strakowski, 2012). The current results in the patient groups are in line with these 
findings and suggest that there is evidence for differences between these disorders at the 
functional level during episodic memory recognition. Activation in a region including the 
caudate and ACC may distinguish between patients with schizophrenia and bipolar 
disorder, with lower activity seen in schizophrenia and enhanced activation in bipolar 
disorder. The ability to distinguish between schizophrenia and bipolar disorder using non-
invasive imaging techniques suggests that there are at least partly distinct mechanisms 
underlying the disorders, which ultimately may facilitate efforts to develop a neuroscience-
based approach to the classification of mental disorders (Hall et al., 2010). 
 
7.7 Episodic memory as an endophenotype 
Episodic memory deficits are evident in both schizophrenia and bipolar disorder, have been 
found in unaffected relatives of patients and individuals at high genetic risk (Christodoulou 
et al., 2012, Hill et al., 2008), and have been found to be moderately heritable and share 
substantial genetic overlap with schizophrenia (Owens et al., 2011). Therefore, episodic 
memory deficits have been suggested as a potential endophenotype for psychosis (Leavitt 
and Goldberg, 2009). 
 
Patients with schizophrenia and bipolar disorder show episodic memory related neural 
abnormalities in prefrontal and temporal regions (Ragland et al., 2009, Oertel-Knochel et 





al., 2014), which have also been demonstrated in unaffected relatives (Cannon et al., 2005), 
supporting a genetic basis for deficits in episodic memory (Leavitt and Goldberg, 2009). 
Studies examining the effects of common variants in DISC1 alleles suggest that variation 
at the DISC1 locus contributes to structural and functional changes across the brain, 
particularly in prefrontal and temporal regions (Duff et al., 2013, Callicott et al., 2005, 
Cannon et al., 2005, Thomson et al., 2013). Genetic studies have also shown that variation 
in DISC1 has an effect on the neural correlates of episodic memory in healthy subjects 
(Callicott et al., 2005, Di Giorgio et al., 2008). The current findings provide evidence to 
support a potential role for the DISC1 translocation on brain activations in prefrontal and 
temporal regions. 
 
Previous research suggests that episodic memory impairments may share a common 
mechanism with other cognitive domains such as working memory, language function, 
executive function, processing speed and attention (Barch and Ceaser, 2012). Research has 
found common neural activity during episodic memory recognition and working memory 
tasks, particularly in the DLPFC (Cabeza et al., 2002, Ranganath et al., 2003). The current 
results found an impact of the translocation on activation in the DLPFC during episodic 
memory recognition. Previous research has also found evidence of an effect of DISC1 
genotype on activity in the DLPFC during a working memory task, interpreting increased 
activity in risk allele carriers as cortical inefficiency (Brauns et al., 2011). These findings 
suggest that the function of a specific brain region should not be over specified. DISC1 
may impact upon DLPFC inefficiency, which may underlie several cognitive deficits 
including episodic memory and working memory, which are also reported in patients with 
both schizophrenia and bipolar disorder. 





7.8 Limitations  
7.8.1 Family members  
The current findings suggest that the DISC1 translocation has a measurable impact upon 
episodic memory-related activation. However, this finding should be considered with 
caution, as there are several confounding factors that may interfere with the interpretation 
of results.  
 
As outlined in chapter one, there is evidence that ageing is associated with impaired 
memory functioning using functional brain imaging techniques. The age of the 
translocation carrier group (mean age of 52) was significantly higher than the non-carrier 
group (mean age of 32) and was therefore entered as a covariate in the second-level 
analyses. It was originally planned to run an additional post-hoc analysis based on a 
subgroup of participants, if there was a significant difference in terms of age between the 
groups. This would be done by removing a group of significantly younger individuals in 
the non-carrier group (seven individuals aged 17-23), as has been performed in other 
studies examining this family (Whalley et al., 2015). However, the non-carrier group who 
successfully completed the fMRI task was not large enough, and this would have left only 
four individuals in the analysis. Therefore, although age was controlled for in this analysis, 
it is still possible that the current findings are confounded by the effects of age. For the 
comparison of patients versus controls, the groups were not significantly different in terms 
of age. 
 
A major limitation of the family member results, and perhaps the most important to 
highlight, is the sample of carriers who were recruited. All the translocation carriers that 





took part had a psychiatric diagnosis of an affective nature ranging from MDD to 
cyclothymia, rather than a psychotic illness such as schizophrenia or bipolar disorder. In 
total 12 family members with the translocation took part in the wider SFMHS, however 
four did not complete the fMRI section of the study for various reasons. It is unfortunate 
that the carriers who did not manage to complete the fMRI task all had a diagnosis of either 
schizophrenia or bipolar disorder. It is possible that these four individuals had worse 
symptomatology that interfered with their ability to take part in the fMRI part of the study. 
However, from a comparison of the carriers who took part vs. those who did not (results 
not reported in thesis), there was no significant difference in age, gender, IQ or any clinical 
measures (all p > 0.05).  
 
It was originally planned to recruit and compare individuals with and without psychosis 
within in the carrier group, to compare the effect of having a psychotic disorder in addition 
to the translocation. However, this was not possible due to the sample of carriers that took 
part. Instead imaging findings were correlated to clinical measures including positive 
symptoms on the PANSS. There was no association between psychotic symptoms and peak 
activation in any region during encoding or recognition in the carrier group. Further to this, 
there were no significant correlations between measures of depression on the HDRS, in the 
carriers. This supports the idea that the results are due to the effect of the translocation, 
rather than having psychotic or depressive symptoms. However, these correlations should 
be interpreted with caution due to small group numbers and the presence of outliers, in 
particular one individual in the carrier group who scored substantially higher on all clinical 
measures. Outliers were not removed from the analysis due to small numbers and 
nonparametric statistics were performed to account for this where possible. Therefore, 





although symptomatology has been taken into consideration, it is still possible that the 
current between group imaging findings are due to the presence of symptoms or affective 
diagnoses in the carrier group, rather than a direct effect of the translocation. 
 
The clinical status and age of the carrier group, in addition to the low number recruited, 
was unavoidable due to the nature of the family being studied, as cases occur infrequently 
and are often difficult to recruit. The unique nature of the family being studied and that no 
research (until recently as part of the SFMHS) has previously investigated the effect of the 
t(1;11) translocation on neuroimaging measures, arguably outweighs such methodological 
limitations. The current findings of this work are novel and provide evidence to suggest 
that the translocation does impact on neuroimaging measures, however it is imperative to 
interpret the results in light of these potential confounding factors.  
 
7.8.2 Patients and controls 
The patient groups recruited to the current study included individuals with schizophrenia 
and bipolar disorder, however it is noted that all family members with the translocation had 
diagnoses of major depressive disorder, as well as other psychiatric disorders including 
cyclothymia and conduct disorder. Therefore, the patient groups recruited might not have 
been the best mix of psychiatric diagnoses. In hindsight it would have been beneficial to 
include a sample of patients with major depressive disorder in addition to schizophrenia 
and bipolar disorder.  
 
In the past, the majority of research into DISC1 has focused on schizophrenia. After the 
initial identification of the DISC1 gene in 2000, subsequent genetic linkage and association 





studies provided evidence to suggest that DISC1 may be implicated in both schizophrenia 
and bipolar disorder (Ekelund et al., 2000, Hennah et al., 2003, Thomson et al., 2005). 
However, there was limited research to examine the association between the DISC1 gene 
and major depression, despite there being more patients with depression than those with 
schizophrenia in the original Scottish family (Hashimoto et al., 2006). Therefore, there is 
substantially more evidence to support a link between DISC1 and schizophrenia, which 
explains the reason for the focus on patients with schizophrenia in the current study. 
However, more recently there has been increasing evidence to support an association 
between MDD and variation in the DISC1 locus, for example the Ser704Cys SNP 
(Hashimoto et al., 2006), suggesting DISC1 is also implicated in the biology of major 
depression.  
 
DISC1 research has been criticized by some, suggesting that linkage analyses are more 
consistent with a mood disorder phenotype (Sullivan et al., 2013), and ultimately 
suggesting that naming this gene ‘disrupted in schizophrenia’ is prone to misinterpretation. 
Some researchers have also highlighted that the spectrum of psychiatric disorders and 
clinical heterogeneity seen in the wider family is of concern and makes results interpretable. 
However, this is what is key to this unique family. Clinically all members of the family 
with the translocation that took part in the wider SFMHS have a mental health diagnosis 
that ranged from chronic schizophrenia to cyclothymia. This phenotypic pleiotropy of 
DISC1 is evident in the wider DISC1 family (St Clair et al., 1990). The spectrum of 
diagnoses seen in this family reflects the genetic and biological overlap between different 
DSM-defined disorders and is consistent with accumulating GWAS evidence for shared 
genetic liability (Smoller et al., 2013). The presence of different diagnoses in the family is 





also consistent with estimates of co-heritability from GWAS research, for example 
schizophrenia and bipolar disorder (0.68), or schizophrenia and MDD (0.43) (Lee et al., 
2013). Further, many neuroimaging abnormalities in specific brain regions and during 
various cognitive tasks have been found not only in one particular disorder such as 
schizophrenia but also in a wide range of diagnoses including bipolar disorder, depression 
and even autism. Therefore, studying DISC1 may help to inform us not only about a single 
disorder such as schizophrenia but also a wider range of potentially overlapping psychiatric 
conditions. Ultimately, DISC1 may not be a specific genetic risk factor for disorders that 
are based on DSM classifications, but instead may confer a risk at the endophenotype level 
that underlies several major psychiatric disorders. The wide spectrum of diagnoses in the 
family may be due to additional genetic or non-genetic factors, such as shared 
environmental influences, which are currently under investigation.  
 
7.8.3 Other limitations 
Retrospectively it is acknowledged that a power calculation should have been performed 
to determine the appropriate sample size for the control and patient sample. For the family 
member comparison a power calculation was not appropriate due to the nature of the 
sample being studied, and therefore as many family members as possible were recruited. It 
is highly recommended to perform a power calculation when designing a research study as 
they allow researchers to calculate the minimum number of subjects required to obtain the 
desired statistical power, which is usually 80% or more. Power calculations allow 
researchers to optimise the cost of an fMRI experiment. They prevent wasting time and 
money on studies that are underpowered to detect a true effect, and avoid recruiting too 





many participants when sufficient power would have been available with a lower number 
(Durnez et al., 2016). 
 
It is relatively simple to perform a power computation for a single, univariate response, 
however it is substantially more complex to determine power for an fMRI study, as several 
parameters must be specified including between and within subject variance, 1st and 2nd 
level design and the size of the hypothesized effect (Durnez et al., 2016). Many of the 
parameters required for power computation need to be estimated based on pilot data, 
however many research studies do not have the funds or resources to generate data for a 
power calculation. Therefore, many published fMRI studies do not present power 
calculations and it is argued by some that much neuroscience research suffers from low 
power as a result.  
 
7.8.4 Strengths and limitations of the task 
The fMRI paradigm used to measure episodic memory has several limitations. For example 
it was a blocked design, which does not allow for the distinction between neural activity 
for correct and incorrect responses during the recognition phase. Examination using a more 
temporally sensitive measure, such as an event related design, would allow for this. 
However, the current block design task was chosen to improve power with our anticipated 
small sample size in the family member groups. This task was also selected as it has been 
used previously to investigate the effect of genetic variation on functional activation and 
has shown to be a reliable activator of the hippocampus, upon which the translocation was 
hypothesised to have an impact. 
 





A further limitation of this task is that the interpretation of the recognition phase is 
particularly complex because it included a mixture of both encoding (new scenes) and 
recognition (old scenes) processes, likely to engage encoding-related activity in addition to 
recognition mechanisms. Passive rest was used as a control condition in the current task, 
which may not offer an optimal baseline condition as previous research has found elevated 
activity of the hippocampus during rest (Di Giorgio et al., 2008). This also may have 
contributed to the lack of findings in the hippocampus.  
 
The memory task used was relatively easy and required low cognitive demand as evident 
by the high performance accuracy seen in all participants, and therefore may not elicit 
BOLD response differences sufficient enough to reach our statistical threshold. Previous 
studies have demonstrated that the effect of genetic variants on functional activation is more 
evident at the highest cognitive load in parametric tasks (Bertolino et al., 2004, Blasi and 
Bertolino, 2006, Egan et al., 2001). These factors together may have significantly 
contributed to the subtlety of some of the differences between the groups. However, the 
relative ease of the current task ensured that all subjects could perform the task adequately 
to be included in analysis. A further strength is that task performance was balanced across 
groups, therefore between group differences in activation are unlikely to be attributed to 
differences in performance. 
 
Furthermore the paradigm used in this study was an incidental memory task, as participants 
were not explicitly instructed to memorize each scene for later recognition. Incidental 
encoding has been associated with substantially fewer differences between controls and 
patients, compared to intentional encoding. Bonner-Jackson et al. (2008) found that use of 





an incidental encoding strategy e.g. making living/non-living judgments, improved 
recognition in patients and resulted in a more similar pattern of activation to that of controls 
(Bonner-Jackson et al., 2008). However, use of an incidental memory task hopefully 
represents a more realistic and ecologically valid representation of everyday memory 
function. 
 
7.9 Future analysis  
Polygenic risk scores had not been calculated for the sample of healthy controls and patients 
included within this thesis at the time of writing, and therefore could not be investigated. 
Future analysis is planned to examine PRS within these groups to investigate the effect of 
cumulative genetic risk on episodic memory-related activation in controls and patients with 
schizophrenia and bipolar disorder.  
 
Future analysis could also examine a measure of cross-disorder polygenic risk, based on 
the additive effects of genetic susceptibility to a range of psychiatric disorders. This is in 
order to reflect the range of diagnoses present in the translocation carriers. A cross-disorder 
measure of polygenic risk is likely to account for a greater proportion of overall risk 
compared to PRS for individual disorders (Smoller et al., 2013). A recent study by Whalley 
et al. (2015) used this technique to investigate the impact of cumulative genetic risk for five 
major psychiatric disorders on brain activation during a language-based executive task 
(Whalley et al., 2015b). This study found that increased cross-disorder PRS was associated 
with increased frontal activation in individuals without a family history of psychiatric 
illness.  
 





7.9.1 Connectivity of brain networks 
The current findings in the family demonstrate a more distributed network of brain regions 
during recognition than during encoding. Translocation carriers showed increased 
activation in frontal, limbic, temporal and cerebellar regions during recognition of scenes. 
In future analyses it would be of interest to investigate the effect of the translocation on 
functional or effective connectivity of brain networks, and compare findings to networks 
disrupted in psychiatric disorders.  
 
Functional connectivity is used to examine statistical patterns in fMRI data whereas 
effective connectivity uses a causal model to investigate how regions interact (Goldenberg 
and Galván, 2015). There are several different methods to explore connectivity using fMRI 
data including psychophysiological interactions, independent component analysis, and 
dynamic causal modelling (DCM). Specifically, DCM offers a tool to explore effective 
connectivity by creating a neuronal model of interacting cortical regions by treating the 
brain as a nonlinear dynamic system (Friston et al., 2003). DCM is not however an 
exploratory method and requires specific priori hypotheses. This analysis would be of 
interest for future study.  
 
Additional future analyses could include a multimodal approach to examine the current 
fMRI results with structural and functional data from the SFMHS, in order to investigate 
whether there is an overlap between different imaging modalities. For example, relating the 
current fMRI findings to magnetic resonance spectroscopy data, to investigate glutamate 
concentrations in regions of interest e.g. the DLPFC (results from the SFMHS show that 
carriers have a reduction in glutamate concentrations in the right DLPFC). This may offer 





a potential neurochemical explanation of the current results. Glutamatergic disruption has 
been implicated in schizophrenia and mood disorders, and research has suggested that 
genetic risk associated with alterations in glutamatergic function may be implicated in the 
pathophysiological pathways of major psychiatric disorders (Coyle, 2006, Yüksel and 
Öngür, 2010, Hall et al., 2009). 
 
7.9.2 Connectivity and DISC1 
Few studies have investigated the effect of DISC1 on functional connectivity. The effects 
of DISC1 on brain connectivity, in networks that have been shown to be implicated in 
different psychiatric disorders, are therefore largely unknown. A recent study by Lui et al. 
(2013) used resting-state fMRI data to examine the effect of the DISC1 Ser704Cys 
polymorphism on functional connectivity of brain networks (Liu et al., 2013a). They found 
an effect of DISC1 on the thalamic-prefrontal network, specifically that Cys carriers 
showed increased functional connectivity and significantly decreased thalamic-prefrontal 
anatomical connectivity.  
 
Another study found evidence of an association between six DISC1 SNPs and connectivity 
between the right precuneus and inferior frontal gyrus, during resting state activity (Gong 
et al., 2014). As previously discussed DISC1 interacts with other genetic variants, and 
evidence has found an effect of DISC1 and interacting SNPs on connectivity. Callicott et 
al. (2013) found that individuals homozygous for risk alleles in both DISC1 and SLC12A2 
resulted in reduced connectivity between the hippocampus and VLPFC during an encoding 
memory paradigm (Callicott et al., 2013). 
 





Non-human studies have also investigated connectivity, for example transgenic mice 
expressing a truncated DISC1 gene demonstrated altered connectivity in hippocampal-PFC 
and thalamus-PFC connectivity, both of which have been reported in psychiatric illness 
(Dawson et al., 2015). Using functional connectivity may help to provide greater insight 
into the neural effects of variation in the DISC1 gene and the link to psychiatric disorders.  
 
A recent study using DTI data from the SFMHS found structural connectivity differences 
in prefrontal association fibers in translocation carriers, including those connecting the 
frontal cortex with temporal and limbic regions. These findings were also replicated in a 
comparison between patients with psychosis and healthy controls and are consistent with 
evidence of abnormal fronto-temporal connectivity in schizophrenia, bipolar disorder and 
unaffected relatives (Sprooten et al., 2011b, Lawrie et al., 2002, Maniega et al., 2008). 
Disconnection between these regions has been hypothesised to underlie cognitive 
impairments in psychosis. Studies examining the effects of common variants in DISC1 
alleles suggest that variation at the DISC1 locus contributes to structural and functional 
changes across the brain, particularly in prefrontal and temporal regions (Callicott et al., 
2005, Cannon et al., 2005, Duff et al., 2013). The current results in this work found an 
effect of the translocation in prefrontal and temporal regions during both encoding and 
recognition, supporting evidence that DISC1 impacts upon these regions. 
 
7.10 Conclusion  
Studying the impact of rare genetic variants offers a powerful method to advance our 
understanding of the pathophysiology of psychiatric disorders. The current findings are 
novel and provide insight into the potential effect of the DISC1 t(1;11) translocation in 





episodic memory related brain activation. Brain regions that were over activated in 
translocation carriers have been shown to be involved in memory encoding and recognition, 
and are known to be affected in patients with major psychiatric disorders, such as 
schizophrenia and bipolar disorder, and their unaffected relatives. Family members with 
the translocation demonstrated a more similar pattern of activation during recognition to 
patients with bipolar disorder compared to schizophrenia, perhaps due to the fact that most 
diagnoses in the carriers were of an affective nature rather than a schizophrenia-related 
psychosis. Based on these findings it can be argued that the translocation has an influence 
on brain activations in areas associated with episodic memory processes, however these 
results must be considered in light of potential confounding factors as discussed throughout. 
Nonetheless, these findings begin to provide a better understanding of the neural effects of 
the t(1;11) translocation, and highlight the significance of rare but biologically informative 
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Appendix I: Genotyping methods 
Genotypes of common nonsynonymous variants in DISC1 were extracted from whole 
genome sequencing data. Whole genome sequencing was performed by W. Richard 
McCombie at the The Stanley Institute for Cognitive Genomics, Cold Spring Harbor 
Genomics Centre under an NIH grant awarded to W. Richard McCombie and David J. 
Porteous (CGE, IGMM, University of Edinburgh; NIH award R01MH102088).  
Briefly, whole genome sequencing of whole blood-derived DNA, or lymphoblastoid cell 
line-derived DNA, was performed on an Illumina HiSeq 2000 at an average read depth of 
>30x. Sequence reads from the Illumina HiSeq 2000 runs were aligned to human genome 
assembly hg19 using the BWA aligner (Li et al., 2009), allowing 2 mismatches in the 30-
base seed. Alignments were then paired, imported to binary (bam) format, sorted and 
indexed using SAMtools. Picard was then used to fix any mate pair information altered by 
the sorting. Bamtools (Barnett et al., 2011) was used to filter alignments to retain only 
properly paired reads (reads aligned with appropriate insert size and orientation). PCR 
duplicates were removed using Picard. Bamtools was then used to select alignments with a 
minimum mapping quality score of 20. Target coverage for each NimbleGen exome capture 
was assessed using Picard’s HSmetrics utility, and both depth and breadth of coverage were 
reviewed for each sample. The Genome Analysis Toolkit (Depristo et al., 2011) GATK was 
used for local read realignment around indels, and for base quality score recalibration using 
corrections for base position within the Illumina read, for sequence context, and for 
platform-reported quality. Variants were filtered for a minimum confidence score of 30, 
and minimum mapping quality of 40. Additional filters were applied for base quality score, 
strand bias and homopolymer stretches. SNP clusters (>3 SNPs per 10 bp window) were 
excluded. SNPs falling within called indel regions were also masked. 
Genotypes were checked using Merlin (Abecassis et al., 2002) to identify errors in 
Mendelian segregation. Pedigree relationships were verified between samples by 
calculation of identity by state matrices between all individuals using a linkage 
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Appendix II: Published literature review 
Literature review contained within this thesis (chapter 2). Permission to include this article 
has been sought by the co-authors.  
 
 
